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Abstract 
Phenotypic variation with a genetic basis is the raw material for natural selection and 
evolution. While it is created by genotypic change, phenotypes are also to some extent 
robust to genotypic perturbations. Such robustness exists on multiple levels of 
biological organization. To understand the origins of phenotypic variation with a basis 
in genetic change, one needs to understand how genotypic changes map to phenotypic 
changes. In this dissertation I study phenotypic variation and robustness on various 
levels of biological organizations. I ask how genotypic properties of synthetic 
metabolisms, such as network size and number of utilizable carbon sources map to 
metabolic phenotypes, that is, biomass synthesis rates. I describe the trade-offs 
between these properties quantitatively and show that they can explain most of the 
variation in synthesis rates of a metabolism. The observations I make are also relevant 
for synthetic metabolism design, which aims at large-scale, fast, and efficient 
synthesis of pharmaceuticals, chemical reagents, and biofuels. In a second project, I 
ask to what extent physicochemical changes in amino acid properties or in protein 
folding caused by mistranslation affect the codon choice of organisms. I find evidence 
that selection has increased the incidence of robust codons for ligand-binding amino 
acids, which suggests that it can affect the robustness of very small units of biological 
organization. A third project focuses on how tandem repeat instability relates to gene 
expression divergence in primates. I observe that genes with tandem repeats in gene 
regulatory regions are associated with high expression divergence. Hence, tandem 
repeats may contribute substantially to gene expression evolution in primates. Since 
tandem repeat instability is a hallmark of colorectal tumors, the final project compares 
phenotypic consequences of tandem repeat instability in gene promoters of tumor and 
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normal tissues. Repeat instability is enhanced in tumors compared to healthy tissues. 
Those genes with repeat instability are significantly overexpressed. These findings 
suggest an important role for tandem repeat instability in the differential gene 
expression observed for colorectal tumors.  
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Zusammenfassung der Dissertation 
Phänotypische Variation verursacht durch genetische Variation liefert die Grundlage 
für die natürliche Selektion und die Evolution. Und obwohl genotypische 
Veränderungen zu neuen Phänotypen führen können, sind bestehende Phänotypen in 
gewissem Umfang auch robust gegenüber solchen genotypischen Störungen. Diese 
Robustheit zeigt sich auf verschiedenen Ebenen der biologischen Organisation eines 
Organismus. Um den Zusammenhang zwischen phänotypischer und genetischer 
Variation zu begreifen, muss man insbesondere verstehen, wie genotypische 
Veränderungen sich auf den Phänotyp auswirken. In dieser Dissertation untersuche 
ich die phänotypische Variation und Robustheit auf verschiedenen Ebenen der 
biologischen Organisation eines Organismus. Ich frage danach, wie genotypische 
Eigenschaften von synthetischen Stoffwechseln, wie zum Beispiel Netzwerkgröße 
und Anzahl nutzbarer Kohlenstoffquellen, sich auf metabolische Phänotypen 
auswirken, beispielsweise auf die die Syntheseraten von Biomasse. Ich beschreibe die 
Kompromisse zwischen diesen sich teilweise widersprechenden genotypischen 
Eigenschaften, und zeige, dass dadurch der grösste Teil der Variation von 
Syntheseraten des Stoffwechsels erklärt werden kann. Die Beobachtungen, die ich 
mache, sind auch für das Design künstlicher Stoffwechsel von Belang, wo es um die 
schnelle und verlässliche Synthese im grossen Umfang von Pharmazeutika, 
chemischen Reagenzien, und Biokraftstoffen geht. In einem zweiten Projekt 
untersuche ich, inwieweit physikalisch-chemische Veränderungen der Eigenschaften 
von Aminosäuren oder Übersetzungsfehler bei der Proteinfaltung die Auswahl von 
Codons beeinflussen. Ich finde Hinweise darauf, dass durch natürliche Selektion 
vermehrt robuste Codons für Aminosäuren verwendet werden, welche Liganden 
binden. Dies bedeutet, dass natürliche Selektion die Stabilität sehr kleiner Einheiten 
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der biologischen Organisation erhöhen kann. In einem dritten Projekt konzentriere ich 
mich auf die Instabilität von Tandem-Repeats und untersuche deren Zusammenhang 
mit den Unterschieden in der Genexpression bei Primaten. Ich zeige, dass Gene mit 
Tandem-Repeats in genregulatorischen Regionen mit grossen Unterschieden in der 
Genexpression verbunden sind. Tandem-Repeats könnten also zur Evolution der 
Genexpression bei Primaten einen wesentlichen Beitrag leisten. Da die Instabilität 
von Tandem-Repeats ein Kennzeichen kolorektaler Tumore ist, vergleiche ich im 
letzten Projekt phänotypische Folgen dieser Instabilität in Gen-Promotoren von 
Tumorgeweben und von gesunden Geweben. Die Instabilität von Tandem-Repeats ist 
in Tumorgeweben erhöht. Jene Gene, deren Instabilität in den Tandem-Repeats 
deutlich grösser ist werden überexprimiert. Diese Ergebnisse deuten darauf hin, dass 
die Instabilität von Tandem-Repeats eine wichtige Rolle in der Differenzierung der 
Genexpression spielt, welche in kolorektalen Tumoren beobachtet werden kann. 
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1. General Introduction 
The genotype holds an organism's full complement of hereditary information (Tautz 
and Schmid 1998), whereas the phenotype comprises its traits. Metabolic activities, 
gene expression, protein folding, morphology, and behavior are examples of 
phenotypes. The distinction between genotype and phenotype is fundamental in 
evolutionary biology. The phenotype determines an organism's chances of survival 
and reproductive output; it is the raw material for natural selection and evolution (Bull 
1987; Mitchell-Olds et al. 2007; Stranger et al. 2007a). The inheritance of the 
phenotype occurs mostly as a secondary consequence of the inheritance of genetic 
material (Benfey and Mitchell-Olds 2008; Frazer et al. 2009; Lehner 2013).  
Phenotypes of biological systems are to some extent robust to genotypic changes, that 
is they remain unchanged after a perturbation. Such robustness exists on multiple 
levels of biological organization. Therefore, to understand the origins of phenotypic 
variation with a basis in genetic change, one needs to understand first the fundamental 
properties of robustness, and then explore how genotypic changes map to phenotypic 
changes.  
1.1. Robustness 
Biological systems are continually subject to mutation and environmental variation. A 
biological system is robust if it continues to function in the face of these perturbations 
(Kitano 2004). Proteins can tolerate many amino acid changes; metabolic pathways 
continue to sustain life even after removal of important enzymes; drastic changes in 
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embryonic development can lead to an essentially unchanged adult organisms (Kitano 
2004; Wagner 2005a). The mechanisms underlying robustness are diverse, ranging 
from thermodynamic stability at the protein level to behavior at the organismal level. I 
will give some examples of robust systems in various contexts, and then describe 
evolutionary origins, and mechanistic causes of robustness. I will also list some 
approaches to study robustness, particularly metabolic models, as the analyses in 
Chapter 2 are based on this approach. I will also describe various strategies biological 
systems apply for achieving a robust translational machinery, because Chapter 3 of 
this dissertation deals with selection for robust translation.  
1.1.1. Examples of robustness to various perturbations 
Robustness to genetic perturbations 
A key example of robustness to genetic perturbations can be found in proteins. 
Proteins can be quite tolerant of genetic mutations. Through selection this can lead to 
highly diverse sequences that fold into similar structures and perform conserved 
biochemical functions. For example, Huang and collaborators (Huang et al. 1996) 
showed that point mutations in 84 percent of the amino acids of an E. coli beta 
lactamase do not have any severe effect on the protein function. In human 3-
methyladenine DNA glycosylase, 66 per cent of single amino acid substitutions do 
not disrupt function (Guo et al. 2004). Even in the highly conserved catalytic core 
regions of proteins, approximately one-third of amino acid sites can tolerate 
substitutions (Guo et al. 2004; Materon and Palzkill 2001). 
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Robustness to non-genetic perturbations 
Non-genetic perturbations comprise two components. The first one is noise, random 
variability of quantities important to cell functions (Pilpel 2011). For example, cells 
that are genetically identical, may occur within the same tissue can have different 
expression levels of proteins, different sizes, and structures (Ladbury and Arold 2012; 
Stewart-Ornstein et al. 2012). Noise, in general, can be an obstacle in tuning a system 
to the “fittest” state and maintaining it there (Pilpel 2011). Therefore, a phenotypic 
trait that is associated with fitness is expected to be to some extent robust against such 
stochasticity. For instance, developmental gene expression is extremely similar in a 
given cell type from one individual to another. Examples include Hox genes, which 
are responsible for anterio-posterior positioning that determines which cells will form 
which body structures, such as legs or antennas in the fruit fly Drosophila (Pearson et 
al. 2005b). Several studies demonstrated robust expression in essential genes 
compared to non-essential ones (Newman et al. 2006), in dosage-sensitive genes 
(Batada and Hurst 2007), and in genes that produce a strong growth defect when 
deleted compared to those producing a weak growth defect (Batada and Hurst 2007).  
The second component of non-genetic perturbations is environmental change, 
including change in temperature, nutrient, oxygen supply, water availability and soil 
conditions. A recent study (Oliveira et al. 2014) revealed a striking example of 
robustness against environmental perturbations in Drosophila development. Oliveira 
and colleagues showed that expression of tissue patterning genes always aligned with 
certain milestones of development, such as moulting and pupariation even if 
developmental times were altered through temperature or hormone synthesis. Another 
example involves microRNA, small non-coding RNA’s which function in gene 
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expression regulation. A highly conserved microRNA, miR-7, functions in several 
feedback and feedforward loops of animal developmental regulatory networks to 
buffer them against perturbations (Li et al. 2009b).  
1.1.2. Evolutionary scenarios for the origins of robustness 
The adaptationist scenario 
Robustness can have three evolutionary origins. One of them is that robustness can be 
an adaptation. Such adaptive robustness evolved primarily to ameliorate the 
detrimental effects of genetic mutations, of environmental change, or of both (Fisher 
1928). Because almost all phenotypic variation represents a deviation from the 
optimum for a well-adapted trait, any mechanism that limits phenotypic variation 
should be favored by natural selection. A compelling example comes from adaptation 
of wild yeast strains to oxygen-limited environments (Fidalgo et al. 2006). The yeast 
gene FLO11 belongs to a family of genes that encode cell surface adhesion molecules. 
At low oxygen levels, a tandem repeat sequence in this gene changes its copy number, 
resulting in a serine- and threonine-rich protein, hence causing the cell surface to 
become more hydrophobic. The more hydrophobic cell surface helps yeast cells attach 
to each other and form a biofilm at the air-liquid interface, which provides them the 
oxygen level they need for survival. Another example can be found in RNA enzymes. 
Hayden and colleagues (2011) showed that RNA enzymes with cryptic variation, that 
is, populations exposed to several rounds of mutagenesis while keeping their native 
functions, adapt more rapidly to a new substrate compared to RNA enzyme 
populations without cryptic variation. 
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The congruent scenario 
The conditions under which genetic perturbations can cause an increase in robustness 
are very restrictive. They require large populations or high mutation rates (Wagner, 
2005). Because environmental perturbations are more frequent and can have high 
impact on fitness, they can drive the evolution of environmental robustness. Wagner 
and colleagues (1997) suggested that genetic robustness can emerge as a by-product 
of selection for environmental robustness. In this case the two forms of robustness are 
said to be congruent. Examples of correlated genetic and environmental robustness 
provide evidence for this suggestion. In a striking example, Ancel and Fontana (2000) 
showed that RNA structures that are robust against thermodynamic perturbations are 
also robust against mutational perturbations. Further support comes from studies of 
heat shock proteins, such as Hsp90 and GroEL. These proteins are thought to have 
evolved to protect organisms from environmental perturbations, but they are found to 
buffer also against genetic perturbations in Drosophila (Rutherford and Lindquist 
1998), plants (Queitsch et al. 2002), and bacteria (Fares et al. 2002). 
1.1.3. Mechanistic causes of robustness  
Redundancy and degeneracy (also known as distributed robustness) are two basic and 
prevalent principles that play an important role in achieving robustness in biological 
systems (de Visser et al. 2003).  
 Redundancy 
Redundancy refers to the coexistence of components with identical functionality such 
as gene duplicates. Loss of function in one duplicate gene can be compensated by the 
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other copy (Conant and Wagner 2004; Gu et al. 2003). Moreover, the more similar 
two duplicates are, the less severe may be the effect of deleting one of them (Conant 
and Wagner 2004; Gu et al. 2003). A remarkable example of how redundancy causes 
robustness involves three thiamin pyrophosphokinase genes from yeast. All of them 
encode catalytic subunits of a key protein kinase in cell signaling. Any two of the 
three genes are dispensable for cell growth (Toda et al. 1987). Kafri and colleagues 
(2005) provided a mechanistic explanation for such robustness, in which they showed 
that more essential duplicate genes have functions more similar to each other, and that 
null-deletion of one copy is often compensated by overexpression of another copy. 
 Degeneracy 
Eliminating duplicates of a gene often causes no severe phenotypic effects, yet 
thousands of genes whose deletion has no detectable effect are single-copy genes. In 
line with this, Wagner (2005a) showed that interactions among unrelated genes may 
be a major cause for mutational robustness. This type of robustness, which emerges 
through the actions of multiple dissimilar parts, is also called distributed robustness. 
Specifically, gene knockout experiments and computational work (Edwards and 
Palsson 2000a; Pál et al. 2006; Segrè et al. 2002) show that in any one environment, 
many individual reactions of a metabolic network, even reactions in the most central 
parts of metabolism, such as glycolysis or the citric acid cycle are dispensable. The 
reason lies in the distributed nature of metabolic systems, where several alternative 
routes may exist around any blocked pathway. For example, eliminating the first 
reaction of the pentose phosphate shunt in E. coli metabolism has a negligible effect 
on cell growth, yet it causes large compensatory flux changes elsewhere in 
metabolism, especially in glycolysis pathway (Edwards and Palsson 1999). In 
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agreement with this finding, Sauer (2006) showed that these two distinct pathways, 
glycolysis and the pentose phosphate pathway, can substitute for each other in glucose 
metabolism. Such alternative metabolic routes can make metabolic networks highly 
robust to mutations, and ensure that a network continues to produce biosynthetic 
building blocks and energy carriers. 
1.1.4. How to study robustness?  
 Perturbation Experiments 
Empirical evidence for robustness can be gained in multiple ways. The most widely 
used approach relies on perturbation experiments (Masel and Siegal 2009). In this 
approach, one perturbs a part of a biological system (a gene), a trait (wing shape) or a 
capability (glucose synthesis) through mutations. Environmental perturbations in such 
experiments involve exposure to heat shock (Waddington 1953), mutagenizing agents 
like ether (Waddington, 1956), or stress conditions such as high salinity (Waddington, 
1959). Genetic perturbations include point mutations, loss-of-function or gain-of-
function mutations, differential gene regulation through small interfering RNA in key 
developmental genes, or in other genes of interest (Masel and Siegal 2009). The less a 
feature’s properties change in the face of perturbation, the more robust it is.  
Modeling approach 
Assessing a system’s robustness through perturbation experiments requires many 
perturbations and subsequent measurements of system properties. This problem is 
partly alleviated by modeling of biological systems, using both analytical and 
computational approaches (Blais and Dynlacht 2005; Edwards and Palsson 2000a; 
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Oberhardt et al. 2009; Price et al. 2002). Such models can provide accurate 
predictions about a system’s robustness, even if systematic perturbations are not 
feasible.  
Gene Regulatory Networks. Models of gene regulatory networks encapsulate 
interactions between a gene/protein and its regulators (such as proteins, transcription 
factors, and mRNA). Garg and colleagues (2009) could estimate the robustness of cell 
differentiation networks to expression noise using a gene regulatory network model. 
In another example, Ciliberti and colleagues (2007) examined the structure and 
robustness of millions of transcription regulation networks that regulate both cellular 
functions and embryonic development in many organisms. They found that radically 
different network architectures can show the same gene expression pattern.  
Metabolic Models. Biochemical network models that represent the metabolism of an 
organism are also widely used to measure robustness against mutations. A metabolism 
is a complex chemical reaction system whose metabolic genotype – the DNA 
encoding the enzymes catalyzing these reactions – can be compactly represented by 
its complement of metabolic reactions. These constructions are called genome-scale 
metabolic models and they contain all of the known metabolic reactions in an 
organism mapped to the genes that encode each enzyme (Becker and Palsson 2005; 
Feist et al. 2009; Oberhardt et al. 2009).  
Metabolisms are highly robust to the elimination of enzyme-coding genes. As 
exemplified in the Section 1.1.3, loss-of-function mutations in many enzyme-coding 
genes can leave a metabolic phenotype unaffected (Edwards and Palsson 2000a; Price 
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et al. 2002). Hence, metabolism can evolve rapidly through mutations that eliminate 
such genes and through horizontal gene transfer that adds new enzyme-coding genes. 
This property of metabolism is important for the project I describe in Chapter 2, 
where, by adding and deleting reactions, I generated random metabolisms, which 
retain their functions.  
To infer metabolic functionality, one can use an important tool for harnessing the 
knowledge encoded in genome scale metabolic models: Flux Balance Analysis (FBA) 
(Kauffman et al. 2003; Orth et al. 2010; Smallbone and Simeonidis 2009). FBA uses 
information about the stoichiometry of reactions in a metabolism to predict the rate at 
which it can synthesize a given set of molecules (Feist and Palsson 2010). Mutations 
in metabolic genes affect the activity of enzymes, and thus the rates at which a 
chemical reaction proceeds. Simulating mutations that will cause metabolic gene 
deletions and additions in FBA allows the prediction of robustness in metabolic fluxes 
(that is, the flow rate of metabolites through a network) or in growth rate to 
perturbations in various enzymes (Edwards and Palsson 2000a; Matias Rodrigues and 
Wagner 2009). Chapter 2 provides more detail on how FBA works. 
1.1.5. Robustness against translation errors 
Chapter 3 of this dissertation focuses on robustness to mistranslation and on 
signatures of selection to minimize the effects of such mutations. Translation is an 
error-prone process. Mistranslation rates are estimated to occur in every 1,000 to 
10,000 translated codons (Ogle and Ramakrishnan 2005a). There are two types of 
translational errors: (i) missense errors in which an incorrect amino acid is 
incorporated into a growing peptide chain, and (ii) nonsense errors in which peptide 
 
 
10 
synthesis terminates prematurely. Both missense and nonsense errors that produce 
non- and dysfunctional proteins are costly to the cell because they consume amino 
acids and energy both in their production and during breakdown (Drummond & 
Wilke, 2009). Accumulation of misfolded or dysfunctional proteins can cause 
diseases or membrane disruption. Additionally, missense errors may have other 
effects of large impact. For example, a missense error in a DNA polymerase may 
temporally increase overall mutation rates (Ninio 1991).  
Translationally robust proteins can fold and function properly even if they are 
mistranslated. Mathematical and computational modeling predicts that this selection 
pressure will cause proteins to be more thermostable and also to be more tolerant to 
genetic mutations (Drummond & Wilke, 2008; Drummond, Bloom, Adami, Wilke, & 
Arnold, 2005; Wilke & Drummond, 2006). One of the first studies to investigate the 
effect of transcription errors on protein evolution in an experimental system 
(Goldsmith and Tawfik 2009) confirmed this prediction by showing that a TEM1 β-
lactamase gene expressed with an error-prone RNA polymerase evolved an increased 
level of gene expression, increased thermostability and increased mutational 
robustness. 
Translational accuracy 
Organisms have evolved various strategies to minimize the effects of mistranslation. 
Selection for accurate translation is one of those strategies. Akashi (1994) argued that 
selection for translational accuracy should lead to inhomogeneous codon usage within 
genes, favoring optimal codons that correspond to abundant tRNAs. In line with his 
argument, Akashi showed that such codons were significantly enriched in more 
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conserved sites, and also in functionally more important sites (e.g. binding sites) in 
Drosophila. Further evidence was provided for E.coli, where Stoletzki and Eyre-
Walker (2007) showed that highly conserved sites and genes have higher codon bias 
than less conserved ones. Furthermore, they showed that codon bias is positively 
correlated to gene length and production costs, both indicating selection against 
missense errors. 
Selection for error-mitigation 
Genes with optimal codons can still produce large amounts of erroneous peptides. 
Selection for error-mitigation is suggested to decrease the usage of codons that have a 
high probability of being mistranslated into radically different amino acids (Archetti, 
2004b). Although it does not lead to a reduction of error frequencies, this selection 
pressure reduces the frequency of the most costly errors at the expense of a larger 
number of more benign errors, hence providing the translational machinery with 
robustness against the effect of mistranslation. Pertinent evidence comes from studies 
on genetic code architecture (Epstein 1966; Woese 1965), which revealed that the 
structure of the genetic code seems to reduce the effects of mistranslations, because 
amino acids with similar chemical properties are encoded by similar codons. Further 
support comes from several studies (Archetti, 2006; Archetti, 2004a, 2004b; 
Najafabadi, Goodarzi, & Torabi, 2005; Najafabadi, Lehmann, & Omidi, 2007), which 
show that genes in various organisms tend to “prefer” codons that minimize the 
effects of mistranslations.  
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Mistranslation-induced protein misfolding hypothesis 
A third strategy to minimize the effects of mistranslation overcomes the disruptive 
effects of mistranslations on protein structures by increasing the usage of optimal 
codons at sites where mistranslation is more likely to cause misfolding. Evidence for 
this strategy is found in multiple organisms, including E. coli, yeast, Drosophila and 
mice (Drummond & Wilke, 2008; Wilke & Drummond, 2006), where translationally 
optimal codons are more frequently used at sites where mutations are more 
destabilizing, such as buried amino acids.  
1.1.6. Neutral Networks 
One common feature of genotype-phenotype interaction is the existence of neutral 
genotype networks -- connected sets of genotypes that adopt the same phenotype 
(Ebner, Shackleton, & Shipman, 2001; Wagner, 2008). Any one genotype in such a 
network can be reached from any other genotype through series of genotypic 
mutations without altering the phenotype. Examples of neutral networks include RNA 
sequences that share the same secondary structure (Jörg et al. 2008; Rendel 2011); 
proteins, where multiple amino acid sequences form the same fold (Bloom et al. 2007; 
Tóth-Petróczy and Tawfik 2013); regulatory circuits, where many genetically encoded 
circuit topologies can form the same expression pattern (Ciliberti et al. 2007; Macneil 
and Walhout 2011), and metabolism, where multiple metabolic genotypes, encoding 
different combinations of chemical reactions, can confer viability on the same 
spectrum of nutrients (Von Dassow and Odell 2002; Edwards and Palsson 2000a). 
Through genotypic changes that do not affect phenotype, vast regions of genotype 
space can be explored, regions in which molecules with novel phenotypes can lie 
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(Wagner, 2005; Wagner, 2005b).  
 
1.2. Robustness and Phenotypic Variation  
The ability of mutations to bring forth new phenotypes is important for Darwinian 
evolution. One would think that mutational robustness could only decrease 
phenotypic variation, because in a robust system, mutations do not easily change a 
phenotype. However, observations on multiple levels of biological organizations 
suggest the contrary. Studying the evolution of thermotolerance in an RNA virus, 
McBride and colleagues (2008) found that populations derived from robust clones 
evolved greater resistance to heat shock relative to populations founded by non-robust 
clones. In laboratory evolution experiments, robust proteins evolve new catalytic 
activities more readily, and proteins with robust folds have evolved a greater diversity 
of catalytic functions than other proteins (Wagner 2005a). Bloom and colleagues 
(2006) found that only robust (thermostable) protein variations could tolerate the 
destabilizing mutations needed to confer novel activities, whereas nonrobust 
(thermosensitive) proteins could not evolve new activities.  
All these studies provide direct empirical evidence that robustness can facilitate 
phenotypic variation. The reason is that robust phenotypes allow a population to 
accumulate neutral mutations, increasing genotypic diversity. Because many of these 
neutral variants harbor distinct phenotypically consequential sensitivities to further 
genetic modification, mutational robustness can enhance access to phenotypic 
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variation over time (Wagner, 2008).  
 
1.3. Phenotypic Variation and Its Genetic Determinants 
What are the genetic causes of phenotypic variation? There is enormous interest in 
finding the genetic determinants of phenotypic variation between individuals, 
populations and species in molecular biology (Frazer et al. 2009; Guryev et al. 2008; 
Henrichsen et al. 2009b; Sumedha et al. 2007; Tirosh et al. 2006). Broadening our 
understanding in this regard will not only be valuable for medical genetics but will 
also provide a better understanding of the phenotypic evolution of complex biological 
systems. A focus of much research in this area regards the genetic basis of primate 
evolution (Khaitovich et al. 2006; King and Wilson 1975; Shea 2005; Yang 1998). 
Striking phenotypic differences exist between humans and their close relatives (Byrne 
2000; Shea 2005). Since the release of human (Hattori 2005) and great ape genomes 
(Locke et al. 2011; Scally et al. 2012; Sequencing and Consortium 2005), numerous 
genetic differences have been identified at least some of which form the basis for the 
complex and rapid cultural change that have characterized recent human evolution 
(Sholtis and Noonan 2010; Varki et al. 2008). Furthermore, it has long been suggested 
that this phenotypic divergence may be mostly caused by changes in gene regulation 
(King and Wilson 1975). Because Chapter 4 and 5 of this dissertation focus on 
expression changes in primates and in human tumors, respectively, I will summarize 
current knowledge about determinants of such phenotypic variation in the next 
sections. 
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1.3.1. Gene regulation  
Much of the phenotypic variation is caused by variation in regulatory sequences 
(Carroll 2000; Romero et al. 2012; Tejedor and Valcárcel 2010; Wray et al. 2003b). 
In multicellular organisms, for example, gene regulation drives cellular differentiation, 
leading to the creation of different cell types that possess different gene expression 
profiles, and hence produce different phenotypes (Barrett, Fletcher, & Wilton, 2012; 
Carroll, 2000; Choi & Kim, 2008; Tirosh et al., 2006; Wray et al., 2003). Variation in 
gene expression can therefore help create novel phenotypes.  
Regulation of gene expression is a multifaceted process. While the binding of 
regulatory proteins to the upstream or downstream of a gene can activate, silence or 
prolong the gene’s expression, epigenetic factors such as DNA methylation and 
histone modifications change the accessibility of the gene to those regulatory proteins 
(Wray et al., 2003). Genetic regulation can both occur on the transcriptional and 
translational level. As Chapter 4 and 5 focus on transcriptional regulation, I will 
briefly introduce the elements of gene expression regulation on the transcriptional 
level. Following that, I will also discuss translational and epigenetic regulation of 
gene expression. 
Transcriptional regulation 
Eukaryotes employ diverse mechanisms to regulate gene expression at the 
transcriptional level (Barrett et al., 2012; Carroll, 2000; Wray et al., 2003). Changes 
in transcriptional regulation are an important component of phenotypic variation in 
physiology, behavior, anatomy, and life history (Burgess, 2013; Spitz & Furlong, 
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2012; Wray et al., 2003; Wright, Yau, Looseley, & Meyers, 2004). Most genes are 
differentially transcribed across an organism’s life cycle, according to environmental 
conditions, in different cell types and compartments, and among sexes through 
diverse regulatory mechanisms (Wray et al., 2003). This is managed through the 
interplay of many cis-regulatory elements, including promoters, enhancers, and 
suppressors and proteins that bind to these elements.  
At its most fundamental level, the function of a promoter is to integrate information 
about the status of the cell in which it resides, and to alter the rate of transcriptional 
initiation of a single gene accordingly. The promoters of genes encoding 
housekeeping proteins are constitutively active, but they can shut down in response to 
specific conditions, such as heat shock or starvation (Pirkkala et al. 2001). Other 
promoters are off by default, but they can be activated in response to specific 
hormonal, physiological, or environmental cues (Aranda and Pascual 2001).  
No consistent sequence motifs exist for promoters of protein-coding genes (Wray et al. 
2003a). Two functional features are always present, although they cannot always be 
recognized from sequence information alone. One is a core promoter, the site upon 
which the enzymatic machinery of transcription assembles. The other functional 
feature is a collection of diverse protein binding sites that confer specificity of 
transcription. Proteins bound to these sites produce a scalar response, the frequency 
with which new transcripts are initiated (Latchman 1997; Spitz and Furlong 2012; 
Warren 2002). Proteins in the mitogen-activated protein kinase (MAPK) pathway, for 
example, control crucial events like cell differentiation, survival and death in 
eukaryotes, by binding to and regulating the activity of other transcription factors 
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(Kim et al. 2011; Plotnikov et al. 2011). Dysfunction of this cascade is associated 
with several types of carcinogenesis (Dhillon et al. 2007). Similarly, the erythroblast 
transformation-specific (ETS) family, another important family of transcription 
factors in animal kingdom, is responsible for cell survival and death. Multiple ETS 
factors become dysfunctional in some disease. For example, the ETS-related gene 
(ERG) transcription factor is fused to the Ewing sarcoma breakpoint region (EWS) in 
Ewing's sarcoma disease (Sorensen et al. 1994). 
Translational regulation 
Translational regulation mostly involves controlling the initiation of mRNA 
translation, which can be modulated by mRNA secondary structure, antisense RNA 
binding, or protein binding. One of the best known examples of expression regulation 
through mRNA secondary structure involves the μ gene that encodes immunoglobulin 
heavy chain. Alteration of its mRNA secondary structure at the ribosome binding site 
by oligonucleotide replacement mutagenesis revealed a correlation between μ gene’s 
expression levels and accessibility of the ribosome binding site (Wood et al. 1984). In 
another example, Hüttelmaier and colleagues (2005) carried out an in vivo experiment 
in rabbits to show that the oncofetal protein ZBP1, is involved in the translational 
repression of β-actin mRNA by blocking translation initiation. 
Epigenetic regulation 
Epigenetics is the study of heritable genetic changes that are not caused by changes in 
the DNA sequence (Choi and Kim 2008). Examples of mechanisms that produce such 
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changes are DNA methylation (Bell et al. 2011; Pai et al. 2011) and histone 
modification (Thurman et al. 2012; Woo and Li 2012). 
DNA methylation is a biochemical process where a methyl group is added to cytosine 
or adenine DNA nucleotides. The rate of cytosine DNA methylation differs strongly 
between species: 14% of cytosines are methylated in plants, 8% in mice, 2.3% in E. 
coli, 0.03% in fruit fly, and virtually none in yeast (Capuano et al. 2014). In 
mammals, genes can be methylated from CpG islands in the upstream (Deaton and 
Bird 2011), where tandem cytosine and guanine nucleotides are clustered together, 
which can help repress gene expression. High methylation of gene promoters 
correlates with low or no transcription (Bell et al. 2011; Suzuki and Bird 2008).  
DNA methylation is essential for normal development (Bergman and Cedar 2013). 
For example, Oct-4, an important transcription factor responsible for self-renewal of 
undifferentiated embryonic stem cells is silenced by hypermethylation during 
differentiation (Feldman et al. 2006). Abnormal methylation is associated with a 
number of diseases, such as cancer and atherosclerosis (Bergman and Cedar 2013; 
Robertson 2005). In cancer, CpG sites in gene promoters acquire abnormal 
hypermethylation, which results in silencing of tumor-suppressor genes, such as 
Adenomatous polyposis coli (APC) and Breast cancer 1, early onset (BRCA1), and of 
genes responsible for DNA repair, such as DNA mismatch repair gene, MLH1 
(Taberlay and Jones 2011).  
The histone proteins of eukaryotic cells package and order the DNA into structural 
units called nucleosomes. A huge catalogue of histone modifications have been 
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described, such as acetylation, methylation and phosphorylation of various amino 
acids on histones, most of which lead to transcriptional activation of the nearby genes 
(Gaffney et al. 2012; Woo and Li 2012). For example, switch/sucrose nonfermentable 
(SWI/SNF) complex in yeast destabilizes DNA-histone interactions and opens up 
chromatin structure, thereby allowing the transcription of genes located within the 
chromatin (Whitehouse et al. 1999). In another example, Polycomb proteins silence 
the expression of Hox genes, which encode a group of proteins responsible for body 
development by changing their chromatin structure in Drosophila (Stankunas et al. 
1998). 
1.3.2. Genetic mutations responsible for phenotypic variation 
Identifying DNA mutations responsible for phenotypic variation is one goal of 
evolutionary genetics. Genetic mutations either alter single nucleotides or create 
insertions and deletions. These inserted or deleted sequences can be very short, and 
comprise only couple of nucleotides, such as in variable tandem repeats (Gemayel et 
al. 2010), or very long such as in chromosomal copy number variation (Redon et al. 
2006). Genes themselves can also be deleted or duplicated (Zhang 2003). Rates for 
these different kinds of mutations vary greatly among organism and among types of 
mutations (Kumar and Subramanian 2002; Lynch 2010; Scally and Durbin 2012). For 
example, in humans point mutations are estimated to occur at a rate of 10
-8
 per 
nucleotide per generation (Scally and Durbin 2012), whereas mutation rates of tandem 
repeat sequences lie between 10
−3
 and 10
−7
 per cell division (Fan and Chu 2007; 
Legendre et al. 2007).  
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Single nucleotide polymorphisms 
The four-winged fly that results from short nucleotide mutations in Ubx gene 
promoter in Drosophila is perhaps the most remarkable example (Simon et al. 1990) 
of how small genotypic alterations can change the phenotype. An important class of 
them, single-nucleotide polymorphisms (SNPs) have long been known to be 
associated with phenotypic variation  (Kruglyak 1999; Shastry 2002; Stranger et al. 
2007a; Wang and Moult 2001). Another famous but more recent example comes from 
the Tibetan population, where multiple SNP’s in the genes Endothelial PAS domain 1 
and Hypoxia-inducible factor prolyl hydroxylase 1, which are involved in the low 
oxygen response confer high altitude adaptation to this population (Peng et al. 2011; 
Yi et al. 2010). Another study on multiple human populations (Li et al. 2010) showed 
that SNPs located in untranslated regions of 18,000 genes elevate expression variation 
between populations. 
Large copy number variants 
During the last few years, copy number variants of DNA segments that are one 
kilobase or larger in size have attracted much attention. They are quite prevalent in 
eukaryotes: roughly 10 per cent of many eukaryotic genomes consist of such 
segmental duplications (Henrichsen et al. 2009a; Jakobsson et al. 2008; Mills et al. 
2011). Copy number variants can have dramatic phenotypic consequences (Chaignat 
et al. 2011; Henrichsen et al. 2009b; Stranger et al. 2007a; Wang et al. 2011; Zhou et 
al. 2011). One example can be found in zebrafish, where copy number amplification 
of regions containing the mannose-binding lectin gene influence its susceptibility to 
bacterial infection (Jackson et al. 2007). Another example involves large structural 
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rearrangements in multiple chromosomes that are found to be strongly associated with 
schizophrenia in human (Stefansson et al. 2008). Multiple studies show that increased 
copy number can be positively (McCarroll 2008; Somerville et al. 2005) or negatively 
(Lee et al. 2006a) correlated with gene expression levels.  
Gene duplication 
Gene duplication is an important kind of genotypic variation for creating new 
phenotypes in organisms. Lynch and Conery (2000) estimated that gene duplications 
arise and get fixed at an approximate rate of 10
-8
 per gene per genome in eukaryotes. 
Many novel gene functions have evolved through gene duplication, which has 
contributed tremendously to the evolution of developmental programs in various 
organisms. Gene duplication is associated with increased gene expression divergence 
and morphological diversification (Conant and Wolfe 2008; Dong et al. 2011; Hanada 
et al. 2009; Magadum et al. 2013). The evolution of the antifreeze protein in Antarctic 
zoarcid fish provides a prime example of phenotypic variation conferred by gene 
duplication (Deng et al. 2010). After a duplication event of the sialic acid synthase 
gene in Antarctic zoarcid fish, one copy accumulated several mutations to gain 
antifreeze functionality, allowing the fish to survive in the frigid temperatures of the 
Antarctic Seas. A remarkable example of how gene duplication causes expression 
variation comes from a comparison of recent human and chimpanzee duplications 
(Cheng et al., 2005), which revealed that more than half of the human-specific 
duplicates show a significant overexpression in the human lineage. 
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Tandem repeat instability 
Another class of copy number variation involves short sequences up to 50 or 100 
nucleotides that are repeated tandemly. They are of a special importance for this 
dissertation as two of the following chapters (Chapter 4 and 5) are devoted to their 
phenotypic consequences for gene expression levels.  
Tandem repeats are extremely unstable. Their copy number varies 10 to 100,000 
times more frequent than other parts of genome in eukaryotes (Gemayel et al. 2010). 
The reason is that tandem repeats are prone to an error called strand slippage, which 
occurs predominantly during cell replication when there is a mispairing between the 
template and complementary DNA strands (Levinson and Gutman 1987). When the 
newly synthesized strand denatures from the template strand during synthesis of the 
tandem repeat sequence, it can occasionally pair with another part of the repeat 
sequence due to self-compatibility. If the template strand is looped out, then tandem 
repeat copy number decreases. If the complementary strand loops out, copy number 
increases.  
Copy number changes in tandem repeats often have tremendous phenotypic 
consequences. For example, unstable repeats located in or near human genes can lead 
to neurodegenerative diseases such as Huntington disease and muscular dystrophy 
(Bates 2005). Apart from their role in disease, variable repeats can confer non-
pathogenic phenotypic variation. A compelling example comes from a study on dog 
skull morphology (Fondon and Garner 2004), which compared genomic and 
morphological data from different dog breeds and revealed immense morphological 
changes caused by variable tandem repeats in two developmental genes, Alx-4 and 
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Runx-2. Another striking example can be found in FLO1, a cell surface adhesion gene 
in yeast. Experimentally altering the copy number of a 100 nucleotide long repeat 
region, which is polymorphic between various yeast strains, changes cell adherence, 
thereby facilitating adaptation to different environments (Verstrepen et al. 2005). 
Vinces and colleagues (2009) showed that changing the copy number of tandem 
repeats in a gene’s promoter has a direct effect on its expression level in yeast species. 
They also demonstrated that genes regulated by repeat-containing promoters show 
significantly higher rates of transcriptional variation. A striking example can be found 
in tilapia, an important aquacultural fish. Variable CA repeats in the promoter of the 
prl1 gene, which encodes a hormone involved in osmoregulation, show an association 
with both prl1 expression as well as the fish’s response to salt stress (Streelman and 
Kocher 2002). Variation in a tandem repeat can modulate gene expression also by 
changing the copy number of binding sites for regulatory proteins, such as 
transcription factors. For example, the tumor suppressor p53 activates the 
transcription of PIG3, a gene involved in p53-mediated cell death, by interacting with 
a pentanucleotide tandem repeat sequence in the promoter of this gene (Contente et al. 
2002). Different copy numbers of the repeat sequence associate with different 
expression levels of the PIG3 gene. 
Tandem repeat instability and cancer 
Tumorigenesis is partly driven by mutations that increase genomic repeat instability 
by allowing tumor cells to rapidly acquire various mutations required for cellular 
transformation through an increase in random mutation events (Aguilera and García-
Muse 2013; Maslov and Vijg 2009). Genomic instability can originate from 
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deficiencies in the DNA mismatch repair system (Hewish et al. 2010; Woerner et al. 
2003; Zienolddiny et al. 1999), which allow DNA damage to accumulate, and give 
rise to further mutations, especially in tandem repeats (Cancer and Atlas 2012; Fearon 
2011; Gurin et al. 1999). For example, multiple studies (Bubb et al. 1996; Cancer and 
Atlas 2012; Fearon 2011; Hewish et al. 2010) have shown that inactivation of one of 
several mismatch repair genes is responsible for increased tandem repeat instability 
seen in more than 90 per cent of hereditary non-polyposis colorectal cancers, and in 
15 per cent of non-hereditary colorectal cancers. This high genotypic variation 
increases the probability of tumors harboring a therapy-resistant phenotype and has 
been hypothesized to endow tumors with the necessary adaptability to survive and 
recur after treatment (Kitano 2004; Tischfield and Shao 2003). In Chapter 5, I 
describe how tandem repeat instability can cause tumor-specific gene expression 
changes. 
 
1.4. Thesis Outline 
This dissertation covers the work of four years, in which I studied phenotypic 
variation and robustness on various levels of biological organizations. Each chapter is 
devoted to one of these projects. The first research chapter (Chapter 2) describes a 
computational analysis that focuses on the tradeoffs between different metabolic 
network properties that contribute to phenotypic variation in a synthetic microbial 
metabolism. These properties include the number of carbon sources a metabolism can 
use to survive, the number of different molecules a metabolism can synthesize, the 
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number of actively used reactions in a metabolism, and how much waste a 
metabolism produces. Variations in these properties explain most of the variation in 
the biomass synthesis rates of a metabolism.  Furthermore, I show that biochemically 
related molecules (e.g. amino acids) can be synthesized at higher rates, because their 
synthesis produces less waste. The observations in this study are relevant for synthetic 
metabolism design, which has become possible thanks to ongoing advances in 
sequencing and de-novo synthesis of DNA (Cheng and Lu 2012; Nandagopal and 
Elowitz 2011; Smolke and Silver 2011).   
In Chapter 3, I ask to what extent codon changes caused by mutation or 
mistranslation may affect physicochemical amino acid properties or protein folding. I 
find that codons of ligand-binding amino acids are on average more robust to errors 
than those of non-binding amino acids. Selection for error mitigation at the 
translational level can be responsible for this phenomenon. The finding of this study 
suggests that natural selection can affect the robustness of very small units of 
biological organization. 
In Chapter 4, I focus on how a particular genotypic instability, tandem repeat 
variation relates to gene expression divergence in primates. By doing so, I find that 
genes with tandem repeats in their regulatory regions have significantly higher 
expression divergence. Similarly, I show that human gene duplicates with tandem 
repeats diverge in expression more than duplicates without tandem repeats. Hence, 
tandem repeats, far from just being a source of genetic diseases, may contribute 
substantially to the divergence of gene expression in primates.  
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Since tandem repeat instability is a hallmark of colorectal tumors, I study in Chapter 
5 the phenotypic consequences of tandem repeat instability between tumor and 
normal tissues of the same individual. I first show that tumor genomes are enriched 
for repeat instability, i.e. de novo repeats, repeat loss, and copy number variation. I 
then show that genes with repeat instability are significantly overexpressed, also in 
well-studied cancer pathways. These findings suggest an important role for promoter 
tandem repeat instability in differential gene expression of colorectal tumors.  
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2.1. Abstract 
 
A metabolism is a complex network of chemical reactions that converts sources of 
energy and chemical elements into biomass and other molecules. To design a 
metabolism from scratch and to implement it in a synthetic genome is almost within 
technological reach. Ideally, a synthetic metabolism should be able to synthesize a 
desired spectrum of molecules at a high rate, from multiple different nutrients, while 
using few chemical reactions, and produce little or no waste. Not all of these 
properties are achievable simultaneously. We here use a recently developed technique 
to create random metabolic networks with pre-specified properties to quantify trade-
offs between these and other properties. We find that for every additional molecule to 
be synthesized a network needs on average three additional reactions. For every 
additional carbon source to be utilized, it needs on average two additional reactions. 
Networks able to synthesize 20 biomass molecules from each of 20 alternative sole 
carbon sources need to have at least 260 reactions. This number increases to 518 
reactions for networks that can synthesize more than 60 molecules from each of 80 
carbon sources. The maximally achievable rate of biosynthesis decreases by 
approximately 5 percent for every additional molecule to be synthesized. 
Biochemically related molecules can be synthesized at higher rates, because their 
synthesis produces less waste. Overall, the variables we study can explain 87 percent 
of variation in network size and 84 percent of the variation in synthesis rate. The 
constraints we identify prescribe broad boundary conditions that can help to guide 
synthetic metabolism design.  
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2.2. Introduction 
Among the most important goals of synthetic biology and biotechnology is to 
engineer organisms with novel properties (Purnick and Weiss 2009; Smolke and 
Silver 2011). Most current efforts focus on designing subsystems of organisms, such 
as regulatory circuits (Purnick and Weiss 2009; Sprinzak and Elowitz 2005) or 
metabolic pathways (Benner and Sismour 2005; Yarmush and Banta 2003). However, 
recent advances in genomics and genome synthesis have allowed synthetic biology to 
make great strides towards the ultimate goal of designing new organisms from scratch 
(Gibson et al. 2010; Gibson et al. 2008; Murtas 2007; Rasmussen et al. 2004; Smith et 
al. 2003).  
To be able to synthesize new life, one needs to understand life’s minimal needs. 
Considerable effort has thus focused on understanding and creating minimal 
organisms (Forster and Church 2006; Glass et al. 2006; Kuwahara et al. 2007; Mira et 
al. 2001; Murtas 2007; Nishikawa et al. 2008; Rasmussen et al. 2004). One line of 
research studies organisms with very small genomes that comprise only a few 
hundred genes, such as the gamma proteobacteria (Kuwahara et al. 2007), Blochannia 
floridanus (Gil et al. 2003) and Carsonella ruddii (Nakabachi et al. 2008). Such 
organisms are typically endosymbionts or endoparasites, and receive substantial 
resources from their host (Mira et al. 2001). Although valuable knowledge has been 
gained by studying these organisms, this property renders them of limited use in 
understanding minimal requirements for a free-living organism.  
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A second, complementary line of research starts from a complex genome, 
successfully eliminates genes from it without affecting viability, and thus creates a 
genome that is (close to) minimal. This is possible because free-living organisms have 
many genes that are dispensable in any one environment (Forster and Church 2006; 
Glass et al. 2006; Mizoguchi et al. 2008; Murtas 2007; Rasmussen et al. 2004). Such 
systematic gene deletion efforts not only provide insight into minimal genomes, they 
can also help to eliminate the synthesis of undesired molecules, avoid excessive waste 
production, and thus increase the efficiency with which an organism synthesizes 
desired molecules (Rude and Schirmer 2009). Based on both computational and 
experimental approaches of genome reduction, several proposals for the gene 
complements of minimal organisms have been made. They range in size from 100 
genes to more than 300 genes in organisms such as Mycoplasmas (Forster and Church 
2006; Glass et al. 2006; Murtas 2007) 
One indispensable feature of any living organisms is its metabolism. A metabolism is 
a complex network of chemical reactions, catalyzed by enzymes that are encoded in 
genes. It uses sources of energy and chemical elements – nutrients – to synthesize 
molecules that an organism needs, including precursors of biomass and various 
secondary products, such as molecules for defense and communication (Kuwahara et 
al. 2007). The manipulation of metabolism for technological purposes is known as 
metabolic engineering (Antoni et al. 2007; Bailey 1991; Lee et al. 2008; Rude and 
Schirmer 2009). 
Metabolic engineering has multiple applications. They include the large-scale, fast, 
and efficient synthesis of pharmaceuticals, chemical reagents, and biofuels (Keasling 
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2010; Rude and Schirmer 2009; Schirmer et al. 2010; Smolke and Silver 2011; Steen 
et al. 2010; Steen et al. 2008). The latter class of molecules is especially important 
given their importance in energy security and in the reduction of greenhouse gas 
emissions (Antoni et al. 2007; Lee et al. 2008; Mukhopadhyay et al. 2008; Schmidt 
2010). Another application is bioremediation, where microbes with properly 
engineered metabolic pathways may be able to clean hazardous waste in inaccessible 
places (Cases and Lorenzo 2005; Schmidt 2010).  
Current metabolic engineering approaches typically manipulate one or a few enzyme-
coding genes (Purnick and Weiss 2009). Because of the highly interconnected nature 
of metabolism, and because of the complexity of enzyme regulation, such 
manipulation faces several challenges. The first is to ensure a high level of expression 
of the genes and the enzymes they encode. A second challenge is to manipulate cells 
into selectively producing desired molecules at high rates and yield. Cells can be quite 
recalcitrant to such manipulations (Stephanopoulos and Vallino 1991). A third 
challenge is to ensure that a desired product can be produced from one source of 
chemical elements and energy, but from multiple sources, to ensure efficient 
production. For example, yeast species are good candidate organisms to synthesize 
ethanol, with the drawback that they are not highly efficient at fermenting cellulosic 
biomass. (In addition to glucose, which yeast strains can catabolize normally, 
cellulosic biomass contains five carbon sugars, such as arabinose and xylose, which 
yeast strains cannot catabolize.) Metabolic engineering can create yeast strains that 
ferment not only glucose but also mixtures of other sugars. (Wisselink et al. 2009). A 
fourth challenge is to overcome the toxicity of some desired products when they 
accumulate at high concentrations in a cell. This holds especially for biofuels that are 
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produced in large amounts (Mukhopadhyay et al. 2008). Finally, metabolic 
engineering needs to control ratios of metabolites such as ATP/ADP or 
NAD+/NADH, which can influence product yields and lead to synthesis of undesired 
byproducts through their global effects on physiology (Lee et al. 2008). 
While contemporary metabolic engineering focuses on altering existing pathways, 
future engineering will design metabolisms and minimal organisms de novo (Lee et 
al. 2008; Liang et al. 2011; Purnick and Weiss 2009; Savage et al. 2008). Ongoing 
technological advances in sequencing and de-novo synthesis and declining prices in 
these technologies (Antoni et al. 2007; Carr and Church 2009; Shendure et al. 2004; 
Smolke and Silver 2011) suggest that de-novo synthesis of minimal organisms for 
biomass production will be feasible soon. A small (synthetic) metabolism may also 
allow better control of metabolic properties than a large metabolism (Mizoguchi et al. 
2008; Purnick and Weiss 2009). 
To be able to design a metabolism, one needs to be able to predict system-wide 
metabolic properties. In recent years great strides have been made towards such 
prediction. Especially noteworthy are constraint-based modeling approaches, which 
can predict the spectrum of biosynthetic properties of a metabolism from knowledge 
about the reactions that its enzymes catalyze, and from the nutrients available in its 
environment (Edwards and Palsson 2000b; Edwards and Palsson 2000a; Segrè et al. 
2002). One such approach, flux balance analysis (FBA) (Edwards and Palsson 2000b; 
Edwards and Palsson 2000a; Orth et al. 2010; Smallbone and Simeonidis 2009), uses 
information about the stoichiometry of reactions in a metabolic network to predict the 
rate at which a network can synthesize a given spectrum of molecules, which we refer 
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to as the network’s biosynthetic flux. FBA makes two main assumptions. The first is 
that a metabolism is in a steady state with a constant nutrient supply. The second is 
that it maximizes some property, such as biosynthetic flux (Feist and Palsson 2010). 
While FBA faces challenges caused by regulatory constraints (Fong and Joyce 2005; 
Fong et al. 2003), it is well suited to answer simple qualitative and quantitative 
questions about important properties of a metabolic system (Schellenberger et al. 
2007). An especially important property is the minimal number of reactions R needed 
to synthesize a given number B of (biomass) molecules from a given spectrum N of 
nutrients. The ideal network has few reactions and can synthesize many molecules 
using a broad spectrum of nutrients. However trade-offs between these properties 
exist, which do not allow all these requirements to be met.  
We here take a first step towards a quantitative understanding of these and other 
trade-offs using constraint-based methods. To this end, we study the properties of not 
just one metabolic network, but of multiple networks that differ in these properties. 
Experimental techniques are not yet suitable to do that, but computational approaches 
are (Oberhardt et al. 2009). The approach we use starts with the observation that any 
one metabolic network exists in a vast space of possible metabolic networks. The 
approach uses recently developed techniques (Matias Rodrigues and Wagner 2009; 
Samal et al. 2010) to create unbiased arbitrary large samples of networks from this 
space, where each network of the sample has a specific property, such as a given 
number of reactions, a given number of carbon sources it can use, and a given set of 
molecules that it can synthesize. The underlying sampling technique, Markov Chain 
Monte Carlo sampling (Paul G. Higgs 2005; Robert and Casella 2004) is a widely 
used approach with a well-developed statistical theory (Brooks 1998; Ciliberti et al. 
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2007; Diaconis 2008; Li 1992; Neal 1993). We use it to quantify the trade-offs and 
thus the design constraints imposed by important metabolic network properties. 
Specifically, a first part of our analysis focuses on three main properties. The first is 
nutrient flexibility N, that is, the number of different carbon sources a metabolic 
network can utilize as sole carbon sources. The second is a network’s biosynthetic 
ability B, that is, the number of biomass molecules that it can synthesize. The third is 
the number of reactions R in a network. We then extend our analysis to further 
properties,  such as the biosynthetic flux S, the rate at which biomass molecules are 
synthesized, and the amount W of waste produced. 
 
2.3. Results 
Each additional nutrient requires on average two additional reactions. 
Due to the presence of alternative metabolic routes that connect many pairs of 
molecules, most metabolic systems are able to tolerate genotypic changes, such as the 
deletion of enzyme coding genes. For instance, 80% of single gene deletions in 
budding yeast have no detectable phenotypic effect in standard laboratory 
environments (Hillenmeyer et al. 2008). More specifically, metabolic systems are to 
some extent robust against deletions of enzyme coding genes, because the resulting 
elimination of metabolic reactions from a metabolic network does not necessarily 
affect cell viability (Beller et al. 2010; Forster and Church 2006; Glass et al. 2006; 
Murtas 2007; Schirmer et al. 2010; Steen et al. 2010; Steen et al. 2008). 
 
 
45 
We first wanted to explore how the minimally needed number of reactions in a 
network depends on the network’s nutrient flexibility and its biosynthetic abilities. 
For example, a network that can synthesize biomass on an increasing number of 
different carbon sources will require more metabolic reactions. But how many more? 
To answer this question we created random minimal networks (see Methods) with a 
given nutrient flexibility N, that is, networks that can use N sole carbon sources to 
synthesize all biomass components, but in which every single reaction is essential, 
such that no reaction can be removed without abolishing viability of the network on at 
least one of the carbon sources. More specifically, we created 50 random viable 
networks that can use N=20, 40, 60, and 80 carbon sources as sole carbon sources (for 
a total of 200 networks), and that could synthesize all B=63 E. coli biomass 
components. We then studied the relationship between N and the number of reactions 
in these minimal networks (Figure 1a, orange data points). Linear regression analysis 
showed that the number of needed reactions increases by a number that is statistically 
indistinguishable from two for every additional carbon source that a network is 
required to be viable on. Specifically, we found R to depend on N as R=(1.9±0.1)N + 
234, where the number 0.1 indicates the 95 percent confidence interval of the 
regression coefficient (see Supporting Information section ‘Confidence Interval 
Calculation’ for details). We then asked whether the same relationship between N and 
R also holds if we vary biosynthetic ability. To this end, we repeated the analysis just 
described, but for networks that are able to synthesize B=20, B=30, and B=40 
biomass components. The slope of the regression line was indistinguishable from that 
of B=63 in all three cases (Figure 1a, green, purple, and blue data; see Figure S3 for 
distributions of R). In other words, regardless of a network’s biosynthetic abilities, 
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every additional carbon source that a network is required to be viable on requires on 
average two additional metabolic reactions.  
 
Figure 1. The number of required reactions 
increases with nutrient flexibility and 
biosynthetic ability. The vertical axis shows 
the number of reactions in minimal networks 
as a function of a) nutrient flexibility and b) 
biosynthetic ability. Dots and length of error 
bars correspond to means and one standard 
deviation based on a sample of n=50 minimal 
networks. Solid lines indicate linear regression 
lines for different values of B in a) and N in b). 
Numerical estimates of regression coefficients 
with 95% confidence intervals are given in the 
inset, in the format y=(a±e)x+b, where a is the 
regression coefficient, e the confidence 
interval, and b is the intercept of the regression 
line with the vertical axis.  
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Each additional biomass molecule requires three additional reactions on 
average.  
We next analyzed the relationship between biosynthetic ability and the numbers of 
reactions in greater detail. To this end, we used the same set of random viable 
minimal networks that we used in the previous analysis. First, we analyzed the 
number of reactions in 50 random viable minimal networks with the ability to 
synthesize B=20, 30, 40, or 63 randomly chosen biomass components, that is, we 
analyzed a total of 200 networks. Each of these networks was required to be viable on 
N=80 different sole carbon sources. We found that the number of reactions needed for 
viability under these conditions increased approximately linearly with biosynthetic 
ability (Figure 1b, orange), such that every additional biomass molecule required 
approximately 3 additional reactions Specifically, R= (3.3±0.2)B + 195. We then 
asked again how this relationship between biosynthetic ability and number of 
reactions depends on N, and thus repeated this analysis for networks viable on N=20, 
N=40, and N=60 sole carbon sources. The slope of the regression line was 
indistinguishable for the different values of N (Figure 1b, green, purple, and blue 
data), but the intercept differed, as one might expect from the analysis of the previous 
section. 
The results of pairwise regression analysis are easy to display graphically and to 
interpret intuitively, which is why we use it here. However, where more than two 
quantities vary, pairwise regression analysis is insufficient to study dependencies 
among all of them. We thus also carried out a multiple regression analysis using all 
800 minimal networks, where nutrient flexibility and biosynthetic ability were 
independent variables, and where the reaction number was the dependent variable. 
 
 
48 
Not unexpectedly, the pairwise regression coefficients estimated from the multiple 
regression analysis were statistically indistinguishable from those estimated from the 
pairwise analysis above (R=2.0N+3.2B+171). Overall, variation in the two 
independent variables explains 87 percent of the variation in the number of reactions 
of a metabolic network.  
Our analysis thus far was only concerned with the qualitative question whether 
networks can synthesize a given number B of molecules, not with the rates at which 
these molecules can be synthesized. One would therefore expect that our observations 
are not sensitive to variation in the proportions in which biomass molecules are to be 
synthesized. An additional analysis (Figure S1) confirms this expectation. 
Network size does not significantly influence biosynthetic flux.  
Engineered metabolic networks that produce one or more desired products at a high 
rate are a key goal of biotechnology. For our purpose, it is therefore important to ask 
whether the maximal rate at which biomass can be synthesized by a network depends 
on B and N. We here used the ability of FBA to predict the maximal biosynthetic flux 
(S) of viable networks to answer this question (see Methods).  
Our analysis thus far was based on minimal networks, but it is possible that 
biosynthetic flux depends on the number of reactions in networks that are larger than 
minimal networks. We therefore first analyzed 1.6×10
4
 random viable networks that 
are not minimal and that differ in size between R=400 and R=800 reactions. (From 
here on, we will use the term random networks to refer to those networks that are not 
minimal, unless stated otherwise.) We found that network size does not influence 
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biosynthetic flux for networks able to synthesize all B=63 E. coli biomass molecules. 
That is, the regression coefficient describing their relationship is statistically 
indistinguishable from zero (f=rR, with r=3×10
-5
±7×10
-5
, n=1000 networks). The 
same holds for networks that can synthesize B=20, B=30, and B=40 biomass 
molecules. (See Figure S2 for flux distributions.) 
High biosynthetic flux is usually achieved by a modest number of active 
reactions.  
We just showed that the number of reactions in a network does not affect its 
biosynthetic flux. However, it is well-known that only a subset of a network’s 
metabolic reactions are usually active in any one environment, that is, they have 
nonzero flux (Nishikawa et al. 2008). We thus wanted to know whether a relationship 
exists between biosynthetic flux and the number of active reactions, RA. This is indeed 
the case, based on an analysis of all our 1.6×10
4
 random networks viable on glucose 
as a sole carbon source. More specifically, this relationship is strongly negative 
(Pearson's r = -0.65 for biosynthetic flux on glucose). That is, the greater the number 
of active reactions, the lower the biosynthetic flux of a network.  
We next used linear regression to ask whether network size R itself influences the 
number of active reactions RA. The answer is no. Network size has no statistically 
significant influence on the number of active reactions for any combination of values 
of N and B. This observation is in agreement with earlier results by Nishikawa et al. 
(Nishikawa et al. 2008), which showed that the number of active reactions in a 
network  is not sensitive to the size of the network.  
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We subsequently asked whether synthesis of each additional biomass molecule also 
needs more active reactions. The answer is yes, as shown by linear regression analysis 
(3.6-4 additional reactions, on average, per biomass molecule).   
The more biomass molecules a network synthesizes, the smaller is its 
biosynthetic flux.  
We next wanted to explore why the number of active reactions is negatively 
correlated with biosynthetic flux. Our observations so far show that the number of 
active reactions increases with biosynthetic ability. We thus hypothesized that 
increased biosynthetic ability entails smaller biosynthetic flux, because biosynthetic 
flux should decrease as the number of biomass molecules to be synthesized grows, 
given a constant nutrient supply. To test this hypothesis, we computed the correlation 
between the number of molecules synthesized and biosynthetic flux in multiple 
environments for all 16000 networks we had generated (see Methods). This 
correlation is significantly negative (Pearson’s r = -0.60; P<10-300). Each molecule to 
be synthesized decreases biosynthetic flux by 0.05 mmoles per g DW per hour, 
equivalent to a 6 percent decline relative to E.coli’s computed biosynthetic flux. Next, 
we analyzed networks viable on 80 different sole carbon sources that were able to 
synthesize B=20, 30, 40, or 63 randomly chosen biomass components (1000 networks 
each, for a total of 4000 networks). Biosynthetic flux under these conditions also 
decreased approximately linearly with biosynthetic ability (Figure 2a, orange data). 
Specifically, every additional biomass molecule that a network needs to synthesize 
decreases the biosynthetic flux by approximately 0.05 mmoles of biomass per g DW 
per hour (6 percent; S=-(0.05±0.001)B + 3.5). Similar relationships also hold for 
networks viable on N=20, N=40, and N=60 sole carbon sources (Figure 2a, green, 
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purple, and blue data). They show that, every additional biomass molecule to be 
synthesized reduces biosynthetic flux by 3-6 percent. Taken together, these 
observations help explain the negative relation between the number of active reactions 
and biosynthetic flux. Networks that can synthesize more biomass molecules need 
more active reactions. Given a constant nutrient supply, the total biosynthetic flux that 
can be realized by these networks must decrease as the number of molecules that they 
can synthesize increases. The negative correlation between the number of active 
reactions and biosynthetic flux is a by-product of the latter two correlations.  
Biosynthetic flux increases weakly with nutrient flexibility.  
We next explored how the nutrient flexibility of a network affects its biosynthetic 
flux. To this end, we analyzed 1000 networks each that can use N=20, 40, 60, and 80 
carbon sources (a total of 4000 networks) and that can synthesize B=63 biomass 
molecules. (Figure 2b, orange data points). We found that biosynthetic flux increases 
weakly but significantly with nutrient flexibility (S= (0.01±0.0001)N + 0.6 mmoles of 
biomass per g DW hour, n=1000 networks) for every additional carbon source that a 
network is viable on. This is equivalent to 1 percent of increase relative to E. coli's 
biosynthetic flux on glucose. Quantitatively similar relationships hold for networks 
able to synthesize B=20, B=30, and B=40 biomass components (Figure 2b, green, 
purple, and blue data). We next turn to a variable that can help explain this 
association: waste production.  
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Figure 2. Biosynthetic flux decreases with 
biosynthetic ability and increases with 
nutrient flexibility. The vertical axis shows 
biosynthetic flux in mmoles per g DW per 
hour in random networks as a function of a) 
biosynthetic ability and b) nutrient flexibility. 
Dots and lengths of error bars correspond to 
means and one standard deviations based on a 
sample of n=1000 minimal networks. Solid 
lines indicate linear regression lines for 
different values of B. Numerical estimates of 
regression coefficients with 95% confidence 
intervals are given in the inset, in the format 
y=(a±e)x+b, where a is the regression 
coefficient, e the confidence interval, and b is 
the intercept of the regression line with the 
vertical axis.  
 
 
 
 
High biosynthetic flux means less waste.  
Some 300 transport reactions are described in E. coli (Feist et al. 2007), many of 
which transport waste products either from the periplasm or the cytoplasm to the 
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extracellular space. Metabolic networks may differ in the extent to which they 
produce waste products that are excreted from cells. Waste products may include 
molecules that are not biomass molecules (such as carbon dioxide or acetate), as well 
as excess biomass molecules (Feist et al. 2007; Nishikawa et al. 2008). Waste 
production consumes resources, such as organic carbon, and will therefore reduce 
biosynthetic flux. With these considerations in mind, we next asked whether lower 
waste production might be responsible for the differences in biosynthetic flux we 
observed in networks with different nutrient flexibility.   
Different metabolic networks may excrete different kinds of molecules, but to 
compare their waste production, it is useful to establish a common waste ‘currency’. 
Since our analysis is focused on carbon metabolism, we use the moles of carbon per g 
DW per hour as our unit of waste production. (Note that these moles of carbon may 
well come from a broad spectrum of different molecules.)   
We first wanted to know if waste has any influence on biosynthetic flux. The answer 
is yes, based on an analysis of all our 1.6×10
4
 random viable networks on glucose as 
the sole carbon source. This relationship is strongly negative (Pearson's r=-0.66) That 
is, the greater waste production is, the lower the biosynthetic flux.  
In the last section, we showed that for each additional carbon source a network was 
required to be viable on, biosynthetic flux increased by 0.01-0.02 mmoles of biomass 
per g DW and hour (Figure 3). If we express biomass synthesis instead as moles of 
carbon (in synthesized biomass) per g DW and per hour, biosynthetic flux increases 
on average by 0.1 mmoles of carbon per g DW hour with increasing nutrient 
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flexibility. We hypothesized that this increase can be explained through the influence 
of nutrient flexibility N on waste production W. To this end, we first analyzed random 
viable networks that vary in N and that can synthesize all B=63 molecules E. coli 
biomass molecules (Figure 3, orange data points). We found that waste production 
decreased by a number that is statistically indistinguishable from 0.1 mmol of carbon 
per g DW hour (W=(-0.09±0.02)N +24, n=1000 networks) for every additional carbon 
source that a network is viable on. Statistically indistinguishable relationships exist 
for networks with B=20, B=30, and B=40 biomass components. (Figure 3, green, 
purple, and blue data). These observations suggest that the positive influence of 
nutrient flexibility on biosynthesis flux comes from reduced waste production. We 
later discuss experimental evidence supporting this observation.  
 
Figure 3. Waste production decreases with 
nutrient flexibility. The vertical axis shows 
waste that is excreted carbon in mmoles per g 
DW hour in random networks as a function of 
nutrient flexibility. Dots and lengths of error 
bars correspond to means and one standard 
deviation based on a sample of n=1000 
minimal networks. Solid lines indicate linear 
regression lines for different values of B. 
Numerical estimates of regression 
coefficients with 95% confidence intervals 
are given in the inset.  
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In a final analysis related to waste production, we studied the relationship between 
biosynthetic ability and waste production, and found no significant such relationship.  
The variables we considered can explain 84 percent of the variance in 
biosynthetic flux.  
Thus far, we have considered five variables and how they influence biosynthetic flux. 
These are network size R, nutrient flexibility N, biosynthetic ability B, waste 
production W, and numbers of active reaction RA. To understand how biosynthetic 
flux depends on not just one but all of these variables, we carried out a multiple 
regression analysis with flux as the dependent variable. This regression analysis 
showed that the variables we analyzed explain 84 percent of the variation in 
biosynthetic flux (R
2
=0.84).  
Synthesis of biochemically related molecules requires fewer reactions, 
because it produces less waste.  
In our analysis of how required reaction numbers depend on a network’s biosynthetic 
abilities, we have purposely focused on randomly chosen biomass precursors, as they 
give us an unbiased view of this dependency. However, this relationship may change 
if one considers biochemically related biomass molecules. To obtain some insights 
how it changes, we next studied a group of molecules whose known biosynthesis 
pathways share several reactions. These are the 20 proteinaceous amino acids (Morot-
Gaudry et al. 2001). Figure 4a shows the number of reactions in minimal networks 
that can synthesize all 20 proteinaceous amino acids (left panel), as well as the 
number of reactions needed to synthesize 20 randomly chosen biomass molecules 
(right panel). Amino acid synthesizing networks need 191±10 (mean ± one standard 
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deviation) reactions, 27 percent fewer than the 261±24 reactions needed to synthesize 
20 arbitrary molecules. This difference is highly significant (P<10
-10
, Mann-Whitney 
U-test, n=100) (Mann and Whitney 1947). 
 Figure 4. Synthesis of biochemically related 
compounds require less reactions, achieve 
higher biosynthetic flux with less waste. 
Box-plot of a) number of reactions, b) 
biosynthetic flux in mmoles per g DW hour, 
and c) waste in mmoles per g DW per hour in 
minimal networks synthesizing twenty amino 
acids (left panel) and synthesizing twenty 
random biomass molecules (right panel). 
Horizontal lines in the middle of each box 
mark the median. The edges of the boxes 
correspond to the 25th and 75th percentiles. 
Data is based on a sample of n=80 for each 
box.  
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In minimal networks every reaction is active under the conditions we study. Our 
observations in the last paragraph thus also show that amino acid biosynthesis needs 
fewer active reactions than biosynthesis of arbitrary biomass molecules. One of our 
analyses above showed that fewer active reactions also imply higher biosynthetic flux, 
which raises the question whether the 20 amino acids can be synthesized at higher 
rates. The answer is yes (Figure 4b). Minimal networks that synthesize 20 arbitrary 
biomass molecules synthesize them 35 percent more slowly than minimal networks 
that synthesize 20 amino acids (P<10
-13
, n=80, Mann-Whitney U-test) (Mann and 
Whitney 1947). 
We next hypothesized that these dependencies might be explicable as a by-product of 
a lower cost of amino acid synthesis. If amino acids have fewer carbon molecules 
than the average biomass molecule, both fewer steps would be needed to synthesize 
them and a higher synthesis rate could be achieved. To test this hypothesis, we 
computed the average carbon content of all 20 amino acids, weighted by each amino 
acid’s stoichiometry in biomass, as 1.28±0.60 mmoles of carbon per mmole biomass. 
This molecular weight turned out not to be smaller but significantly larger than the 
carbon content of 20 random biomass molecules, also weighted by their stoichiometry 
in biomass (0.87±0.15 mmoles of carbon, P<2.2×10
-16
, one sample t-test, for n=105 
sets of 20 random biomass molecules). This means that low amino acid cost cannot 
explain a higher rate of amino acid production. 
We next asked whether lower waste production might be responsible for the lower 
biosynthetic flux we observed. We therefore analyzed the quantity of secreted waste 
products in 80 networks that synthesize 20 amino acids, and in 80 networks that 
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synthesize 20 random biomass compounds. Waste production is indeed significantly 
lower in networks that synthesize amino acids (P<10
-17
, Mann-Whitney U-test) (Mann 
and Whitney 1947). Specifically, amino acid synthesizing networks produce 47 
percent less waste than networks that synthesize arbitrary molecules. They excrete on 
average 22.8 mmoles of carbon waste per g DW hour (Figure 4c). 
To provide a concrete example of a prominent waste molecule, consider the amount 
of secreted carbon dioxide. For each mole of carbon entering a network in the form of 
glucose, amino acid synthesizing networks excrete 0.18±0.12 (mean ± one standard 
deviation) moles of carbon per g DW hour as carbon dioxide, whereas networks 
synthesizing 20 arbitrary molecules excrete 0.31±0.06 mmoles of carbon per g DW 
hour as carbon dioxide (P<10
-25
, Mann-Whitney U-test) (Mann and Whitney 1947). In 
sum, waste production is an important factor in explaining the smaller costs of amino 
acid biosynthesis compared to arbitrary biomass molecules. 
 
2.4. Discussion 
We here studied typical properties of metabolic networks with recently developed 
techniques to create random and unbiased samples of metabolic networks from a vast 
space of such networks (Matias Rodrigues and Wagner 2009; Samal et al. 2010). 
Specifically, we studied the quantitative relationships between 6 different properties. 
These are the number of alternative sole carbon sources N that a network can use – its 
nutrient flexibility –, the number of (biomass) molecules B it can synthesize, the rate S 
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at which it can synthesize these molecules, the number of reactions R in the network, 
the number of active reactions RA, that is, reactions that have nonzero metabolic flux, 
and the amount of waste W the network produces.  
We focused first on how the number of minimally needed reactions R depends on N 
and B, because this number of reactions is an important design variable. Smaller 
networks would be easier to design and smaller genomes would be easier to 
synthesize (Carr and Church 2009). More than that, biosynthetic processes are more 
controllable and predictable in a small metabolism (Mizoguchi et al. 2008; Purnick 
and Weiss 2009). We found that for every additional molecule to be synthesized, a 
network needs on average three additional reactions.  
In a related analysis, we focused on nutrient flexibility. The ability of a metabolic 
network to sustain life on multiple sources of chemical elements and energy is highly 
desirable in industrial production processes (Wisselink et al. 2009). Examples include 
biofuel production from cellulosic biomass. Cellulosic biomass contains both hexoses 
(e.g., glucose) and pentoses, whose major constituent is xylose (Ho et al. 1998; 
Wisselink et al. 2009). Many yeast species, for instance, do not consume pentoses, 
and need to be engineered to have greater nutrient flexibility to make biofuel 
production more efficient (Ho et al. 1998). In our analysis, we found that for every 
additional carbon source to be utilized, a network needs on average two additional 
reactions. Thus, it is more expensive, in terms of the number of needed reactions, to 
synthesize additional molecules than to synthesize the same molecules but from a 
larger number of alternative carbon sources.  
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Anecdotal evidence for the tendency that increased nutrient flexibility requires larger 
networks is provided by two networks for which nutrient flexibility is experimentally 
known (Feist et al. 2007; Oh et al. 2007). These are E. coli where N=54 and R=1396 
and Bacillus Subtilis where N is smaller (N=41) and so is R (R=769). We also 
compared the computationally predicted number of carbon sources that can be utilized 
by metabolic models of seven organisms (Column 4 of Table 1). Although based on 
few data points, this analysis suggests that there is a significant correlation (Pearson’s 
r=0.9, P=0.005) between the in silico nutrient flexibilities and networks sizes of these 
model organisms. 
Organism B R RA N References 
Buchnera Aphidicola 43 205 183 2 (Thomas et al. 2009) 
Helicobacter pylori 52 394 298 35 (Schilling et al. 2002) 
Staphlococcus aureaus 58 534 286 41 
(Becker and Palsson 
2005) 
Bacillus Subtilis 59 769 327 97 (Oh et al. 2007) 
Methanosarcina barkeri 63 531 352 6 (Feist et al. 2006) 
Escherichia coli 67 1396 388 175 (Feist et al. 2007) 
Mycobacterium tubeculosis 93 836 408 39 (Beste et al. 2007) 
 
Table 1. Biosynthetic ability B, number R of metabolic reactions (size of metabolic networks), number RA of 
number of active reactions and number N of carbon sources predicted to be catabolized in computational 
metabolic models of various organisms.   We took the number of synthesized molecules B, and the number of 
metabolic reactions R from the genome scale metabolic network reconstructions of those organisms as listed in the 
column ‘References’. Active reactions are reactions that have non-zero flux as determined by FBA. We computed 
nutrient flexibilities by testing the viability of metabolic models on all known carbon containing metabolites that 
are educts or products of reactions in the global network by FBA and assumed a metabolite to be a carbon source if 
the metabolic model can utilize it. 
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As a result of these dependencies, the minimally needed number of reactions varies 
widely among the networks we study. For example, for networks that can use 20 
alternative carbon sources, it ranges from an average of 260 reactions (which would 
be, for comparison 19% of the whole E. coli network) needed to synthesize B=20 
molecules to an average of 381 reactions (29% of the E. coli network) to synthesize 
all B=63 biomass molecules of E. coli. For networks that can use 80 alternative 
carbon sources, the largest number we studied, it increases from 398 (27%) to 518 
reactions (37% of the E. coli network) as B increases from 20 to 63.  
N and B can explain the vast majority (87%) of the variance in R, in a relationship that 
is close to linear. Note that the proportions in which biomass molecules are to be 
synthesized are immaterial, as long as the metabolic reactions to synthesize each 
required molecule are present. This is why the stoichiometry of biomass composition 
would not influence the relationships we observe. The remaining 13% is variance 
unexplained by linear relationships among the variables we considered. Such 
unexplained variance could have multiple sources, and especially nonlinear 
relationships among the variables. For example, as the number of biomass molecules 
to be synthesized increases, fewer and fewer additional reactions might be required, 
because most precursors of the additional biomass molecules may already be 
synthesized by existing reactions. 
We showed that the reactions that are needed to utilize an additional carbon-
containing molecule or to synthesize an additional biomass molecule typically involve 
the additional molecule.  For example, the utilization of an additional carbon source 
requires a reaction that catabolizes that molecule. The synthesis of an additional 
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molecule requires a reaction that produces that molecule. We emphasize that the 
required numbers of reactions we found for an additional carbon source or biomass 
molecule are statistical patterns, averages over multiple networks. Some additional 
carbon sources or biomass molecules need more reactions than the average we 
identified, whereas others need fewer. (For some examples see Supporting 
Information, Table S3, Table S4, sections ‘Examples of reactions needed to 
metabolize new carbon sources’ and ‘Examples of reactions needed to synthesize 
additional biomass molecules’.) 
We also studied the number of active reactions – reactions with nonzero flux on a 
given carbon source. Quantitatively, we found that the number of active reactions 
increases by 3.6-4 reactions for each additional biomass molecule to be synthesized. 
Qualitatively, this tendency – increasing synthetic ability requires more active 
reactions – is not surprising. Table 1 shows, as an example of this tendency, several 
well-known organisms with known metabolic network sizes R and biosynthetic 
abilities B. Note that, with exceptions, the number of active reactions RA tends to 
become higher as B increases for these organisms. Albeit based on few species, a 
regression analysis of the data in Table 1 shows that the relationship between RA and 
B is similar to what we find in our much larger samples of random networks 
(RA=3.4B+120). Our approach has the advantage of allowing us to make quantitative 
statements about the number of active reactions required to synthesize additional 
molecules that are not just based on few, well studied organisms, as in Table 1, but on 
arbitrarily large and random samples of metabolic networks.  
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The identity of active metabolic reactions can depend strongly on the nutrient 
environment (Nishikawa et al. 2008; Samal et al. 2010; Wang and Zhang 2009). A 
reaction active in one environment may be inactive in another. Organisms would cope 
with such variation by regulating the activity of reactions, for example by regulating 
the expression of enzyme-coding genes or by regulating the enzymes themselves 
(Cooper 2008). The importance of reaction activity in our analysis thus points towards 
the importance of regulating metabolic flux in response to the environment. 
Engineering optimal regulation of enzymes is a key challenge in metabolic 
engineering (Kim and Reed 2010; Wessely et al. 2011). It will be an even greater 
challenge in a synthetic metabolism, especially if such a metabolism is to function 
efficiently in multiple chemical environments.  
A second major set of analyses focused on how metabolic network properties 
influence biosynthetic flux S. These analyses are motivated by the fact that high 
synthesis rates of one or more target molecules are important goals of metabolic 
engineering (Antoni et al. 2007; Lee et al. 2008; Rude and Schirmer 2009). Our first 
major observation in this regard concerns the number of reactions in a metabolic 
network. This number has virtually no influence on the attainable biosynthetic flux S. 
In stark contrast, the number of active reactions – reactions with nonzero flux – shows 
a strong negative association with biosynthetic flux. That is, the higher the 
biosynthetic flux is, the smaller is the number of active reactions. (This analysis is 
based on networks that have more than the minimally necessary number of reactions 
in a given environment. In minimal networks, all reactions must be active.) This 
observation is consistent with earlier work based on four microbial metabolic 
networks (Nishikawa et al. 2008).  
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A second important influence on biosynthetic flux S is the number of biomass 
molecules to be synthesized. Specifically, every additional such molecule reduces S 
by approximately 5 percent. This influence is stronger than the influence of nutrient 
flexibility, where each additional carbon source changes biomass synthesis flux by 1 
percent. That nutrient flexibility influences biosynthesis rates is known from 
experiment (Garcia Sanchez et al. 2010; Liu and Hu 2010; Madhavan et al. 2009; 
Nevoigt 2008; Wisselink et al. 2009).  For example, engineered yeast strains capable 
of growing on more carbon sources achieve higher product yields (Wisselink et al. 
2009).  
The amount of waste W that a network produces is a third, and the most important 
influence on biosynthetic flux S. Metabolic networks generally excrete waste, for 
example, in the form of carbon dioxide (Nishikawa et al. 2008), acetate (Nishikawa et 
al. 2008; Weber et al. 2005),  pyruvate (Weber et al. 2005) or glycerol (Ho et al. 1998; 
Nevoigt 2008). Not only does this mean wasted resources, some waste products may 
also be toxic and interfere with goals of metabolic engineering (Mukhopadhyay et al. 
2008). We found that biosynthetic flux S shows a strong negative correlation with 
waste production W in the form of excreted carbon. This relation is in agreement with 
experimental observations (Ho et al. 1998; Nevoigt 2008; Weber et al. 2005). For 
example in E. coli, Weber et al (Weber et al. 2005) demonstrated that excretion of 
methylglyoxal, D- and L-lactate, pyruvate, and acetate decreases growth rates. We 
also observed that networks with higher nutrient flexibility produce less waste, such 
that for each additional carbon source, networks produce 0.1 mmoles less in excreted 
carbon waste. This relationship can help explain the positive influence of N on flux S. 
Experimental support for this observation exists as well. For example, Wisselink et al. 
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(Wisselink et al. 2009) observed that increased ethanol production in engineered yeast 
with higher nutrient flexibility is caused by reduced production of the waste products 
xylitol and arabinitol. Relatedly, the elimination of glycerol formation increases the 
yield of ethanol up to 10 percent in yeast (Nevoigt 2008). Ho et al. (Ho et al. 1998) 
report similar observations.  
We also found that an analogous association does not exist for B. Networks seem to 
produce indistinguishable amounts of waste products regardless of how many biomass 
molecules they synthesize.  
Overall, the quantities we examined can explain 84 percent of the variance in 
biosynthetic flux S we observed. This means, that these quantities account for most of 
the variation in the biosynthetic flux, and are thus important factors in the design of a 
synthetic metabolism. 
In our final analysis, we showed that the nature of the molecules to be synthesized can 
influence biosynthetic flux. For example, in biotechnological applications, a 
metabolic network may need to synthesize molecules that are closely related, and 
whose biosynthetic pathways are therefore similar, in the sense that they share many 
reactions. Examples include vitamins and coenzymes (Vandamme 1992), taxols and 
related taxoids (Expósito et al. 2009), hydrocarbons and related ether lipids (Metzger 
and Largeau 2005), amino acids (Leuchtenberger et al. 2005). We examined the 
influence of biochemical relatedness by studying metabolic networks that synthesize 
all 20 amino acids, and comparing them with networks that synthesize 20 arbitrary 
biomass molecules. In this analysis, we found that the amino acids could be 
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synthesized by networks with fewer reactions, thus demonstrating their biosynthetic 
relatedness. They can also be synthesized at a rate that is 35 percent higher, because 
their biosynthesis produces 47 percent less waste as excreted carbon. These 
differences are substantial, given that metabolic engineering in biotechnological 
processes typically increases synthesis rates of desired products by 5-10 percent 
(Dueñas-Sánchez et al. 2010; Nevoigt 2008; Raab et al. 2011; Raghevendran et al. 
2006).  
We conclude with some caveats and limitations of our analysis. First, we are well 
aware that there is still a gap between current metabolic engineering and synthetic 
biology experiments, and theoretical studies such as ours. We see the value of studies 
like ours as providing quantitative reference points for future experimental work in 
this area.  
Second, flux balance analysis, on which our approach rests, assumes a metabolic 
system that is in a steady-state, such as might be achieved by a microbial population 
growing under a constant nutrient supply. This assumption ignores possible additional 
constraints that regulation and enzyme kinetics exert on a metabolism (Kauffman et 
al. 2003; Price et al. 2004). While achieving proper regulation remains a big challenge 
in synthetic biology, we note that some of our observations are unlikely to be affected 
by this assumption. For example, relaxing this assumption would not reduce the 
minimal number of reactions needed for a given biosynthetic task. 
Third, we focus on typical network properties, that is, properties of metabolic 
networks sampled at random from a large space of such networks. Optimization 
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procedures that search metabolic networks space systematically may be able to 
identify individual networks whose properties deviate from those we identified as 
typical. For example, they may identify networks that are able to synthesize biomass 
with even fewer reactions or at higher rates. Such procedures have been successful in 
other combinatorial optimization problems. They include simulated annealing 
(Gonzalez et al. 2007; Tomshine and Kaznessis 2006), bi-level optimization 
(Domingues et al. 2010; Yang et al. 2008), OptFlux (Rocha et al. 2010), convex 
optimization (Julius et al. 2008) and evolutionary optimization (Ebenhöh and 
Heinrich 2001; Patil et al. 2005). The extent to which they can identify networks with 
superior design remains an important subject of future work.   
Fourth, the expression of enzymes itself has a metabolic cost. This cost may be 
reduced by regulating enzyme expression depending on the nutrient environment 
(through regulatory machinery whose expression may itself be costly.) We did not 
consider costs like these here, because they are poorly understood on a quantitative 
level. Their analysis remains an important goal for future work.  
Finally, we note that an organism’s genome encodes more than metabolism. 
Nonmetabolic genes, even in small genomes serve roles in systems that allow cell 
motility, signaling, secretion, and defense (Kuwahara et al. 2007). The heterogeneity 
of these systems will make general, quantitative statements about design constraints 
for entire genomes more difficult to obtain. In this regard, we note that the proportion 
of a gene’s genome devoted to metabolism increases in small genomes. For example, 
in the free-living E. coli with a large genome, fewer than 75 percent of genes exert 
metabolic functions (Riley 1997). In contrast, in some endosymbionts including 
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Buchnera, Wiggleswothia glossinidia and Thiomicrospira crunogena more than 80 
percent of genes are devoted to metabolic functions, and in yet others, such as the 
gamma proteobacteria, Blochmanni floridanus and Wolbachia pipientis more than 95 
percent have metabolic functions (Kuwahara et al. 2007). Thus, the constraints we 
identified here would affect the majority and perhaps the vast majority of a synthetic 
minimal organism’s genome.   
 
2.5. Methods 
The metabolic genotype of an organism comprises all genes that encode metabolic 
enzymes. This genotype can be compactly represented through a list of reactions that 
can take place in the organism and that are catalyzed by enzymes (Edwards and 
Palsson 2000b; Edwards and Palsson 2000a; Goto et al. 2002; Goto et al. 2000; 
Kanehisa and Goto 2000; Klasson 2004). Each metabolic genotype exists in a vast 
metabolic genotype space that contains all possible metabolic networks – all possible 
combinations of reactions drawn from a set of biochemically feasible reactions – that 
could take place in a living system. According to our current knowledge, there are 
more than 5000 such reactions, which means that metabolic genotype space comprises 
2
5000
 possible metabolic networks. The metabolic genotype or metabolic network of 
any one organism can be viewed as a point in this space. Two genotypes differing 
from each other in a single reaction are neighbors in this space. We refer to a 
network’s metabolic phenotype as the spectrum of chemical environments – defined 
by nutrients these environments contain – on which the network can synthesize a 
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predetermined spectrum of molecules, as well as the rate at which it can synthesize 
these molecules. We call a network viable in a given environment if it can synthesize 
all these molecules in the environment.  
Flux Balance Analysis 
Flux balance analysis (FBA) is a constraint-based modeling approach that predicts 
steady state metabolic fluxes – rates of substrate to product conversion – for all 
metabolic reactions in a metabolic network. It can thus also predict the biomass yield 
and other complex metabolic attributes of a metabolic network (Kauffman et al. 2003; 
Price et al. 2004). Because FBA does not need kinetic information, but only 
stoichiometric information about the reactions involved, it is a widely used approach 
for analyzing the metabolism of well-studied organisms such as E. coli and S. 
cerevisiae (Kauffman et al. 2003; Orth et al. 2010; Price et al. 2004). The needed 
stoichiometric information comes from experimental biochemical analysis, as well as 
from comparative analyses of enzyme-coding genes in different, completely 
sequenced genomes. This information is encapsulated in a stoichiometric matrix S of 
dimensions m × n, where m denotes the number of metabolites, and n is the number 
of reactions in a network (Kauffman et al. 2003; Orth et al. 2010). FBA assumes that 
a metabolic network is in a metabolic steady-state, such as may occur in a microbial 
population that proliferates in an unchanging environment. Because mass needs to be 
conserved under these conditions, any vector v of metabolic fluxes – the rates at 
which a network’s metabolic reactions convert substrates into products – must satisfy 
the equation  
Sv = 0 
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This equation typically has a large solution space of allowable fluxes. The size of this 
space can be reduced somewhat by placing biochemically motivated constraints on 
the irreversibility of some reactions and on maximal flux magnitudes (Covert et al. 
2001). In the (reduced) solution space, FBA then uses linear programming to identify 
regions in the space that maximize a quantity of interest, which can be represented by 
a linear objective function Z (Kauffman et al. 2003; Orth et al. 2010). More 
specifically, the linear programming formulation of an FBA problem can be written 
as: 
max Z = max {c
T
 v | Sv = 0, a ≤ v ≤ b}         (1)  
where the vector c
T
  stands for a transposed (
T
) array c of scalar coefficients that 
define the objective function. Vectors a and b contain lower and upper limits of 
reaction fluxes in the flux vector v, respectively. A particularly important quantity to 
be maximized is the rate of synthesis of a given set biomass molecules. We refer to 
this quantity as the biosynthetic flux (in units of mmol per g DW per hour) of a 
metabolic network. We used the software packages CPLEX (11.0, ILOG; 
http://www.ilog.com/) and CLP (1.4, Coin-OR; https://projects/coinor.org/Clp) to 
solve all linear programming problems that arise in this study.  
Biomass Molecules 
The starting point of our analysis was a set of 67 biomass molecules from E. coli 
(Feist et al. 2007). We used these molecules, because E. coli’s biomass composition is 
well studied, and many of its components – amino acids, nucleotides, etc. – also occur 
in most other free-living organisms. In addition, E. coli and its biomass molecules are 
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highly relevant to biotechnological applications (Lee et al. 2008; Mizoguchi et al. 
2008; Rude and Schirmer 2009). For some of our analyses, we needed to vary the 
spectrum of metabolites that a metabolic network needs to synthesize. Among the 67 
E. coli biomass molecules, we allowed all but four molecules to vary. These four 
molecules are the “currency metabolites” adenosine 5'-diphosphate (ADP), 
phosphoric acid (Pi), pyrophosphoric acid (PPi), and hydrogen ions. A complete list 
of the biomass molecules we used can be found in Supplementary Table S1.  
Carbon Sources 
Any one metabolic network can only synthesize biomass if its chemical environment 
contains specific nutrients (Handorf et al. 2008). In FBA, these nutrients are 
represented by special exchange reactions that reflect transport of nutrients into the 
cell. The environments we study are minimal chemical environments that contain a 
single molecular source for each essential chemical element. These sources are 
oxygen, ammonium, inorganic phosphate, sulfate, sodium, potassium, cobalt, iron, 
protons, water, molybdate, copper, calcium, chloride, magnesium, manganese and 
zinc, as well as a single source of carbon. We study how variation in carbon sources 
constrains the composition of metabolic networks that needs to synthesize a given 
spectrum of molecules. We chose to vary carbon sources for this purpose, because of 
carbon’s centrality as a chemical element in biomass. A complete list of the carbon 
sources we used is given in the Supplementary Table S2.  
We computed the biomass growth of a network by taking the average of its biomass 
growth rates on each carbon source that the network is required to be viable on, 
except where mentioned otherwise. 
 
 
72 
Global Network 
Some of our analyses use a “global reaction network”. This global network contains a 
comprehensive set of known biochemical reactions from multiple organisms, and it 
has universal biosynthetic abilities. We are fully aware that no such network is likely 
to exist in any one organism. We use this global network merely as a starting point for 
successive elimination of reactions, as described in the next section. We generated 
this global network by merging reactions from two sources, as described in more 
detail in (Matias Rodrigues and Wagner 2009). The first is the LIGAND reaction 
database of the Kyoto Encyclopedia of Genes and Genomes (KEGG) (Edwards and 
Palsson 2000b; Edwards and Palsson 2000a; Goto et al. 2002; Goto et al. 2000; 
Kanehisa and Goto 2000; Klasson 2004). The second is the complete metabolic 
reaction set of E. coli (iAF1260), which contains 1397 non-transport reactions (Feist 
et al. 2007). We excluded from this network  (i) all reactions involving polymer 
metabolites of unspecified numbers of monomer units, (ii) general polymerization 
reactions with uncertain stoichiometry, (ii) reactions involving glycans, due to their 
complex structure, (iv) reactions with unbalanced stoichiometry, and (v) reactions 
involving complex metabolites without chemical information about their structure 
(Matias Rodrigues and Wagner 2009). After these procedures the global network 
contained 5906 internal (non-transport reactions) and 5030 metabolites. 
Essential Reactions and Minimal Networks  
A gene whose deletion abolishes the viability of an organism is called an essential 
gene. Analogously, an essential reaction in a metabolic network is a reaction that 
cannot be removed without abolishing the organism’s viability in a given 
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environment. A minimal metabolic network is a network from which not a single 
reaction can be removed without abolishing viability in a given environment. In other 
words, all reactions of a minimal network are essential in that environment. We 
emphasize that a minimal network is not the smallest possible viable network, which 
would be difficult to find in a vast space of metabolic networks. We note that there 
may be multiple minimal networks, which contain different pathways among a set of 
possible alternate pathway from a nutrient to a biomass precursor. These networks 
need not have the same size. We also note that the number of essential reactions in 
any one non-minimal network may be smaller than the size of a minimal network, 
because non-minimal networks may contain alternate pathways able to by-pass any 
one reaction. 
Generation of Minimal Networks  
To analyze the smallest number of reactions that a network needs to have in order to 
(i) synthesize a given number B of biomass molecules on (ii) each of N different 
carbon sources, we created and analyzed many minimal networks with different 
values of B and N. Because there are astronomically many combinations of different 
values of B and N, and because the FBA approach we use is computationally 
expensive, we focused on subsets of such combinations, which we created as follows. 
First, we created 10 different sets each of B=40, B=30, and B=20 randomly chosen 
biomass molecules from the set of 63 E. coli biomass molecules (excluding the four 
‘currency’ metabolites mentioned above in the Section ‘Biomass Molecules’, which 
are found in all of the sets) (Feist et al. 2007). These sets served as the basis for our 
analysis of networks that vary in their biosynthetic ability B. To arrive at identical 
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sample sizes for subsequent analyses, we also included 10 “sets” with B=63, that is, 
each of these sets contained all 63 biomass molecules. In total, we thus created a total 
of 40 (10×4) sets of biomass molecules. 
Second, for each of these 40 sets we determined 4 different sets of nutrients, where 
each set contained a different number of randomly chosen carbon sources from the list 
of carbon sources we used (see Section Carbon Sources). Specifically, these sets of 
nutrients contained N=20, N=40, N=60, and N=80 carbon sources. Thus, up to this 
second step we had generated a total of 160 (40×4) combinations of sets of biomass 
molecules and nutrients. 
Finally, for each of these 160 combinations, we created 5 minimal metabolic 
networks. To create each minimal network, we used the following procedure. We 
started from the global network and sequentially removed individual randomly chosen 
reactions from it. After each reaction removal we verified that the network was still 
viable – able to synthesize all B biomass molecules in the set – when each of the N 
nutrients was provided as the sole carbon source, that is, the network was required to 
be viable on each carbon source. If that was not the case, we reversed the reaction 
elimination and removed a different, randomly chosen reaction, until the resulting 
network was viable. We continued this procedure until no further reactions could be 
removed from the network without abolishing viability. In this fashion, we generated 
800 (160×5) minimal networks. Note that carrying out this procedure repeatedly may 
not arrive at the same minimal network, because reactions are removed at random. 
That is, different minimal networks may contain different numbers and different sets 
of reactions. What unites them is that all their reactions are essential. 
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Minimal Networks with Isostoichiometric Biomass Composition 
We asked whether the stoichiometric composition of biomass, that is, the relative 
amounts of different biomass molecule in biomass, influences the relationships we 
explore here. To this end, we generated minimal networks synthesizing given biomass 
compounds, as described in the previous section, with the difference that these 
networks synthesized these compounds in equal molarities that is 
isostoichiometrically. In other words, for the purpose of this analysis we changed the 
stoichiometric coefficients c
T
 in the biomass growth function of Equation 1 to a value 
of one. We used the same combinations of sets nutrients and biomass molecules as 
described above, except that we generated only 2 minimal networks (instead of 5) for 
each combination, in order to reduce computational cost. In total, we thus analyzed 
320 minimal networks with isostoichiometric biomass composition. 
Minimal Networks Synthesizing 20 Amino Acids 
To study examples of networks that synthesize biochemically related biomass 
molecules, we studied minimal networks synthesizing only the 20 proteinaceous 
amino acids. We generated these networks as described in ‘Generation of Minimal 
Networks’, except that we did not choose the biomass molecules to be synthesized at 
random. More specifically, we created 10 sets each of N=20, N=40, N=60, and N=80 
randomly chosen carbon sources, and analyzed 8 minimal networks for each set, for a 
total of 320 networks. 
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MCMC Sampling and Random Networks 
As we mentioned earlier, changing the genotype of a network does not necessarily 
cause a change in its phenotype. One can take advantage of this property to generate 
arbitrarily large and unbiased random samples of metabolic networks with any desired 
property (see Figure 5), such that viable networks with a given number of reactions 
are sampled uniformly from the space of such networks. Such samples are central to 
our analysis. To create them we used a procedure built on Markov Chain Monte Carlo 
(MCMC) sampling described previously (Matias Rodrigues and Wagner 2009; Samal 
et al. 2010). This procedure fulfills the important detailed balance condition for 
MCMC sampling. Briefly, the procedure constructs a sequence of metabolic 
networks, where the next network in the sequence is created from the previous 
network through a reaction swap. Such a reaction swap consists of the removal of a 
randomly chosen reaction from the network, followed by the addition of a randomly 
chosen reaction taken from the global network. We used such reaction swaps, because 
they preserve the exact number of reactions in a metabolic network, which is 
important for our analysis. If a reaction swap preserves viability of the network in a 
given environment, then the swap is accepted, otherwise it is rejected, and a new swap 
is attempted until a viable genotype is found. We note that subsequent networks in a 
sequence show autocorrelation in their properties, and are thus not suitable for 
random sampling. Past work has shown that after 5 × 10
3
 swaps, the autocorrelation 
of two genotypes becomes negligible (Samal et al. 2010). We therefore started the 
random walk from E. coli metabolic network and after 2.5 × 10
6
 reaction swaps, we 
sampled networks every 5 × 10
3
 steps in a sequence. Overall, the network samples we 
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created comprise 1000 networks for each condition we study. We did not subject 
transport reactions to the reaction swap procedure. 
 Figure 5. Exploration of a metabolic network 
space. Metabolic networks can be viewed as 
subsets of enzyme-catalyzed metabolic reactions 
in a global reaction set. Formally, they can be 
represented as binary vectors listing the 
reactions catalyzed by enzymes in an organism, 
as indicated for two hypothetical metabolic 
networks (N1, N2) in the figure. Metabolic 
phenotypes are computed from metabolic 
networks using FBA. They can be represented 
as binary vectors indicating the carbon sources 
(i.e.: alanine, glucose, melibiose,...) on which a 
network is viable, that is, on which it can 
synthesize a given set of (biomass) molecules. 
Neighboring networks (blue circles linked by 
edges) differ by a single reaction swap (edges 
between circles) that leaves the metabolic 
phenotype unchanged.  A reaction swap consists of two changes: one random reaction addition (R4 in the 
example) and one random reaction deletion (R3 in the example).  A series of successful reaction swaps is called a 
random walk (indicated by red arrows). The Markov Chain Monte Carlo (MCMC) technique allows one to 
randomly sample networks with a given phenotype by generating long random walks through genotype space, 
where each step in a walk consists of a reaction swap. The advantage of using reaction swaps is that they leave the 
number of reactions constant.   
To compare our observations from randomly sampled metabolic networks to a 
reference from biology, it is useful to use a network from a well-studied organism. 
For this purpose, we used the metabolic network of E. coli, because E. coli is able to 
survive in multiple different environments (Touchon et al. 2009; Welch et al. 2002). 
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Generation of Starting Networks for MCMC Sampling 
To initiate the MCMC procedure that generates random samples of networks with a 
given set of properties, we needed starting networks that have these properties. 
Specifically, we needed to create networks with a given number of reactions R, 
nutrient flexibility N, and biosynthetic ability B. To this end, we started with the same 
160 sets of N nutrients and B biomass molecules described in ‘Generation of Minimal 
Networks’. We created for each set 5 viable networks that differ in their number of 
reactions, that is, they had 400, 500, 600, 700 and 800 reactions. To create these 
networks, we used the same procedure as for the production of minimal networks, 
except that we stopped removing reactions when a network with the desired number 
of reactions had been reached. At the end of this procedure, we had 800 networks 
(160×5) with various combinations of the 3 network properties. We used each of 
these networks as starting networks for MCMC sampling, and generated 20 random 
viable networks from each of the 800 starting networks, for a total of 16000 random 
networks. This amounts to 200 networks for each different combination of N, B, and 
R. 
We performed all our analyses using MATLAB (7.10.0, The MathWorks Inc., Natick, 
MA, R2010a) and R (R Development Core Team, 2008). 
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2.8. Supplementary Material 
 
Supplementary Tables 
 
L-alanine  
L-arginine potassium 
L-asparagine ammonium 
L-aspartate magnesium 
L-cysteine calcium 
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L-glutamine reduced iron 
L-glutamate iron trication 
glycine copper 
L-histidine manganese 
L-isoleucine molybdenum 
L-leucine cobalt 
L-lysine zinc 
L-methionine chloride 
L-phenylalanine sulfate 
L-proline water 
L-serine coenzyme-A 
L-threonine NAD 
L-tryptophan NADP 
L-tyrosine FAD 
L-valine 5,6,7,8-tetrahydrofolate 
datp 5,10-methylenetetrahydrofolate 
dttp 10-formyltetrahydrofolate 
dgtp thiamine diphosphate 
dctp pyridoxal 5'-phosphate 
CTP protoheme 
GTP siroheme 
UTP undecaprenyl diphosphate 
ATP S-sdenosyl-L-methionine 
murein disaccharide 2-octaprenyl-6-hydroxyphenol 
KDO(2)-lipid IV(A) riboflavin 
Phosphatidylethanolamine 
 (dihexadecanoyl, n-C16:0) 
phosphatidylethanolamine  
(dihexadecanoyl, n-C16:1) 
Phosphatidylethanolamine 
phosphate 
 (dihexadecanoyl, n-C16:0) 
phosphatidylethanolamine phosphate 
(dihexadecanoyl, n-C16:1) 
 
Table S1. List of E. coli’s Biomass Compounds [57] 
 
1,4-alpha-D-glucan UMP Lactose 
3-hydroxycinnamic Glycerol Butyrate 
3-(3-hydroxy-
phenyl)propionate 
alpha-D-Ribose Hexadecanoate 
Phosphate D-Ribose D-Lactate 
AMP Fumarate D-Gluconate 
Pyruvate D-Galactose L-Arabinose 
L-Glutamate IMP Hypoxanthine 
2-Oxoglutarate D-Alanine N-Acetylneuraminate 
UDPglucose Putrescine D-Mannose 
D-Glucose N-Acetyl-D-glucosamine Inosine 
Acetate GMP Uridine 
Glycine Adenine L-Xylulose 
L-Alanine L-Proline D-Glucosamine 
Succinate L-Malate Deoxyguanosine 
UDP-N-acetyl-D-glucosamine L-Asparagine D-Galacturonate 
L-Aspartate Citrate 4-Aminobutanoate 
Reduced D-Mannose D-Glucosamine 
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UDPgalactose Glycolate dAMP 
CMP Propionate dGMP 
Formate Acetoacetate dTMP 
Sulfate UDP-D-glucuronate dUMP 
L-Arginine Agmatine Xanthine 
L-Glutamine D-Xylose Guanosine 
L-Serine Dihydroxyacetone D-Mannitol 
Formaldehyde L-Lactate alpha-D-Galactose 
L-Ascorbate L-Threonine Ethanol 
L-Tryptophan Ethanolamine Cytidine 
Acetaldehyde D-Glucuronate Propanal 
D-Fructose UDP-N-acetyl-D-galactosamine D-Malate 
Sucrose 2-Dehydro-3-deoxy-D-gluconate L-Rhamnose 
D-Glucose Maltose Deoxyuridine 
Glycerol Adenosine Deoxyadenosine 
D-Fructose Thymidine D-Glyceraldehyde 
L-Cysteine dCMP N-Acetyl-D-mannosamine 
D-Glucose Guanine Xanthosine 
sn-Glycero-3-phosphocholine 2',3'-Cyclic octadecanoate 
D-Serine 2',3'-Cyclic Allantoin 
L-Idonate Dodecanoate Decanoate 
D-Cysteine N-Acetylmuramate Hexanoate 
D-Sorbitol Glycerol Ornithine 
D-Glucarate Glycerophosphoglycerol Galactitol 
D-Galactarate N-Acetyl-D-glucosamine Xanthosine 
D-Galactonate D-Glucuronate Maltotriose 
Deoxycytidine Melibiose Maltohexaose 
L-tartrate Deoxyinosine Maltotetraose 
D-Fructuronate Phenylpropanoate 2',3'-Cyclic 
D-Alanyl-D-alanine 3'-cmp butanesulfonate 
O-Phospho-L-serine 3'-GMP ethanesulfonate 
L-Fucose 2',3'-Cyclic fructoselysine 
5-Dehydro-D-gluconate dIMP Glycerophosphoserine 
Trehalose Fe(III)dicitrate Galactonate 
sn-Glycero-3-phospho-1-
inositol 
2,3-diaminopropionate Hexadecenoate 
sn-Glycero-3-
phosphoethanolamine 
octanoate Maltopentaose 
Ammonium tetradecanoate octadecenoate 
3'-AMP 2(alpha-D-Mannosyl)-D-glycerate L-Prolinylglycine 
3'-UMP L-Threonine psicoselysine 
Cys-Gly L-Lyxose tetradecenoate 
L-alanine-D-glutamate-meso-
2,6-diaminoheptanedioate 
N-Acetyl-D-
glucosamine(anhydrous)N-
Acetylmuramic 
L-alanine-D-glutamate-meso-2,6-
diaminoheptanedioate-D-alanine 
D-Allose   
 
Table S2. List of carbon sources used in this study 
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Examples of reactions required to synthesize additional biomass molecules 
 
Biomass 
Molecule 
Required Additional Reactions 
2-octaprenyl-
6-
hydroxypheno
l 
2-octaprenylphenol hydroxylase, octaprenyl-hydroxybenzoate decarboxylase, 
hydroxybenzoate octaprenyltransferase, chorismate pyruvate lyase, octaprenyl 
pyrophosphate synthase 
arginine 
N-acetylglutamate synthase, N-acetyl-g-glutamyl-phosphate reductase, 
acetylglutamate kinase, acetylornithine transaminase, acetylornithine deacetylase, 
argininosuccinate lyase, argininosuccinate synthase, ornithine carbamoyltransferase 
asparagine asparagine synthase 
coenzyme A 
2-dehydropantoate 2-reductase, 3-methyl-2-oxobutanoate hydroxymethyltransferase, 
phosphopantothenate-cysteine ligase, phosphopantothenoylcysteine decarboxylase, 
pantothenate synthase, aspartate 1-decarboxylase, dephospho-CoA kinase, 
pantetheine-phosphate adenylyltransferase, pantothenate kinase 
dATP ribonucleoside-triphosphate reductase (ATP) 
dCTP ribonucleoside-triphosphate reductase (CTP) 
dGTP 
nucleoside-diphosphate kinase (ATP:dGDP), ribonucleoside-diphosphate reductase 
(GDP) 
dTTP 
nucleoside-diphosphate kinase (ATP:dTDP), dTMP kinase, uridylate kinase (dUMP), 
thymidylate synthase, ribonucleoside-diphosphate reductase (UDP) 
FAD FMN adenylyltransferase, riboflavin kinase 
histidine 
ATP phosphoribosyltransferase, imidazoleglycerol-phosphate dehydratase, imidazole-
glycerol-3-phosphate synthase, histidinol-phosphate transaminase, histidinol-
phosphatase, histidinol dehydrogenase, phosphoribosyl-AMP cyclohydrolase, 
phosphoribosyl-ATP pyrophosphatase, 1-imidazole-4-carboxamide isomerase 
isoleucine 
dihydroxy-acid dehydratase, ketol-acid reductoisomerase, 2-aceto-2-
hydroxybutanoate synthase, isoleucine transaminase, L-threonine deaminase 
KDO(2)-lipid 
IV(A) 
UDP-3-O-glucosamine acyltransferase, UDP-N-acetylglucosamine acyltransferase, 3-
deoxy -D-manno-octulosonic -acid 8-phosphate, tetraacyldisaccharide 4'kinase, 3-
deoxy-D-manno-octulosonic acid transferase, 3-deoxy-manno-octulosonate 
cytidylyltransferase, 3-deoxy-manno-octulosonate-8-phosphatase, UDP-sugar 
hydrolase, UDP-3-O-acetylglucosamine deacetylase, lipid A disaccaride synthase, 
arabinose-5-phosphate isomerase 
leucine 
2-isopropylmalate hydratase, 3-isopropylmalate dehydrogenase, 3-isopropylmalate 
dehydratase, 2-Oxo-4-methyl-3-carboxypentanoate decarboxylation, 2-
isopropylmalate synthase, leucine transaminase 
lysine diaminopimelate decarboxylase 
acetyl-CoA 
2-octaprenylphenol hydroxylase, octaprenyl-hydroxybenzoate decarboxylase, 
hydroxybenzoate octaprenyltransferase, chorismate pyruvate lyase, octaprenyl 
pyrophosphate synthase 
alanine phosphogluconate dehydrogenase 
aspartate malic enzyme 
chorismate 
2-dehydropantoate 2-reductase, 3-methyl-2-oxobutanoate hydroxymethyltransferase, 
phosphopantothenate-cysteine ligase, phosphopantothenoylcysteine decarboxylase, 
pantothenate synthase, aspartate 1-decarboxylase, dephospho-CoA kinase, 
pantetheine-phosphate adenylyltransferase, pantothenate kinase 
protoheme Valine-pyruvate aminotransferase 
putrescine Undecaprenyl diphosphate synthase 
 
Table S3. Examples of reactions required to synthesize additional biomass molecules.  The table contains 20 
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arbitrary biomass molecules (left), and a list of reactions that are required to synthesize the molecule in a random 
minimal network (in addition to the reactions that the network needed to synthesize other biomass molecules). The 
analysis is based on minimal networks that are required (i) to synthesize 62 E. coli biomass molecules and (ii) to 
be viable on glucose. The Table illustrates that the number of additional reactions needed depends on the biomass 
molecule. (It may also depend on other reactions in a network, but for each biomass molecule results from only 
one network are shown.)   
Examples of reactions required to utilize additional carbon sources 
 
Carbon Source Required Additional Reactions 
D-galactose 
galactokinase, UDPglucose--hexose-1-phosphate uridylyltransferase, 
UDPglucose 4-epimerase 
glycerophosphoserine glycerophosphodiester phosphodiesterase 
1,4-alpha-D-glucan maltodextrin glucosidase 
2(alpha-D-Mannosyl)-D-
glycerate 
2(alpha-D-Mannosyl-6-phosphate)-D-glycerate hydrolase 
L-ascorbate 
3-keto-L-gulonate 6-phosphate decarboxylase, L-ribulose-phosphate 4-
epimerase, L-xylulose 5-phosphate 3-epimerase 
agmatine agmatinase 
IMP 5'-nucleotidase 
dAMP deoxyadenosine deaminase, purine-nucleoside phosphorylase 
L-tartrate L(+)-tartrate dehydratase 
deoxyguanosine purine-nucleoside phosphorylase (Deoxyguanosine) 
2',3'-Cyclic 2',3'-Cyclic UMP phasphatase 
phenylpropanoate 
4-hydroxy-2-oxopentanoate aldolase, 2,3-dihydroxyphenylpropionate 
dehydrogenase, diaminohydroxyphosphoribosylaminopryrimidine 
deaminase, 2,3-dihydroxypheylpropionate 1,2-dioxygenase, 
phenylpropanoate Dioxygenase, 2,3-dihydroxypheylpropionate 1,2-
dioxygenase, 2-hydroxy-6-ketonona-2,4-dienedioic acid hydrolase, 2-
oxopent-4-enoate hydratase 
glycerophosphoglycerol glycerophosphodiester phosphodiesterase 
L-idonate L-idonate 5-dehydrogenase 
D-ribose ribokinase 
lactose b-galactosidase 
D-galactarate 5-dehydro-4-deoxyglucarate aldolase, galactarate dehydratase 
hypoxanthine 
ureidoglycolate hydrolase, malate synthase, allantoinase, 5'-nucleotidase 
(GMP), purine-nucleoside phosphorylase (Guanosine), guanine 
deaminase, purine-nucleoside phosphorylase (Inosine), L-serine 
deaminase 
N-acetyl-D-glucosamine 
1-phosphate 
glycerophosphodiester phosphodiesterase 
asparagine asparaginase 
 
Table S4. Examples of reactions required to utilize additional carbon sources.  The table contains arbitrary carbon 
sources (left) and a list of reactions that are required to utilize the carbon source in a random minimal network (in 
addition to the reactions that the network needs to utilize other carbon sources). The analysis is based on minimal 
networks that were required (i) to synthesize all E. coli biomass molecules and (ii) to be viable on 30 other carbon 
sources. The Table illustrates that the number of additional reactions needed depends on the carbon source. (It may 
also depend on other reactions in a network, but for each carbon source results for only one network are shown.)   
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Supplementary Figures 
 
Figure S1. Biomass stoichiometry does not affect the number of reactions in a minimal network. The vertical 
axis shows the number of reactions in minimal networks as a function of a) biosynthetic ability and b) nutrient 
flexibility. Dots and lengths of error bars correspond to means and one standard deviation. Each blue dot of size 
200 indicates networks with the biomass stoichiomery of E. coli [57]. Each red dot of size 80 indicates networks 
with isostoichiometric biomass (see Methods). Red and blue means do not differ from each other significantly 
(P>0.40, Mann-Whitney U-test). 
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Biosynthetic Flux Distribution 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. Biosynthetic flux distribution. The flux distributions in units of mmoles per g DW per hour are 
shown for each combination of biosynthetic ability (B=20 first row, B=30 second row, B=40 third row, B=63 last 
row) and nutrient flexibility (N=20 first column, N=30 second column, N=40 third column, N=63 last column) that 
we examined. Data are based on 16,000 random viable network, as described in methods (1000 networks per 
panel). 
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Distribution of number R of reactions 
  
 
 
 
 
 
 
 
 
 
 
 
Figure S3. Distribution of number R of reactions. The distributions of R are shown for each combination of 
biosynthetic ability (B=20 first row, B=30 second row, B=40 third row, B=63 last row) and nutrient flexibility 
(N=20 first column, N=30 second column, N=40 third column, N=63 last column) that we examined, and for in 
total 800 minimal viable networks (50 Networks per panel). 
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Other Supplementary Material 
Confidence Interval Calculation 
We used the Matlab Statistical Package to calculate confidence intervals throughout 
the paper. The function makes use of the expression below to calculate 95% 
confidence limits for means: 
𝑃 {?̅? −
1.96𝜎
√𝑛
≤ 𝜇 ≤ ?̅? +
1.96𝜎
√𝑛
} = 1 − α 
where P is the probability that an actual mean μ lies in the indicated interval;  ?̅? is the 
sample mean, σ is the sample variance, and n is the sample size. α is 0.05, for we 
calculated 95% confidence intervals of mean.  
To calculate 95% confidence limits for variances, we made use of the expression: 
𝑃 {
(𝑛 − 1)𝑠2
𝑋(𝛼/2)[𝑛−1]
2 ≤ 𝜎
2 ≤
(𝑛 − 1)𝑠2
𝑋
(1−(
𝛼
2))
[𝑛−1]
2 } = 1 − α 
Where P is the probability that the actual variance σ2 lies in the indicated interval, 
where n is the sample size, s
2
 is the sample variance, and X
2 
 is the value of the chi 
square distribution with n-1 degrees of freedom at a value α/2 (for the left argument). 
α is 0.05, for we calculated 95% confidence intervals of variance. 
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Examples of reactions needed to metabolize new carbon sources 
These examples take a network size reduction approach to illustrate the kinds of 
reactions needed to metabolize new carbon sources.  
Example 1. We generated a minimal network that was required to synthesize B=63 
biomass components with the ability to metabolize glucose, acetate and glycine. We 
used this network as a starting point for further reaction elimination to generate a 
minimal network that was required to be viable on acetate and glycine but not on 
glucose. The network able to grow only on acetate and glycine had two fewer 
reactions than the network able to grow on all three carbon sources. One of these is a 
glycolytic reaction (atp + fructose-6-phosphate → adp + fructose 1,6-bisphosphate + 
h), the other is an anaplerotic reaction (atp + oxaloacetate → adp + co2 + 
phosphoenolpyruvate). 
Example 2: We generated a minimal network that was required to synthesize B=63 
biomass components with the ability to metabolize glucose, glutamate and pyruvate. 
We used this network as a starting point for further reaction elimination to generate a 
minimal network that was required to be viable on glutamate and pyruvate but not on 
glucose. The network able to grow only on glutamate and pyruvate had two fewer 
reactions than the network able to grow on all three carbon sources. Both of them are 
glycolytic reactions ((1) atp + fructose-6-phosphate → adp + fructose 1,6-
bisphosphate + h, (2) glucose-6-phosphate → fructose-6-phophate). 
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Examples of reactions needed to synthesize additional biomass molecules 
These examples take a network size reduction approach to illustrate the kinds of 
reactions needed to synthesize additional biomass molecules.  
Example 1: We generated a minimal network that was able to synthesize glutamate, 
asparagine and proline with glucose as the sole carbon source. We used this network 
as the starting point for further reaction elimination to generate a minimal network 
synthesizing glutamate and asparagine but, not proline. This resulted in the 
elimination of the following three reactions: (1) atp + glutamate →  adp + glutamate 
5-phosphate, (2) glutamate 5-phosphate + h + nadph → glutamate 5-semialdehyde + 
nadp + inorganic phosphate, (3) glutamate 5-semialdehyde → 1-pyrroline-5-
carboxylate + h + h2o. These reactions are involved in the conversion of glutamate to 
proline. 
Example 2: We generated a minimal network that was able to synthesize glutamate, 
arginine and adenonsine-3,5-bisphosphate in glucose. We used this network as the 
starting point for further reaction elimination to generate a minimal network 
synthesizing glutamate and arginine but not adenonsine-3,5-bisphosphate. This 
resulted in the elimination of the following three reactions: (1) acetyl-glutamate 5-
semialdehyde + h2o → acetate + glutamate 5-semialdehyde, (2) acetyl-glutamate 5-
semialdehyde --> 1-pyrroline-5-carboxylate + h + h2o, (3) 1-pyrroline-5-carboxylate 
+ h + nadph → nadp + adenosine-3,5-bisphosphate. These reactions are involved in  
adenosine-3,5-bisphosphate synthesis. 
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3. Selection shapes the robustness of 
ligand-binding amino acids. 
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3.1. Abstract 
The phenotypes of biological systems are to some extent robust to genotypic changes. 
Such robustness exists on multiple levels of biological organization. We analyzed this 
robustness for two categories of amino acids in proteins. Specifically, we studied the 
codons of amino acids that bind or do not bind small molecular ligands. We asked to 
what extent codon changes caused by mutation or mistranslation may affect 
physicochemical amino acid properties or protein folding. We found that the codons 
of ligand-binding amino acids are on average more robust than those of non-binding 
amino acids. Because mistranslation is usually more frequent than mutation, we 
speculate that selection for error mitigation at the translational level stands behind this 
phenomenon. Our observations suggest that natural selection can affect the robustness 
of very small units of biological organization. 
 
3.2. Introduction 
Two computational approaches to characterize functionally important amino acids of 
a protein are widespread. The first focuses on the accessible surface area, which 
describes the accessibility of an amino acid by the solvent surrounding a protein (Lee 
and Richards 1971). Amino acids that are involved in binding ligands commonly 
occur in large and deep clefts on a protein’s surface with low accessible surface area, 
which may help to increase the specificity and stability of binding (Bartlett et al. 
2002; Laskowski et al. 1996). The analysis of solvent accessibility requires detailed 
knowledge of ligand binding sites, which is limited to proteins with known ligand-
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bound structures. The second approach uses evolutionary conservation of amino acids 
(Capra et al. 2009; Lichtarge and Sowa 2002). For example, amino acids in catalytic 
sites of enzymes are more conserved on average (Bartlett et al. 2002). However, 
because evolutionary conservation is influenced by multiple factors, such as the 
divergence time between orthologs, the background rate of amino acid substitutions, 
and mutational biases (Sasidharan and Chothia 2007), information on conservation 
alone is not enough to characterize functional sites. Many studies thus combine these 
two approaches to improve the characterization of binding sites (Bartlett et al. 2002; 
Capra et al. 2009). Here we suggest a third, complementary approach that may help 
characterize specifically those amino acids that bind ligands. It focuses on their 
robustness to mutation or mistranslation. Because such amino acids are especially 
important for the function of a protein, they can be subject to selection increasing 
their robustness relative to non-ligand-binding amino acids.  
Biological systems on multiple levels of organization are to some extent robust to 
genetic or environmental change. Examples include the genetic code of extant 
organisms, which is more robust to nucleotide changes than the vast majority of 
hypothetical alternative codes (Freeland and Hurst 1998); proteins, which can 
continue to function when many of their amino acids are mutated (Bowie et al. 1990; 
Guo et al. 2004; Huang et al. 1996; Loeb et al. 1989; Markiewicz et al. 1994; Suckow 
et al. 1996); gene regulatory  circuits, whose phenotypes are to some extent robust to 
changes in regulatory interactions (Von Dassow and Odell 2002; Ingolia 2004; Isalan 
et al. 2008; Isalan et al. 2005; Li et al. 2006); and genome-scale metabolic networks, 
which can tolerate deletions of multiple enzyme-coding genes without detectable 
phenotypic effects in standard laboratory environments (Hillenmeyer et al. 2008). 
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Such robustness may reflect intrinsic system properties that may not have been shaped 
by natural selection. Alternatively, it may be the result of evolutionary adaptation, 
either to ameliorate the detrimental effects of DNA mutations, of environmental 
change, or of both.  
Among the four principal ways in which random change in a codon can occur – DNA 
mutation, mistranscription, mRNA alteration, and mistranslation – we focus on 
mutation and the mistranslation of mRNA, which are well documented and probably 
most frequent. Such mistranslation occurs when a ribosome incorporates incorrect 
amino acids when synthesizing a protein from an mRNA template. There are at least 
three non-exclusive classes of evolutionary mechanisms by which the cost of 
mistranslation can be minimized. The first is selection of translational accuracy. 
Akashi (Akashi 1994) suggested that such selection causes genes or specific sites in 
genes to be encoded by codons that correspond to abundant tRNAs. Such high fidelity 
codons have higher chances of being accurately translated. The second is selection of 
translational robustness, which has been proposed by Drummond and Wilke 
(Drummond and Wilke 2008; Wilke and Drummond 2006). According to these 
authors, proteins (and especially highly expressed proteins) show evolved tolerance in 
their fold to missense translational errors (Zhou et al. 2009). The third involves error 
mitigation. Among those synonymous codons that encode the same amino acid, some 
are more robust to changes in individual nucleotides than others. That is, even though 
a random change in a robust codon may change the encoded amino acid, the new 
amino acid has, on average, similar physicochemical properties or does not perturb 
protein folding strongly (Archetti 2006; Archetti 2004a). In error mitigation, codons 
that are likely to be mistranslated into radically different amino acids are avoided. 
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Previous studies (Archetti 2004a; Najafabadi et al. 2007) showed that amino acids in 
eukaryotic and prokaryotic proteins are often encoded by codons whose 
mistranslation leads to the substitution of amino acids with limited deleterious effects. 
The most important of these three causes for our work is error mitigation. 
Here we ask whether selection helps shape the codon usage of ligand-binding amino. 
To this end, we analyze the robustness of codons to mutation or mistranslation for two 
classes of codons in a protein, that is, codons that encode amino acids, which are or 
are not involved in the binding of a small molecular ligand. We use an estimator of 
robustness that incorporates the likely effects of an amino acid change on the 
physicochemical properties of an amino acid, and on protein folding. Our analysis 
shows that ligand-binding amino acids are on average more robust to mutation or 
mistranslation than non-binding amino acids, which is consistent with selection 
pressure for error mitigation. 
 
3.3. Methods  
We use a codon robustness score φ(c) derived from the weighted average load 
function of Ardell (Ardell 1998). This score aims to capture the predicted effect that a 
particular amino acid change has on the folding free energy of a protein and on 
physicochemical amino acid properties. Specifically, 
𝜑(𝑐) = ∑ 𝑝(𝑐′|𝑐) 𝑔[𝑎(𝑐), 𝑎(𝑐′)]9𝑐′=1        (1) 
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 where summation is applied over all nine 1-mutant neighbors of a codon c. In this 
expression, p(c’|c) p(c'|c) is the probability of changing a codon c for another codon 
c’, which is computed by multiplying the position-specific transition-transversion bias 
of mistranslations with the relative mistranslation frequency of a given nucleotide 
position. 𝑔[𝑎(𝑐), 𝑎(𝑐′)] is the physicochemical effect or “cost” of substituting the 
amino acid encoded by codon c, a(c), with that encoded by codon c’, a(c').We used 
the mutation matrix generated by Gilis and colleagues (Gilis et al. 2001), to calculate 
the cost of such an amino acid change (see Online Resource 1a for the matrix). This 
matrix uses information on changes in folding free energy and physiochemical 
properties of amino acid features, such as hydrophobicity, after an amino acid change. 
We note that the use of different substitution matrices would not strongly affect codon 
robustness scores (Najafabadi et al. 2005).  
To give an example of how we calculated robustness scores, consider the codon tta 
that encodes leucine. It has nine 1-mutant neighbors, one of them being tca. 
Mistranslation from tta to tca corresponds to a transition at a nucleotide in the second 
position of a codon. With a relative mistranslation frequency of second position 
nucleotides of 0.1 and a transition transversion bias at second position nucleotides of 
5, we computed a value of  p(tca|tta) = 0.5, by multiply these numbers. Because tca 
encodes serine, we multiply this value by -1, which is the cost of mutation from 
leucine to serine based on the Mutation Matrix. We perform an exactly analogous 
calculation for all other 1-mutant neighbors of tta to arrive at 𝜑(𝑡𝑡𝑎) . We then 
normalize this score by dividing it by the mean codon robustness of all leucine-
encoding codons to eliminate the possible effects of amino acid biases. Finally, we 
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normalize the scores of all codons to the interval (0,1). The resulting scores are shown 
in Online Resource 2.  
We used proteins in our analysis (Online Resource 3) that (i) have a reviewed (non-
putative) 3D structure deposited in the protein data bank (PDB) (Bourne et al. 2004), 
(ii) exert their biological function as monomers, and (iii) bind to one of the small 
ligands in Online Resource 4. Binding to large molecules, such as other proteins, 
RNA and DNA involve highly divergent interaction types, and large interface areas, 
which might decrease functional importance of amino acids that contact a molecule 
(Lichtarge and Sowa 2002). As Clackson and Wells (Clackson and Wells 1995) 
showed, only a fraction of those residues actually contribute to binding. We therefore 
excluded those larger molecules. From this data set, we eliminated proteins that bind 
to multiple ligands, as well as proteins with more than 90 percent sequence identity to 
other proteins, thus arriving at a final data set of 275 proteins. We extracted a 
protein’s coding exons by aligning the encoding gene (obtained from NCBI (Benson 
et al. 2004)) and the amino acid sequence (Bourne et al. 2004) with the tool Exonerate 
(Slater and Birney 2005).  
 
3.4. Results and Discussion 
We subdivided all amino acids of the proteins in our data set into two categories, 
those not involved in the binding of small ligands, and those involved in the binding 
of small ligands, which we defined to be lying within a 5 Ångstrom radius of a ligand 
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in the published tertiary structure. We then computed the robustness scores of codons 
using a wide range of mistranslation parameters. We varied two key parameters at 
each nucleotide position, the transition-transversion bias for which we used 5 different 
values between one and five, and the mistranslation frequency, for which we used 10 
different values between 0.1 and 1. We then asked for each of 50 different parameter 
combinations whether robustness scores encoding the binding and the non- binding 
amino acids differ. We found that codons encoding ligand-binding amino acids are 
significantly more robust in all cases, with either the same or very similar P values 
(greatest P <10
-30
, smallest P < 10
-36
, Wilcoxon Rank Sum test used throughout, 
unless otherwise mentioned). For the sake of simplicity, we thus used one particular 
parameter combination for all subsequent analyses, which is that of Freeland and 
Hurst (Freeland and Hurst 1998, see Online Resource 1b). Even though it may not be 
universally accurate (Kramer et al. 2010), it has also been employed by several other 
studies similar to ours and on a wide range of organisms (Archetti 2006; Archetti 
2004; Drummond and Wilke 2008; Najafabadi et al. 2007). Figure 1a indicates the 
distribution of robustness scores based on these mistranslation biases (P < 10
-35
, thick 
horizontal lines indicate medians).  
We then repeated our analysis using an estimator of codon robustness by Archetti, 
which takes only the physicochemical effects of changed amino acids into account 
[15], but not the likely effect on protein misfolding, as does our estimator. Again, 
ligand-binding amino acids are significantly more robust when using this estimator (P 
< 10
-8
). We also compared the Z-statistic, which is the standardized value of U, the 
Wilcoxon Ranked Sum statistic. For large samples like ours, U is normally distributed 
(Rice 1995), and thus Z follows a standard-normal (N(0,1)) distribution. We found 
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that the Z-statistic is much greater for our own robustness estimator (Z = 12.38) than 
for Archetti’s estimator (Z = 3.77). This means that taking effects on misfolding into 
account, binding and non-binding amino acids differ to a much greater extent in their 
robustness.   
We next compared differences in codon robustness to differences between more 
conventional indicators of functionally important binding amino acids. The first of 
them is the accessible surface area. We obtained the accessible surface area scores of 
each amino acid from (Kabsch and Sander 1983) and normalized them, so that they 
range between 0 and 1. As previous studies did (Bartlett et al. 2002; Laskowski et al. 
1996), we found that ligand-binding amino acids indeed have significantly smaller 
accessible surface area (P < 10
-27
) (Fig. 1b). The difference becomes more significant 
(P < 10
-300
), when we remove the residues in the hydrophobic core, that is the residues 
with normalized accessible surface area values less than 0.25 from the analysis.  
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Fig. 1 Box-plot of a) robustness b) accessible surface area 
(ASA) c) amino acid conservation scores. Thick black 
horizontal lines in the middle of each box mark the median. 
The edges of the boxes correspond to the 25th and 75th 
percentiles. Data is based on a sample of n = 49,133 non-
binding amino acids (left box in each panel) and of n = 
5,552 ligand-binding amino acids (right box in each panel).  
 
 
 
 
 
 
The second indicator is the extent of evolutionary conservation. We compared amino 
acid conservation scores (obtained from (Goldenberg et al. 2009)) for ligand-binding 
and non-binding amino acids in our data set. In line with previous studies (Bartlett et 
al. 2002; Capra et al. 2009), we found that the binding amino acids are significantly 
more conserved (P < 10
-258
) (Fig. 1c). We next asked whether codon robustness 
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discriminates to a similar extent between binding and non-binding amino acids as do 
these two quantities. To this end, we examined again the Z-statistic of the Wilcoxon 
test, and found that evolutionary conservation differs most between binding and non-
binding amino acids (Z = 34.35), the accessible surface area differs least (Z = 10.89) 
and codon robustness lies in between them (Z = 12.38). These observations suggest 
that robustness, while not as informative as evolutionary conservation, may have 
similar value as accessible surface area to characterize functionally important amino 
acids. Finally, we calculated the association of codon robustness with the other two 
indicators, and found that neither accessible surface area (r
2
 = 0.15, P <10
-300
) nor 
evolutionary conservation (r
2
 = -0.06, P <10
-48
) are strongly correlated with 
robustness. These weak correlations suggest that robustness is complementary to the 
two other two quantities in characterizing ligand-binding amino acids. 
We next asked whether different genes also differ in the robustness scores of the 
ligand-binding amino acids they encode. To this end, we ranked proteins according to 
the mean robustness score and displayed the corresponding data as a rank plot (Fig. 
2a). Specifically, the plot shows the rank-ordered codon robustness scores of ligand-
binding amino acids (orange dots), together with the robustness of the non-binding 
amino acids (grey dots). For 63 percent or 173 proteins, the mean codon robustness of 
the binding amino acids was greater than the mean codon robustness of the non-
binding amino acids, where the mean is taken over all non-binding amino acids in all 
proteins. A minority of 37 percent of proteins had a lower robustness of binding 
amino acids than those of non-binding amino acids. To investigate these differences 
in robustness further, we focused on two classes of proteins, the 28 proteins in the 
bottom 10
th
-percentile (blue shading in Fig. 2a), and the 28 proteins in the top 10
th
-
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percentile (pink shading in Fig. 2a). We refer to them as the proteins with the lowest 
and highest robustness of ligand-binding amino acids.  
 
Fig. 2 a) Plot of mean robustness scores, ranked based on the mean robustness of ligand-binding amino acids for 
each of our 275 study proteins. Grey dots correspond to mean robustness scores of non-binding amino acids, 
orange dots correspond to mean robustness scores of ligand binding amino acids. The pink and blue regions 
correspond to the upper and lower 10th percentiles in robustness, respectively. b) Box-plot of RNA expression 
levels in the brain for the proteins with lowest (right box) and highest (left box) robustness of ligand-binding 
amino acids. The edges of the boxes correspond to the 25th and 75th percentiles. Data is based on a sample of gene 
expression values n = 168 for the left box, n = 56 for the right box. c) Gene ontology (Ashburner et al. 2000) 
functional annotations of proteins with lowest (right bar) and highest (left bar) robustness of ligand-binding amino 
acids. Legend displays the major functional classes presented in the bars.  
We first asked whether the genes encoding these two classes of proteins differ 
substantially in their expression. To this end, we used a gene expression data set 
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(Brawand et al. 2011) from 6 humans and five different organs (brain, heart, kidney, 
liver and testis), obtained through high throughput RNA sequencing (RNA seq). The 
genes in the highest robustness category did not show significantly higher expression 
when we analyzed pooled data from all organs, nor when we analyzed data from four 
of the five organs. The only exception was expression data from the brain, where 
these proteins were significantly more highly expressed (P = 0.029) (Fig. 2b). 
Although the signal becomes insignificant after a correction for false discovery rate 
(FDR, Benjamini and Hochberg 1995)), this pattern is consistent with an earlier 
analysis (Drummond and Wilke 2008), which showed that selection for translationally 
robust codons is strongest in brain and other neural tissues. The likely reason is the 
extreme sensitivity of neuronal functions to protein misfolding and dysfunction, 
which is associated with neurodegenerative diseases and neurotoxic effects 
(Bucciantini et al. 2002; Lee et al. 2006b). Using the Gene Ontology (Ashburner et al. 
2000) classification of gene functions, we also found that proteins with highest 
robustness are significantly more enriched in functions related to development, 
differentiation (Exact Binomial Test, P < 10
-3
), whereas proteins with lowest 
robustness are significantly more enriched in metabolic functions (Fig. 2c). In sum, 
these analyses reveal differences between proteins whose ligand-binding amino acids 
differ most in their robustness, although they fall short of explaining the low 
robustness we observe for these amino acids in some proteins.   
That functionally or structurally important amino acids or codons are subject to 
special constraints has been proposed by previous work and in contexts different from 
ours. First, Bartlett and colleagues provided evidence that catalytic sites harbor certain 
classes of amino acids. Specifically, charged amino acids are more often found in 
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catalytic sites, whereas hydrophobic amino acids are more often found in the 
structure-stabilizing hydrophobic core (Bartlett et al. 2002). Second, Pakula and Sauer 
(Pakula and Sauer 1989) showed that such sites are highly constrained in the 
substitutions they can tolerate. Third, Zhou and colleagues (Zhou et al. 2009) 
provided evidence in several eukaryotes and prokaryotes that some parts of proteins 
are more sensitive to misfolding, and show a more constrained codon usage, the 
phenomenon that different synonymous codons for the same amino acid are not used 
equally frequently in protein coding genes (Akashi 1994; Akashi and Eyre-Walker 
1998; Comeron and Aguadé 1998; Duret 2002; Gouy and Gautier 1982; Ikemura 
1985; Ikemura 1981; Moriyama and Hartl 1993; Plotkin et al. 2004; Sharp et al. 1986; 
Sharp and Li 1987; Stoletzki and Eyre-Walker 2007). In general, the strength of this 
bias varies within genes and becomes stronger at functionally important sites (Akashi 
1994; Stoletzki and Eyre-Walker 2007). In sum, our observations that robust codons 
are favored at ligand-binding amino acids are consistent with a broad range of related 
evidence. 
Limitations of our analysis include the moderate number of 275 proteins we could 
study, as well as a small number of binding amino acids (18 on average) per protein, 
which renders rigorous statistical analysis of individual proteins infeasible. Despite 
these limitations, our joint analysis of multiple proteins showed a significant 
preference of robust codons in ligand-binding pockets of proteins, exactly where 
amino acid changes can have a highly detrimental effect on protein function.  
Another limitation is that codon robustness alone – like accessible surface area and 
conservation – does not have much power to predict ligand-binding sites. To predict 
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such sites, more complex models incorporating multiple characterizing elements are 
necessary (see for example, Capra et al. 2009; Lichtarge and Sowa 2002; Wass et al. 
2011). Because codon robustness differs more than accessible surface area between 
ligand binding and non-binding amino acids, our approach can help improve such 
models and their predictive power. 
Selection may have favored robust codons in ligand-binding amino acids because they 
are robust to mutation or to translation. Although mistranslation is not genetic change 
–it leaves the DNA encoding a mRNA unchanged – it does alter the encoded protein 
randomly (Drummond and Wilke 2009). Translational error rates in microbes have 
been estimated at 10
-3
-10
-4
 per codon. This number is at least five orders of magnitude 
higher than typical mutation rates (Kramer et al. 2010; Kramer and Farabaugh 2007; 
Ogle and Ramakrishnan 2005b). At this error rate, 15 percent of protein molecules 
would contain at least one mistranslated amino acid. Translation errors can induce 
protein misfolding, aggregation, toxicity and cell death, which underlie a broad array 
of neurodegenerative diseases (Bucciantini et al. 2002; Lee et al. 2006b). Also, 
mistranslation at functionally important sites can disrupt protein function  (Guo et al. 
2004; Markiewicz et al. 1994). For these reasons, we speculate that selection for error 
mitigation at the translational level is the prevalent driving force of high robustness in 
codons that encode ligand-binding amino acids. Why a minority of ligand-binding 
amino acids has especially low codon robustness remains an open question for future 
work.  
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3.7. Supplementary Material 
Online Resource 1 
 
 
[
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
𝐀
𝐀 +7 𝐂
𝐂 −3 +7 𝐃
𝐃 0 −4 +7 𝐄
𝐄 0 −5 +2 +7 𝐅
𝐅 0 −2 −2 −3 +7 𝐆
𝐆 −2 −4 −1 −2 −3 +7 𝐇
𝐇 +1 −2 +1 +1 −1 0 +7 𝐈
𝐈 −2 −3 −4 −4 0 −4 −2 +7 𝐊
𝐊 +1 −5 +2 +3 −2 −1 +1 −3 +7 𝐋
𝐋 −1 −3 −3 −3 0 −4 −2 0 −2 +7 𝐌
𝐌 −1 −3 −1 −1 0 −2 0 0 −1 +1 +7 𝐍
𝐍 0 −3 +2 +2 −2 0 +2 −3 +2 −2 −1 +7 𝐏
𝐏 −3 −6 −1 −2 −4 −4 −2 −5 −1 −5 −4 −1 +7 𝐐
𝐐 +1 −4 +2 +3 −1 −1 +2 −2 +3 −1 0 +2 −2 +7 𝐑
𝐑 +1 −4 +2 +2 −2 −1 +1 −3 +3 −2 0 +2 −2 +2 +7 𝐒
𝐒 +1 −2 +2 +1 −1 0 +2 −2 +2 −1 0 +2 −1 +2 +2 +7 𝐓
𝐓 0 −2 +1 0 0 −1 +2 −1 +1 −1 0 +1 −1 +1 +1 +2 +7 𝐕
𝐕 −1 −3 −3 −4 0 −4 −2 +1 −3 0 0 −3 −4 −2 −2 −1 0 +7 𝐖
𝐖 +1 −2 0 −1 0 −2 +1 −1 0 −1 +1 0 −3 0 0 +1 0 −1 +7 𝐘
𝐘 0 −1 −1 −2 +1 −1 +1 −1 −1 −1 0 0 −3 0 −1 +1 +1 0 +1 +7]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Online Resource 1a The Gilis Mutation Matrix (Gilis et al. 2001). Mutations to stop codons have the value -10. 
 
 First 
Nucleotide 
Second 
Nucleotide 
Third 
Nucleotide 
Relative mistranslation frequency 0.5 0.1 1 
Transition-transversion bias of 
mistranslations 
2 5 1 
 
 
Online Resource 1b Relative frequencies and biases of mistranslation used in the robustness score calculations 
(Freeland and Hurst 1998). 
Online Resource 2 
 
 T C A G  
T 
0.798 0.955 0.606 0.585 T 
0.798 0.955 0.606 0.585 C 
0.857 0.944 0.326 0.000 A 
0.870 0.948 0.293 0.407 G 
C 0.923 0.875 0.877 0.906 T 
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0.923 0.875 0.877 0.906 C 
0.990 0.875 0.803 0.898 A 
1.000 0.875 0.803 0.994 G 
A 
0.873 0.943 0.880 0.842 T 
0.873 0.943 0.880 0.842 C 
0.805 0.943 0.805 0.805 A 
0.684 0.944 0.806 0.902 G 
G 
 
0.939 0.912 0.854 0.882 T 
0.939 0.912 0.854 0.882 C 
0.939 0.912 0.794 0.813 A 
0.929 0.912 0.794 0.899 G 
 
Online Resource 2 Codon robustness scores for all 64 codons. 
 
Online Resource 3 
 
1A17 1I8U 1PB5 1WEM 2CO8 2EGM 2PJZ 
1A44 1IG5 1PHR 1WEO 2CON 2EGP 2PL5 
1A76 1IGS 1PLQ 1WES 2COT 2EJ4 2PLZ 
1A77 1IGV 1PNT 1WEV 2CR8 2EKL 2PRD 
1AIN 1ILE 1PXE 1WFH 2CS3 2ELI 2PT1 
1ALA 1INP 1Q1F 1WFP 2CSV 2EWT 2Q18 
1ANN 1IQ3 1Q1N 1WG2 2CSY 2FC6 2UY2 
1AVC 1ISP 1QGO 1WIL 2CT0 2FC7 2UY9 
1AXN 1J55 1QME 1WKB 2CT2 2FGF 2V07 
1B5M 1JE6 1QWG 1WY9 2CT5 2FR7 2V5D 
1BCI 1JNI 1R03 1X0T 2CT7 2GJL 2VRG 
1BDB 1K49 1R79 1X3H 2CU2 2GQJ 2VW0 
1BOR 1KIT 1RDV 1X4J 2CUL 2H0L 2W38 
1C6S 1KPF 1RK9 1X4V 2CVC 2H3M 2YQL 
1CO4 1KT0 1RQG 1X4W 2CW7 2H6E 2YQM 
1CTL 1L4B 1RWJ 1X5W 2D8S 2H9L 2YQP 
1D9V 1LC0 1SBP 1X61 2D8T 2HBK 2YS2 
1DHR 1LC5 1SIQ 1X62 2D8U 2HPJ 2YT5 
1DT1 1M36 1SQ9 1X64 2D9G 2HQQ 2YUU 
1DXH 1M47 1SRK 1X6E 2D9K 2I0M 2YYG 
1EE9 1M6N 1TFA 1XF7 2DAR 2I4I 2Z0Z 
1EF4 1M9I 1TFI 1XFI 2DB6 2I5O 2ZAO 
1EK5 1M9O 1U96 1XWI 2DJ7 2I6J 2ZJ2 
1F62 1MDF 1UHN 1Y02 2DJA 2ILK 2ZLB 
1FF9 1MGT 1UKY 1YGT 2DJB 2J8H 3B4X 
1FLV 1MHO 1UL4 1YK4 2DJR 2JGU 3BI9 
1FUE 1MNH 1UM8 1YWQ 2DUL 2JM4 3C5K 
1G0W 1MPT 1UPQ 1ZMR 2E5S 2JMI 3CJ7 
1G25 1MVL 1UV0 1ZW8 2E61 2JMO 3CU4 
1G2P 1N67 1UZ5 2A3M 2E6I 2JQ6 3DD4 
1GCG 1NJ3 1V5N 2A4E 2E6R 2JYD 3EIE 
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1GGZ 1NMW 1V9M 2A6Y 2E6S 2K1W 3F6Y 
1GV9 1NOX 1VCI 2AEU 2E73 2K4X 3H2X 
1HDR 1NSJ 1VCN 2AYJ 2EBL 2KGG 4CLN 
1HEX 1NVG 1VD6 2B1O 2ECI 2MM1 4TNC 
1HI5 1NX2 1VJI 2B71 2ECL 2NVH   
1HQV 1NZ3 1W5D 2BWK 2ECM 2O72   
1HTN 1OG3 1WAB 2BWL 2ECN 2OO3   
1HYJ 1OL6 1WD2 2CCQ 2ECT 2P5Y   
1I7P 1OOT 1WEE 2CEI 2ECY 2PCN   
 
Online Resource 3 List of PDB identifiers for all proteins used in this study. 
 
Online Resource 4 
 
acetate chlorine iron potassium 
adenosine diphosphate copper magnesium protoporphyrin 
adenosine monophosphate flavin adenin dinucleotide manganese sodium 
adenosine triphosphate flavin mononucleotide mercury sulfate 
bromide glycerol nicotinamide adenine 
dinucleotide 
zinc 
calcium heme c phophate  
 
Online Resource 4 List of ligands used in this study in alphabetic order. 
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4.1. Abstract 
Tandem repeats tend to be highly variable in their length, and are thus an important 
source of genetic variation. Repeat variants are associated with many diseases, 
including cancers, but they may also play a role in the evolution of gene regulation. 
We here analyze the potential influence of tandem repeats on gene expression 
evolution in the genomes of humans, chimpanzees, and macaques. To this end, we 
identified tandem repeats with repeat units of up to 50 base pairs. We found that 30 
percent of 13,035 orthologous genes in the three species contained tandem repeats 
within five kilo base pairs (kbp) of their transcription start site. Genes with repeat-
containing promoters show significantly higher expression divergence in all three 
species. Moreover, duplicate genes show greater expression divergence if one or both 
duplicates contain repeats in their promoter. Genes with repeats in their 3’ 
untranslated region, in introns, and in exons also show higher expression divergence. 
Hence, tandem repeats, far from just being a source of genetic diseases, may 
contribute substantially to the divergence of gene expression in primates.  
 
4.2. Introduction 
Gene expression divergence is a major driver of phenotypic change in evolution 
(Carroll 2000; Dixon et al. 2007; Jordan et al. 2005; King and Wilson 1975; Li et al. 
2010; Ponting 2008; Wray et al. 2003a). A key challenge is to understand the factors 
contributing to this divergence. The most prominent such factor is single-nucleotide 
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polymorphisms (SNPs), which has long been known to associate with phenotypic 
variation (Stranger et al. 2007a; Stranger et al. 2007b; Stranger et al. 2005). SNPs in 
human cis-regulatory regions can explain more than 70 per cent of gene expression 
variation (Li et al. 2010; Rockman and Wray 2002; Stranger et al. 2007a; Stranger et 
al. 2007b). A second potentially important factor is copy-number variation, which 
comprises polymorphic duplications of chromosome segments, and  correlates with 
gene expression levels (Hurles et al. 2008; Stranger et al. 2007a). 
Tandem repeats are candidates for a third major contributor to gene expression 
divergence (Gemayel et al. 2010; Kashi and King 2006; Rockman and Wray 2002; 
Vinces et al. 2009). These are DNA tracts in which a short (1-50) base-pair motif, the 
repeat unit, is repeated several times in tandem, i.e., in a closely spaced, head-to-tail 
orientation. They are among the most variable loci in the human genome, 
experiencing mutations in the copy number of repeat units that are 100 to 100,000 
times more frequent than point mutations, and occur at a rate of 10
−3
 to 10
−7
 copy 
number alterations per cell division (Brinkmann et al. 1998; Legendre et al. 2007; Li 
et al. 2002; Weber and Wong 1993). Most mutations giving rise to variable tandem 
repeats result from replication slippage (Levinson and Gutman 1987; Li et al. 2002; 
Schlötterer 2000; Schlotterer and Tautz 1992; Webster et al. 2002).  
While variable repeats found in genes are responsible for over 40 human 
neurological/neuromuscular diseases, such as Huntington’s disease and the 
spinocerebellar ataxias (reviewed in (Pearson et al. 2005a) and in (Bates 1996)), not 
all such repeats cause disease. They can also contribute to normal phenotypic 
variation and help fine-tune gene products and their gene expression adaptively 
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(Fondon et al. 2008; Kashi and King 2006). For example, the expression of H. 
influenzae fimbriae is subject to reversible phase variation between three expression 
levels, which is required for different stages of infection. Responsible for this 
variation are copy number changes of repetitive TA tracks in hifA and hifB promoter 
regions (van Ham et al. 1993). 
Repeat-induced gene expression variation is not restricted to microbes, but can also 
induce non-pathological variation in higher organisms. In tilapia (Oreochromis 
niloticus), an important aquacultural fish, variable CA repeats in the promoter of the 
prl1 gene, which is involved in osmoregulation, are associated with both gene 
expression levels and gene functionality (Streelman and Kocher 2002). An especially 
remarkable example regards features of a dog’s snout, such as the degree of 
dorsoventral nose bend and midface length, which correlate with the ratio of the 
length of two tandem repeats in a gene that regulates bone formation (Fondon and 
Garner 2004). Repeat polymorphisms may also contribute to behavioral and cognitive 
functions. For example, the presence of tandem repeats in the 5’ untranslated region 
of the vole vasopressin 1a receptor gene correlates with social behavior (Fondon et al. 
2008). Mutations in this gene have been implicated in autism (Kim et al. 2002).  The 
gene’s orthologue in chimpanzees has a partial deletion in those tandem repeats, 
whereas the more social human and bonobo (Waal 2009) have the complete set of 
repeats (Hammock and Young 2005).  
Because gene expression changes are so important in evolution, it is important to 
study mechanisms that can permit rapid expression change on short evolutionary time 
scales (Choi and Kim 2008; Landry et al. 2007; Tirosh et al. 2009; Tirosh et al. 2006; 
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Wray et al. 2003a). Promoter features such as TATA boxes, nucleosome-covering, as 
well as tracts of tandem repeats can mediate such change (Tirosh him et al., 2009). 
Among these features, tandem repeats are especially attractive study objects, because 
of their high incidence in regulatory regions (Gemayel et al. 2010; Payseur et al. 
2011) and their high mutability (Brinkmann et al. 1998; Legendre et al. 2007; Li et al. 
2002; Weber and Wong 1993).   
One species where an association between tandem repeat variation and gene 
expression divergence has been demonstrated, and where regulatory regions are 
enriched in repeats is the yeast Saccharomyces cerevisiae (Vinces et al. 2009). 
Proximal upstream sequences of human repeat containing genes, which are likely to 
function as promoters, are also enriched for repeats compared to distant upstream and 
coding sequences (Supplementary Material in Vinces et al., 2009). This observation 
suggests a similar role for repeats in human expression evolution. To characterize this 
role, we examined the influence of tandem repeats in promoters on gene expression 
divergence in humans, chimpanzees, and macaques. We found that the presence of 
tandem repeats is indeed associated with greater expression divergence. This 
association holds for all three species, and for genes expressed in each of several 
organs. These observations extend to repeats in the promoters of duplicate genes, and 
to repeats in other gene regions that can influence gene regulation, including 3’ 
untranslated regions, introns, and exons. 
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4.3. Results 
Many primate promoters contain tandem repeats. 
We identified genes with tandem repeats in the 5 kilo base pairs (kbp) upstream from 
the transcription start site of n = 13,035 orthologous genes in humans, chimpanzees, 
and macaques. We found that, depending on the species, on average 29-31% of all 
genes in these orthologs harbored tandem repeats. Specifically, 3820, 3910 and 4032 
gene promoters harbored at least one repeat in human, chimpanzee and macaque, 
respectively.    
Next we wanted to find out whether repeats contained in the first 5 kbp base pairs 
upstream of a gene are relevant for gene expression. To this end, we retrieved data on 
DNase hypersensitive site locations from ENCODE (Material et al. 2004) using the 
UCSC Genome Browser Database (Karolchik et al. 2003). We then mapped these 
locations to the promoter sequences of the genes in our data set, based on genomic 
locations of transcriptional start sites, as reported in the GENCODE human alignment 
(Harrow et al. 2012). The vast majority (93%) of our 5 kbp-long promoter sequences 
contains DNase hypersensitive sites, and 60 percent of repeats overlap with a DNase 
hypersensitive site. This suggests that many of our repeat sequences could potentially 
be involved in gene regulation. 
Genes with tandem repeats in promoters have significantly increased 
expression divergence. 
We used previously published RNA-seq based gene expression data from our three 
study species (human, chimpanzee or macaque) and from different individuals (up to 
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six individuals per species), where each sample contained gene expression values for 
13,035 genes in a given organ (brain, cerebellum, heart, kidney, liver or testis). We 
first asked if genes that contain tandem repeats in their promoters have higher 
expression divergence compared to genes without repeats in their promoter region. To 
this end, we computed the mean of gene expression values belonging to different 
individuals for each gene and organ. For each pair of species, we then calculated the 
difference between the mean expression values of the orthologous gene pairs, 
normalized by the sum of the mean expression values in a given organ. We then 
partitioned these pairwise expression differences into two subsets according to 
whether orthologous genes did or did not contain tandem repeats in their promoters. 
We observed a significant increase in pairwise expression differences of genes with 
repeats. More specifically, human-chimpanzee orthologs with repeats had higher 
mean expression difference (P < 10
-6
, based on Wilcoxon Rank Sum Test (Mann and 
Whitney 1947)) compared to those without repeats. Similarly, human-macaque 
orthologs (P < 0.01, for all organs) and chimpanzee-macaque orthologs (P < 10
-5
, for 
all organs) with repeats showed a higher mean expression difference than orthologous 
genes without repeats.  
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Figure 1. Presence of tandem repeats in promoters associate with increased expression divergence. (A) 
Schematic phylogenetic tree of our three study species with a bar-chart superimposed on each branch. The length 
of each bar indicates the ratios of branch lengths in 1000 sampled gene expression trees for genes with repeats 
relative to genes without repeats.  Bars in each chart, from left to right, correspond to expression divergence in 
brain (B), cerebellum (C), heart (H), kidney (K), liver (L), and testis (T), respectively. Bars extending above the 
horizontal line indicate that genes with repeats show greater expression divergence.  (B) Box plot of total tree 
lengths of genes with repeats (thick lines) and genes without repeats (thin lines). Horizontal lines in the middle of 
each box mark the median, edges of boxes correspond to the 25th and 75th percentiles, and whiskers cover 99.3 
percent of the data points.  
B CHK L T
macaque chimpanzee human
 A
 B
      
0
0.01
0.02
0.03
0.04
B
ra
in
C
er
eb
el
lu
m
H
ea
rt
K
id
ne
y
Li
ve
r
Te
st
is
T
o
ta
l 
T
re
e
 L
e
n
g
th
genes with repeats
genes without repeats
 
 
126 
The preceding analysis, albeit simple and intuitive, can overestimate noise and 
underestimate organ-specific gene expression variation differences. In order to avoid 
these drawbacks, we next took a phylogenetic approach and performed a bootstrap-
like resampling analysis, where gene expression values were sampled from different 
individuals of a species (see Material and methods). We used 1000 bootstrap-like 
replicates in this analysis, each with 13,035 sampled gene expression values. We then 
calculated the expression distance between each species pair separately for genes with 
repeats and without repeats for six different organs. Through this procedure, we 
arrived at 2 different expression distance matrices of (1000 replicates) × (3 species 
pairs) for each organ. We used these matrices to construct neighbor-joining gene 
expression trees. The constructed are thus unrooted trees, which have three branches 
that lead to the human, the chimpanzee, and the macaque lineage. The lengths of these 
branches indicate the amount of expression change that took place in each of the three 
lineages. 
Figure 1A summarizes the ratios of branch lengths in these expression trees for genes 
with repeats relative to genes without repeats. Each bar in each chart corresponds to 
the branch lengths of an organ–specific gene expression tree for the lineage leading to 
this species. Specifically, from left to right, bars reflect gene expression divergence in 
brain (B), cerebellum (C), heart (H), kidney (K), liver (L), and testis (T). Bars 
extending above the horizontal line indicate that genes with repeats show greater 
expression divergence. Except for the macaque branch for liver- and heart-specific 
expression trees, all branches are significantly longer for repeat-containing genes (P < 
10
-10
; based on a t-test with N = 1000, df = N-1, throughout unless otherwise 
mentioned). Figure 1B indicates, separately for each organ, the distribution of total 
 
 
127 
tree length (summed over all three branches) for the 1000 bootstrapped trees. The 
total tree length of genes with repeats is significantly greater in all organs (P < 10
-200 
except for liver, where P = 0.02). This analysis is based on repeats found in human 
genes. An analogous analysis with repeats found in the other two species shows that 
for most organs, genes with repeats have diverged to a significantly greater extent in 
those species as well. Specifically, P < 10
-207
, in chimpanzee except for liver and 
testis, where P-values were non-significant (n.s.); and P < 10
-300
 for macaques, except 
for testis (n.s.) (see supplementary figure S1, Supplementary Material online). Greater 
expression divergence in repeat containing genes persists also when we calculate 
expression distance with other methods (supplementary text S1, figure S2, 
Supplementary Material online) or when we correct for higher expression divergence 
in chimpanzee (supplementary text S2, figure S3, Supplementary Material online). 
Most of our analysis relies on the program Tandem Repeat Finder (Gelfand et al. 
2007). To confirm that our analysis is robust to alternative means of repeat detection, 
we used the algorithm implemented in Phobos 
(http://www.rub.de/spezzoo/cm/cm_phobos.htm) to detect human repeats. This 
analysis also showed that expression trees of genes with tandem repeats have 
significantly longer branches (P < 10
-9
, except for testis (n.s.); see supplementary 
figure S4, Supplementary Material online). 
Gene duplicates with tandem repeats have significantly increased 
expression divergence. 
Gene duplication and subsequent divergence in gene expression is an important 
means of creating genes with new and specialized functions (Conant and Wolfe 2008; 
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Dong et al. 2011; Ganko et al. 2007; Gu et al. 2002; Hanada et al. 2009; Leach et al. 
2007; Li et al. 2005). Because our previous analysis showed that the presence of 
tandem repeats increases expression divergence in general, we wondered whether 
repeats could also be associated with increased expression divergence in duplicate 
genes. To this end, we identified 8531 genes with one or more duplicates in our 
human gene data set (see Material and methods). Because some of these genes had up 
to 10 duplicates (mean number of duplicates: 2.9) the duplicates yielded a data set of 
12,176 gene duplicate pairs. Of these, 48 percent (5879 pairs) had no repeats in their 
promoters, 42 percent (5130) had one or more tandem repeats in one copy, and in the 
remainder (1167) both duplicates had tandem repeats in their promoters. 
We wanted to find out whether gene duplicates with repeats show increased 
expression divergence. To this end, we repeated our bootstrap-like analysis (see 
Material and methods) to generate 1000 replicates of our gene expression data, where 
the gene expression level of each human gene duplicate was sampled from different 
individuals among replicates. We then calculated expression distance matrices of size 
(1000×2) for our three categories of gene duplicates. For each of the six organs, we 
found that gene duplicates where both members carried repeats are much more 
divergent than gene duplicates where no member carried a repeat (P < 10
-261
; see 
Figure 2). Gene pairs where only one member has a repeat showed greater expression 
divergence than gene pairs with no repeats (P < 0.05). 
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Figure 2. Presence of tandem repeats in duplicate genes associate with increased expression divergence. Box 
plot of total tree lengths of gene duplicates without repeats (left-most box in each panel), with repeats in the 
promoter of one duplicate (middle box), in the promoter of both duplicates (right-most box) for (A) brain, (B) 
cerebellum, (C) heart, (D) kidney, (E) liver, (F) testis. Horizontal lines in the middle of each box mark the median. 
The edges of the boxes correspond to the 25th and 75th percentiles. Whiskers cover 99.3 percent of the data points.  
Repeat-containing genes are not under relaxed selection. 
We next wondered whether the higher expression divergence of repeat-containing 
genes was simply due to relaxed selection that these genes experience, which can be 
detected through analysis of sequence divergence in their coding region. To 
investigate this possibility, we decided to use dN/dS, which is the ratio of the number 
of nonsynonymous substitutions per non-synonymous site to the number of 
synonymous substitutions per synonymous site, as an indicator of selective pressure 
acting on a protein-coding gene. We downloaded dN and dS values of the genes in our 
data set with Ensembl’s Biomart tool (Kinsella et al. 2011), and calculated the ratio 
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dN/dS for duplicate genes and single copy genes, and subdivided genes in both 
categories into genes with and without tandem repeats in their promoter. We then 
asked whether repeat-containing genes show a higher dN/dS ratio, and thus evidence 
for relaxed selection, compared to genes without repeats. The answer is no, both for 
single-copy genes (P = 0.57; N = 7912, df= N-1) and for multi-copy genes (P = 0.45; 
N = 5123).  
Association between tandem repeats and expression divergence is not 
dependent on expression level. 
Because gene expression levels may play a role in expression divergence (Lehner 
2008; Macneil and Walhout 2011; Pilpel 2011), we asked whether the association 
between tandem repeats and expression divergence varies with expression level. To 
this end, we distinguished between highly and lowly expressed genes, and chose the 
median expression level of all genes among all individuals in a species (and 
separately for each organ) as a threshold for high and low expression. We then 
followed our previously explained procedure to calculate 24 expression distance 
matrices of size (1000×3). We generated 1000 separate expression trees for genes 
with high and low expression, genes with and without repeats, and expression data 
from each organ, and calculated the total tree lengths for these trees. We then pooled 
tree lengths of different organs and asked whether total tree lengths differentiate to a 
similar extent between genes with repeats and genes without repeats for highly and 
lowly expressed genes. The answer is yes. Tandem repeats associate with expression 
divergence to a similar extent for highly expressed genes, (P < 10
-117
, all organs 
considered together; N = 6000; df = N-1) as they do for lowly expressed genes (P < 
10
-129
, N = 6000). We then computed the pairwise difference in tree lengths between 
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pairs of trees derived from genes with repeats and genes without repeats for both of 
the sets, where two members in each pair of trees were obtained from expression data 
sampled from the same individuals. The mean differences in tree lengths are 
statistically indistinguishable between highly expressed genes (95% confidence 
intervals: 0.0034, 0.0042) and lowly expressed genes (95% CI: 0.0036, 0.0042).   
The association still holds when repeats in CpG-islands are removed. 
CpG islands play an important role in mammalian gene regulation (Saxonov et al. 
2006) and may thus affect gene expression divergence. Because the G+C content 
(supplementary figure S5A, Supplementary Material online) of tandem repeats 
increases for repeats close to the transcription start site, we suspected that the 
association between repeats and increased expression divergence might stem from 
CpG islands. To find out, we first asked if repeats overlap with CpG islands. We 
retrieved experimentally identified CpG island locations from ENCODE (Material et 
al. 2004) and allocated these sites to the promoter sequences of the genes in our data 
set, based on genomic locations of transcription start sites, as reported in the 
GENCODE human alignment (Harrow et al. 2012) (see supplementary figure S5B, 
Supplementary Material online). We found that only 6% (215) of the repeats we 
identified overlap with a CpG island, a fraction that may be too small to influence all 
of the associations we observe. Indeed, when analyzing expression divergence while 
excluding repeats overlapping with CpG islands, we found that the presence of 
repeats is still strongly associated with expression divergence (P < 10
-178
, for all 
organs except for liver, where P < 10
-6
). To compare CpG island-associated repeats 
with other repeats more directly, we pooled tree lengths of different organs and 
computed the pairwise difference between replicates of genes with repeats and genes 
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without repeats. We found that mean differences in tree lengths are statistically 
indistinguishable, when we considered all repeats (95% CI: 0.0098, 0.0110) or only 
non-CpG repeats (95% CI: 0.0098, 0.0120).  Hence, the presence of CpG island 
repeats is not likely to be a confounding factor in our analysis.  
Repeat-associated divergence is even stronger for orthologous repeats. 
Because we use expression values coming from multiple species, we wondered 
whether the association between repeats and expression divergence is stronger for 
orthologous repeats, i.e., for repeats with the same repeat unit that are present in both 
members of an orthologous gene pair. To this end, we first identified those repeats 
where regulatory regions of orthologous gene triplets in all three species contained a 
repeat with the same repeat unit (see Material and methods). However the number of 
such repeats was too small (45) for analysis. We therefore focused in the rest of this 
analysis on 718 orthologous repeats shared only between human and chimpanzee 
genes. 
Figure 3. Orthologous repeats are associated 
more strongly with increased expression 
divergence. Box plot of total tree lengths of 
genes with repeats (thick boxes) and genes 
without orthologous repeats (thin boxes) for 
organ-specific gene expression, as indicated on 
the horizontal axis. Horizontal lines in the 
middle of each box mark the median. The 
edges of the boxes correspond to the 25th and       
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75th percentiles. Whiskers cover 99.3 percent of the data points.   
After constructing expression trees for genes with orthologous repeats and genes 
without orthologous repeats, we calculated total tree lengths for the two gene sets. We 
found that genes with orthologous repeats have significantly higher expression 
divergence than genes without orthologous repeats (P < 10
-350
 for each of the six 
organs; see Figure 3). We then asked whether the association is stronger for 
orthologous repeats than the association for all repeats (including the non-orthologous 
ones). To this end, we pooled tree length data from different organs and computed the 
pairwise difference in tree-length for genes with orthologous repeats and genes 
without orthologous repeats. The mean difference (95% CI: 0.0290, 0.0288) was 
significantly higher than the mean differences computed based on all repeats in 
human (95% CI: 0.0098, 0.0110) or in chimpanzee (95% CI: 0.0083, 0.0087).  
Genes with the highest divergence are two fold more enriched with 
orthologous repeats than genes with lowest divergence. 
We next asked whether genes with especially high expression divergence are 
especially highly enriched with tandem repeats. Our calculation of expression 
divergence so far had depended on tree lengths, which provides divergence 
information only for a set of genes, not for individual genes. For this analysis, it was 
necessary to distinguish individual genes with differential expression. We did so with 
the aid of the R package edgeR (Robinson et al. 2010), which estimates the extent of 
differential regulation of each gene, based on sharing information across the whole 
dataset using an empirical-Bayes-like procedure (Smyth 2004). To increase the 
quality of its divergence estimate, we used an expanded primate expression data set 
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(Brawand et al. 2011) that contains expression values not only from human, 
chimpanzee, and macaque, but also from gorilla and orangutan. We computed the 
extent of differential regulation for each gene in our data set and used the 1000 genes 
with the highest and lowest divergence in each organ for our analysis. In a majority of 
organs, genes with the highest divergence were twofold more enriched with 
orthologous repeats (P < 0.01 except for kidney and testis, where the enrichment was 
not significant.) When repeating our analysis with all repeats (including the non-
orthologous repeats), we did not encounter a significant enrichment in any of the 
organs. 
Repeats closer to the transcription start site show a stronger association 
with expression divergence. 
Next we asked how our results would be affected if we changed the length of the 
upstream regions we consider. We thus identified human genes that contain repeats in 
upstream windows of length 1kbp (2404 genes with repeats), 10kbp (8736), 15kbp 
(10,056), and 20kbp (10,971; 2064 genes without repeats). As in our earlier analyses, 
we constructed expression trees based on repeat-containing and non-repeat-containing 
genes and compared the tree lengths for each window. These tree lengths were 
significantly different for windows of length 1 kbp (P < 10
-226
), 10 kbp (P < 10
-12
, 
except for liver, which shows an opposite trend  with P < 10
-145
), 15 kbp (P < 10
-15
, 
except for liver, which shows an opposite trend with P < 10
-295
) and 20 kbp (t-test; P 
< 10
-58
, except for liver, which shows an opposite trend  with P < 10
-350
; see 
supplementary figure S6, Supplementary Material online). Figure 4 shows the mean 
difference in total expression tree length between repeat-containing and non-repeat-
containing genes, based on 6000 gene expression trees when all organs are considered. 
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The difference is always positive, i.e., repeat-containing genes diverge more rapidly, 
but it is most pronounced for repeats 1kbp upstream of the transcription start site 
(95% CI: 0.0145, 0.0146). The difference gets progressively smaller as we include 
repeats that are further away from the transcription start site (95% CI for windows of 
length 10 kbp: 0.003, 0.006; 15 kbp: 0.0021, 0.0024; 20 kbp: 0.0004, 0.0007). 
Repeats in other genic regions are also associated with increased 
expression divergence. 
Although most transcriptional regulation is exerted by promoters, (Castillo-Davis et al. 
2004; Ganapathi et al. 2007; Leach et al. 2007; Rockman and Wray 2002; Spitz and 
Furlong 2012; Wray et al. 2003a), sequences downstream of the gene, and especially 
3’ untranslated regions (3’ UTRs) can also play an important role in gene regulation. 
We therefore wondered if repeat-containing 3’UTRs are also associated with higher 
expression divergence. To this end, we identified human genes in our data set that 
contained repeats within 1 kb of the 3’ UTR There are 647 such genes, and they show 
significantly greater expression divergence in all organs except the testis (P < 10
-47
, 
for all organs; supplementary figure S7A, Supplementary Material online).  
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Figure 4. Presence of tandem repeats associate with higher expression divergence. Bars present mean 
differences in expression divergence, based on pairwise expression tree length differences between repeat-
containing and non-repeat-containing genes. Repeats found in upstream regions of length 20kbp, 15kbp, 10kbp, 
5kbp, 1 kbp, as well as in 3’UTRs, exons, first introns and all introns were considered, as indicated on the 
horizontal axis. Note that all expression differences are positive, indicating that repeat-containing genes, regardless 
of category, diverge more rapidly. Whiskers represent 95 percent confidence intervals. 
Next we extended our analysis to repeats in exons and introns, because regulatory 
regions can also occur in these sequences (Charron et al. 2007; Gemayel et al. 2010; 
Jonsson et al. 1992; Rohrer and Conley 1998; Stranger et al. 2007a). We identified 
2468 human genes with exon-containing repeats and found that they are associated 
with greater expression divergence in all organs (P < 10
-269
, for all organs; 
supplementary figure S7B, Supplementary Material online). Furthermore, we 
analyzed 1336 human genes with repeats in their first intron, and 9521 genes with 
repeats in at least one intron, regardless of its location. We found that repeats in the 
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first intron are associated with high expression divergence (P < 10
-158
) for all organs 
except for liver, which shows the opposite (P <10
-3
; supplementary figure S7C, 
Supplementary Material online). When we considered repeats found in all introns, 
repeat-containing genes showed again greater expression divergence (P < 10
-198
) for 
all organs except for the heart (P <10
-85
) and the liver (P <10
-292
), both of which show 
opposite patterns (supplementary figure S7D, Supplementary Material online). 
However, the mean difference (95% CI: 0.0026, 0.0034) of tree lengths between 
repeat-containing and non-repeat-containing genes for repeats found in any intron was 
smaller compared to the mean difference for the repeats found in first introns (95% 
CI: 0.0080, 0.0086). Figure 4 illustrates that repeats found in 3’UTRs are associated 
with the strongest expression divergence (95% CI: 0.021, 0.022), followed by repeats 
found in exons (95% CI: 0.0166, 0.0167). 
 
4.4. Discussion 
Previous studies showed that tandem repeats found in various gene locations can 
change gene expression levels (Bennett et al. 1995; Fondon and Garner 2004; 
Hamada et al. 1984; Hammock and Young 2005; Lesch et al. 1996; Streelman and 
Kocher 2002). Here, we extended such analyses of individual genes to thousands of 
genes expressed in several organs of three primate model species, namely macaque, 
chimpanzee and human, and to gene expression divergence on evolutionary time 
scales. We found that the presence of repeats in gene promoters is strongly associated 
with evolutionary gene expression divergence, an observation that is robust to 
changes in the method to identify tandem repeats and to assess gene expression 
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divergence. The association exists for most of all organ-specific expression data, 
except for some analyses in testis and liver. Similar distinct expression patterns in 
these organs have been observed  also by others (Brawand et al. 2011; Hsieh et al. 
2003; Somel et al. 2008) in different contexts.  
 Repeats that are closer to the transcription start site are associated with greater 
expression divergence, an observation that can be explained through core promoter 
modules that occur preferentially close to this site and exert strong influence over 
transcriptional regulation (Spitz and Furlong 2012; Wray et al. 2003a). Moreover, an 
association with expression divergence holds also for repeats in other genic regions 
(Figure 4). The strongest of them is evident for 3’UTRs, consistent with their known 
role in gene regulation (Yoon et al. 2012). In addition, repeats in first introns are 
associated with greater expression divergence than repeats in other introns. This 
observation is consistent with previous work showing that most intronic regulatory 
regions occur in the first intron (Rohrer and Conley 1998), and that the first intron 
influences gene expression more than others  (Charron et al. 2007; Jonsson et al. 
1992). Taken together, our observations suggest an important role for tandem repeats 
in gene expression evolution.  
Tandem repeats in the human genome are perhaps best-known for their pathological 
effects. Examples of diseases caused by variable tandem repeats are numerous and 
include Fragile X Syndrome, Huntington disease and spinobulbar muscular atrophy 
(Gemayel et al. 2010; Pearson et al. 2005a). Our work is consistent with previous 
analyses demonstrating that not all phenotypic variability that tandem repeats confer 
is deleterious, at least on an evolutionary time scale. A compelling example in 
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animals comes from the Runx-2 gene, a major regulator of osteoblast differentiation. 
In human, repeat copy number variation in the promoter and exon of this gene cause 
cleidocranial dysplasia, a syndrome characterized by a variety of craniofacial and 
other skeletal malformations (Lee et al. 1997), whereas repeat variation in the dog 
Runx-2 ortholog is a major source of non-pathological dug skull variation (Fondon 
and Garner 2004).  Non-pathological expression variation associated with repeats has 
also been demonstrated in microbes. Specifically, (Vinces et al. 2009) showed that 
yeast genes with tandem repeats in their promoters have high expression divergence. 
And although a recent study (Elmore et al. 2012) in two different fungal species 
(Aspergillus flavus and Apergillus oryzae) found little evidence for such an 
association, the rarity of tandem repeats in fungal promoters (found in 2 percent of 
gene promoters, as opposed to some 30 percent in primate promoters) may be partly 
responsible.  
Even though no study of associations can prove causation, we analyzed confounding 
factors that might have been at the root of the associations we observe. One of them 
was relaxed selection. Earlier work had detected that an increase in expression 
divergence for genes associated with species-specific transposable elements was 
caused by relaxed selection on those genes, rather than by the transposable elements 
themselves (Warnefors, Pereira, & Eyre-Walker, 2010). To exclude this factor, we 
showed that repeat-containing genes are not subject to relaxed purifying selection on 
their coding sequence. While we cannot exclude with certainty that relaxed selection 
acts only on the expression level of genes, we think this is unlikely, because we also 
analyzed the association between repeat presence and expression divergence in genes 
with high and low expression levels, and found no difference. A second possible 
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confounding factor is the presence of CpG islands, which are known to influence gene 
regulation, and which may cause the association we observed if many such islands 
overlap tandem repeats. However, we found out that this is not the case when we 
removed repeats containing CpG islands from our analysis, and showed that the 
association persists.  
In a seminal paper, King and Wilson (King and Wilson 1975) observed about humans 
and chimpanzees that “their macromolecules are so alike that regulatory mutations 
may account for their biological differences.” Since then, we have learned that such 
mutations, and in particular mutations that cause gene expression change, are indeed 
important in the evolution of primates and other organisms (Dimas et al. 2009; 
Fondon et al. 2008; Gemayel et al. 2010; Stranger et al. 2007a; Stranger et al. 2005; 
Vinces et al. 2009; Wren et al. 2000). Our work shows that tandem repeats and their 
high mutability may be an important class of regulatory mutations that are responsible 
for such species differences. 
 
4.5. Methods 
Gene expression and sequence data  
The gene expression data we used is based on RNA sequencing of ~3.2 billion 76-
base pair-long Illumina Genome Analyser IIx reads (Brawand et al. 2011). Expression 
levels are indicated as log2-transformed reads per kilobase of exon model per million 
mapped reads. It provides one-to-one gene expression measurements from multiple 
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primates, where each genes’ expression had been measured in six different organs 
(brain, cerebellum, heart, kidney, liver, testis) and for 1-6 individuals per species, 
depending on species and organ (Brawand et al. 2011). From this data set, we used 
RNA-seq based expression values of all 13,035 one-to-one gene orthologs from 
humans, chimpanzees and macaques. We obtained DNA sequences of the genes in 
our expression data set through the Biomart tool of Ensemble (Kinsella et al. 2011), 
using human annotation version GRCh37.p10, chimpanzee annotation CHIMP2.1.4, 
and macaque annotation MMUL_1.0. 
Tandem Repeat Identification 
We identified tandem repeats in various regions of the genes we studied. These 
included the promoter (5,000 base pairs [bps] upstream from the transcription start 
site, unless stated otherwise), exons, the first intron, all introns, and the 3’ 
untranslated region (1000 bps downstream from each gene’s stop codon). We 
considered both micro- and minisatellites with tandem repeat units up to 50 
nucleotides in length. Longer repeats are less variable and therefore less likely to 
cause phenotypic divergence (Kelkar et al. 2008; Li et al. 2004; Li et al. 2002; 
O’Dushlaine and Shields 2008; Payseur et al. 2011). We identified repeats with the 
program Tandem Repeat Finder v2.30 (Gelfand et al. 2007). Specifically, we 
analyzed only repeats with Tandem Repeat Finder scores exceeding 80, an incidence 
of indels in adjacent repeat units below 10 percent (e.g., a repeat unit of 20 
nucleotides can have up to two indels relative to the consensus pattern, that is the 
repeat unit most similar to the whole repeat sequence (Gelfand et al. 2007)), and 
sequence identity of adjacent repeat units above 90 percent (e.g., at least 18 
nucleotides of a repeat unit of 20 nucleotides must match the consensus pattern). One 
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motivation for these stringent thresholds is that the variability of tandem repeats 
increases strongly for repeats of high sequence similarity and Tandem Repeat Finder 
Scores (O’Dushlaine and Shields 2008). To validate the robustness of our results to 
the repeat identification process, we used another tool with a higher repeat detection 
power (Schaper et al. 2012), the Phobos 3.3.12 Tandem Repeat Search Tool 
(http://www.rub.de/spezzoo/cm/cm_phobos.htm) with the same match and indel 
criteria for repeat identification.  
Identification of Orthologous Repeats 
In the list of identified repeats based on the above criteria, we designated repeats that 
have the same repeat units and that lie upstream of orthologous genes as orthologous 
repeats. While it is in principle possible that the same orthologues could contain 
different repeats with the same repeat unit, there are only 10 such genes. This means 
that our rate of false positive orthologous repeat detection is very small. We allowed 
positional variation of repeats by up to 250 nucleotides, because promoter sequences 
and thus the position of regulatory elements can show substantial variation due to 
indels, even between closely related species (Hu and Ng 2012).  
Calculation of Expression Divergence 
The gene expression data set we used (Brawand et al. 2011) contains gene expression 
measurements from several individuals of a species for each gene and organ. We took 
advantage of this fact to assess statistical differences in gene expression divergence 
with a bootstrap-like resampling procedure (Brawand et al. 2011), where we sampled 
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gene expression values from different individuals of a species to create 1000 replicate 
data sets (n = 13,035) for each organ, and species.  
We partitioned gene pairs in each such data set into two groups: gene pairs where 
genes of a given species contained tandem repeats in a specific region of interest, such 
as a promoter, and gene pairs without such repeats. We then computed, separately for 
genes in the two groups, a pairwise matrix of Euclidean gene expression distance 
between all genes in a pair of species, based on the formula (Tirosh et al. 2006) 
𝐸𝐷𝑖,𝑗(𝑔) =  √
1
𝐴𝑔
∑ (
𝑥𝑖(𝑔,𝑘)−𝑥𝑗(𝑔,𝑘)
𝑥𝑖(𝑔,𝑘)+𝑥𝑗(𝑔,𝑘)+2
)
2
𝐴𝑔
𝑘=1 , 
where i and j stand for species i and j (e.g. human and chimpanzee), g is a (binary) 
indicator variable reflecting which of two sets of genes (with or without repeats) are 
analyzed, Ag is the number of genes in that set, k is a gene-specific index and x is the 
expression level of a gene. To give an example, 𝑥ℎ𝑢𝑚𝑎𝑛(𝑛𝑜 𝑟𝑒𝑝𝑒𝑎𝑡, 1) is the gene 
expression value of the first gene in the human gene set without repeats for a given 
organ, and EDhuman, macaque (repeat) is the expression distance between repeat-
containing human and macaque gene pairs for a given replicate data set. 
Overall, we created 12 separate expression distance matrices of size (1000×3), for two 
gene subsets based on repeat presence and for six organs. We used these matrices to 
construct gene expression trees using the neighbor-joining approach (implemented in 
the ‘ape’ package (Paradis et al. 2004) in R (http://www.R-project.org/)). We used the 
branch lengths of the trees we constructed as a measure of gene expression divergence. 
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To test the null-hypothesis that the expression divergences (branch lengths) of the 
1000 sampled trees were significantly different between the two gene subsets for each 
organ, we used paired t-tests (N=1000, df = N-1 unless otherwise mentioned). All P 
values are reported after Bonferroni correction (Dunn 1961) for multiple testing and 
they were robust to number of bootstrap replicates. We performed all statistical 
analyses using MATLAB (7.10.0, The MathWorks Inc., Natick, MA, R2010a).  
Identification of Gene Duplicates 
We obtained a list of gene duplicates in our human data set using the Biomart Tool in 
Ensemble (Kinsella et al. 2011). We excluded duplicates that were listed as merely 
“predicted paralogs” (as opposed to bona fide “within-species paralogs”), as well as 
duplicate pairs where the fraction Ka of non-synonymous substitutions per non-
synonymous site exceeded one (Gu et al. 2004; Gu et al. 2003), because their 
divergence cannot be reliably estimated. We then grouped these duplicate pairs into 
three subsets, depending on whether none, one, or both of their member genes 
harbored repeats.  
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4.7. Supplementary Material 
Text S1: The association between tandem repeat presence and expression 
divergence persists for different measures of expression distance.  
In most of our analyses we used Tirosh’s Euclidean distance (Tirosh et al. 2006) as a measure 
of gene expression divergence, because it does not amplify gene expression noise (Glazko 
and Mushegian 2010). Other ways to estimate gene expression distance include Pearson’s 
correlation coefficient (Brawand et al. 2011; Meisel et al. 2012), various test statistics, such as 
that of the Kolmogorov-Smirnov test (Choi and Kim 2008), the t-test (Elmore et al. 2012; Li 
et al. 2010), and the Wilcoxon-Mann-Whitney test (Gu et al. 2004), as well as logarithmically 
transformed expression ratios (Enard et al. 2002). To determine how robust our observations 
are to changes in the divergence measure, we repeated our analysis with several other distance 
measures, including the Spearman’s rank correlation coefficient r, as well as t-statistics and 
log-transformed ratios of expression values, as proposed by (Enard et al. 2002).  
Results of these analyses (Supplementary Figure 4) suggest that the greater expression 
divergence of repeat-containing genes does not depend on the specific distance measure used. 
For example, a t-test of the null hypothesis that expression divergence of genes with repeats 
and genes without repeats are statistically indistinguishable is rejected at P < 10
-85
 for a 
correlation-based distance measure, at P < 10
-350
 for a t-statistic-based distance measure, and 
at P < 10
-350
 for expression ratios, when the tree lengths of different organs are pooled in one 
matrix. Moreover, genes with repeats were significantly more diverged when we analyzed 
expression in different organs separately with a t-statistic-based expression distance (P < 10
-
100
) except for heart (n.s.) and liver (an opposite trend of P < 10
-5
), with a correlation-based 
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approach (P < 10
-3
, for each organ) and with an expression ratio approach (P < 10
-233
, for each 
organ). 
Text S2: The association between tandem repeats and expression 
divergence holds after correction for higher within-species expression 
divergence in chimpanzees.  
Because chimpanzees may have greater within-species expression divergence than humans 
(e.g.,  Warnefors & Eyre-Walker (2012) reported a 2.5-fold difference) our analysis thus far 
may have overestimated the overall extent of expression divergence, especially for those 
genes with already high expression divergence. We therefore decided to repeat our analysis 
while correcting for potential differences in within-species divergences. As a crude estimate 
independent of that by Warnefors & Eyre-Walker (2012) for the expected ratio of gene 
expression divergence between human and chimpanzee, we used the ratio 2Ne/t (Hsieh et al. 
2003), where Ne is the effective population size and t is the time elapsed (in generations) since 
their split. Based on effective population sizes of Ne = 10,000 (Hill 1981)  and Ne = 25,000 for 
humans and chimps, respectively, (Eyre-Walker et al. 2002; Won and Hey 2005), as well as 
on generation times of 30 and 25 years for humans and chimps, respectively,  (Langergraber 
et al. 2012), one would expect a 2.1 fold greater expression divergence for chimpanzees, 
which is similar to the previously observed value of 2.5 (Warnefors and Eyre-Walker 2012). 
Motivated by this analysis, we divided all chimpanzee expression values by 2.5, recalculated 
the expression distances for all species pairs as previously described and recomputed the 
expression trees. Comparison of total tree lengths between genes with repeats and genes 
without repeats suggest that tandem repeats are still associated with higher expression 
divergence (P < 10
-350
, except for liver (n.s.); see Supplementary Figure 3).   
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Figure S1. Expression divergence calculated through non-human repeats. Box plot of total tree lengths 
(vertical axes) of genes with repeats (green) and genes without repeats (orange) constructed based on (A) 
chimpanzee and (B) macaque repeats for organ-specific gene expression trees, as indicated on the horizontal axis. 
Each colored dot represents the length of one among the 1000 replicate gene expression divergence trees. The 
horizontal line in the middle of each box marks the median. The edges of each box correspond to the 25th and 75th 
percentiles. Whiskers cover 99.3 percent of the data points. 
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Figure S2. Expression divergence calculated by other approaches. The horizontal axes show the organs for 
which we constructed organ-specific gene expression trees. The vertical axes show the distribution of total gene 
expression divergence tree lengths of genes with repeats (green) and genes without repeats (orange), constructed 
by gene expression distances calculated from (A) correlation (Spearman’s Rho) (B) t-test statistics (C) logarithm 
of expression ratios (as in (Enard et al. 2002)). Horizontal lines in the middle of each box mark the median. The 
edges of the boxes correspond to the 25th and 75th percentiles. Colored dots present the distribution of tree lengths 
for each of 1000 replicates. Whiskers cover 99.3 percent of the data points. 
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Figure S3. Expression divergence analysis after correction for higher divergence in chimpanzees. The 
horizontal axis shows the organs for which we constructed organ-specific gene expression trees. The vertical axis 
shows the distribution of total gene expression divergence tree lengths of genes with repeats (green) and genes 
without repeats (orange). Horizontal lines in the middle of each box mark the median. The edges of the boxes 
correspond to the 25th and 75th percentiles. Colored dots present the distribution of tree lengths for each of 1000 
replicates. Whiskers cover 99.3 percent of the data points. 
 
 
 
 
 
 
 
155 
 
Figure S4. Expression divergence analysis based on repeats identified by Phobos. The horizontal axis shows 
the organs for which we constructed organ-specific gene expression trees. The vertical axis shows the distribution 
of total gene expression divergence tree lengths for genes with repeats (green) and genes without repeats (orange), 
as identified by Phobos. Horizontal lines in the middle of each box mark the median. The edges of the boxes 
correspond to the 25th and 75th percentiles. Pair of different colored boxes corresponds to the tree lengths of gene 
expression trees for their below specified organ. Colored dots present the distribution of tree lengths for each 1000 
replicate. Whiskers cover 99.3 percent of the data points. 
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Figure S5. Higher G+C content and more CpG sites close to transcription start site. Plot of (A) (G+C) 
content of repeats, calculated as (G+C)/(C+G+A+T) based on the median of sliding windows that are 100 
nucleotides long (B) number of CpG islands frequency (locations retrieved from ENCODE) in upstream regions of 
human genes. 
 
 
 
157 
 
Figure S6. Repeats closer to transcription start site are associated more strongly with expression divergence. 
The horizontal axes show the organs for which we constructed organ-specific gene expression trees. The vertical 
axes show the distribution of total gene expression divergence tree lengths for genes with repeats (green) and 
without repeats (orange), where repeats could occur in upstream regions of length (A) 1kbp  (B) 10kbp  (C) 15kbp  
(D) 20kbp.  Horizontal lines in the middle of each box mark the median. The edges of the boxes correspond to the 
25th and 75th percentiles. Colored dots present the distribution of tree lengths for each of 1000 replicates. 
Whiskers cover 99.3 percent of the data points. 
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Figure S7. Tandem repeats are associated with increased expression divergence. The horizontal axes show the 
organs for which we constructed organ-specific gene expression trees. The vertical axes show the distribution of 
total gene expression divergence tree lengths for genes with repeats (green) and genes without repeats (orange), 
based on repeats found in (A) exons, (B) 3’UTR regions, (C) the first intron of a gene, (D) all introns.  Horizontal 
lines in the middle of each box mark the median. The edges of the boxes correspond to the 25th and 75th 
percentiles. Colored dots present the distribution of tree lengths for each of 1000 replicates. Whiskers cover 99.3 
percent of the data points. 
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5.1. Abstract 
Colorectal cancer is a major contributor to cancer morbidity and mortality. A better 
understanding of tumor-associated molecular alterations is needed to gain insight into 
its carcinogenesis. Tandem repeat variation, a hallmark of colorectal cancer, and its 
effect on cancer phenotype remain so far poorly studied on a genome-wide scale. 
Here we present a systematical analysis of tandem repeat instability in the genomes of 
37 colorectal tumors and their matched normal tissues for the upstream regulatory 
regions of 18,709 genes. We find that 5 percent of tandem repeats vary in copy 
number between tumor and their matched normal genomes, whereas between normal 
genome pairs only 2.7 percent of repeats vary. Furthermore, tumor/normal genome 
pairs show almost twice as much repeat loss or gain as normal genome pairs. We find 
that genes with repeat instability are significantly overexpressed. When we analyze 
well-studied cancer-associated signaling pathways, we find that most pathways are 
significantly enriched for repeat instability in tumor/normal pairs compared to normal 
genome pairs, and genes in these pathways with such unstable repeats are consistently 
overexpressed. Our results suggest an important role for promoter tandem repeat 
instability in differential gene expression of colorectal tumors.  
 
 
 
162 
5.2. Introduction 
Microsatellites, short tandem DNA repeats, are among the most variable loci in the 
human genome, experiencing mutations in the copy number of repeat units at a rate of 
10
−3
 to 10
−7
 per cell division (Legendre et al. 2007; Li et al. 2002). Most mutations 
giving rise to such unstable tandem repeats result from replication slippage that 
escaped the proofreading activity of mismatch repair systems (Schlötterer 2000). 
Repeat instability is associated with disease susceptibility and pathogenesis (Gemayel 
et al. 2010; López Castel et al. 2010; Vilar and Gruber 2010). It is common in many 
cancers, including colorectal, gastric, endometrial, ovarian, and breast cancer (Imai 
and Yamamoto 2008; Woerner et al. 2003). For example, a CAG tri-nucleotide repeat 
associated with prostate cancer has been identified in the first exon of the androgen 
receptor gene. Expansion of this repeat decreases gene expression, and increases 
disease incidence and tumor aggression (Giovannucci et al. 1997). In breast cancer, a 
dinucleotide CA-repeat within the first intron of the epidermal growth factor receptor 
(EGFR) gene correlates with the gene’s transcription levels. Mutant alleles of the 
highly polymorphic 28 base pair long repeat in the downstream region of the proto-
oncogene HRAS1 significantly increases disease susceptibility for many cancers, 
including breast, colon, rectum, urinary, bladder cancer, and leukemia (Krontiris et al. 
1993).  
Colorectal cancer is the third most commonly diagnosed cancer in the world, and the 
second leading cause of cancer-related deaths in western societies (Siegel et al. 2013; 
UK 2014). Despite a large number of studies on colorectal cancer treatment, current 
therapeutic approaches cure only a fraction of patients (Hewish et al. 2010; Vilar and 
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Gruber 2010), which necessitates a better understanding of molecular alterations 
causing carcinogenesis. Colorectal cancers are initiated by several genetic alterations, 
including inactivation of p53, a tumor-suppressor gene mutated in most cancer types 
(Kan et al. 2010) and of the adenomatous polyposis coli (APC) gene, a key member of 
the Wnt signaling pathway (Van Limbergen et al. 2002). Mutations in APC silence 
the gene’s expression, which leads to uncontrolled cell growth (Van Limbergen et al. 
2002). Another gene in the Wnt pathway, Dickkopf-3 (DKK3) helps microvessels to 
feed cancer cells and is expressed only in angiogenic tumors (Zitt et al. 2008).  Like 
the Wnt pathway, mTOR pathway, which regulates cell growth and survival is 
activated in most colorectal cancers (Laplante and Sabatini 2012; Wang and Zhang 
2014). Increased expression levels of mTOR correlate well with cancer stage 
(Alqurashi et al. 2013).  
Several gene expression profiling studies of colorectal adenomas showed that tumors 
with mutations in different genes have distinctive expression patterns (Di Pietro et al. 
2005; Tian et al. 2012). The patterns detected from such large-scale gene expression 
data sets are already being used to stratify tumor subtypes and to predict patient 
survival (Burgess 2013; Nosho et al. 2005). A study on comparability of gene 
expression changes in colorectal cancer, based on data produced in different 
laboratories showed that on average 95 percent of genes show consistent gene 
expression changes between two major subtypes of colorectal cancer, independent of 
the source of the data (Jorissen et al. 2008). The importance of gene expression 
patterns in tumor characterization requires a more complete understanding of the 
kinds of mutations that contribute to tumor-specific gene expression divergence.  
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Colorectal cancers are associated with chromosomal instability and microsatellite 
instability, which are not mutually exclusive (Imai and Yamamoto 2008). 
Microsatellite instability is found in at least 15 percent of sporadic colorectal cancers 
and is the major characteristic of hereditary colorectal cancer (Vilar and Gruber 2010). 
Most of the work on repeat instability in colorectal cancer focuses on variation 
between tumor and matched normal genomes in five marker repeats (Umar et al. 
2004), which captures only a fraction of variation from more than 3 million human 
microsatellite loci (Payseur et al. 2011). To date, there are few studies that focus on 
genome-wide tandem repeat instability in cancers. One such study (McIver et al. 
2014) compared repeat variation in breast cancer exomes with that in healthy tissues. 
Two other studies focused on repeats in colorectal cancer (Di Pietro et al. 2005; 
Woerner et al. 2003), but did not report repeat variation between tumor and healthy 
tissues.  
Regulatory repeat variation in tumors has been poorly studied in the context of gene 
expression alterations. Recent advances in next generation sequencing and accurate 
repeat genotyping algorithms enabled us to investigate repeat variation in tumor 
genomes and their potential consequences on gene expression divergence. Here we 
analyze tandem repeats and repeat variation in 37 colorectal tumors and their matched 
normal genomes in the upstream regulatory regions of 18,709 genes, as well as in a 
smaller subset of genes in known cancer-associated pathways.  
We found a significant enrichment for de novo repeat gain, repeat loss and copy 
number variation between tumor and their matched normal genomes compared to 
normal/normal genome pairs. We observed that genes with repeat instability are 
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overexpressed. Moreover, most well-studied cancer pathways, including the p53 and 
Wnt pathway are significantly enriched in repeat instability and show overexpression 
in those genes with repeat instability.  
 
5.3. Methods 
Genome sequence analysis 
We obtained whole genome sequences of colon and rectal tumors, together with 
matched genomes -- the same individual’s genomic sequences from blood samples -- 
from the controlled access data tier of the Cancer Genome Atlas Data Portal (TCGA, 
https://tcga-data.nci.nih.gov/tcga/). The genome sequence data is based on 3-5X 
coverage Illumina HiSeq2000 sequencing of 80-100 million 2X100 long base pair 
reads, aligned against human genome build #18 (Cancer and Atlas 2012) using the 
indel-compatible software package BWA (bwa-0.5.9rcl (Li 2012)).  
We generated consensus sequences for gene promoters in the tumors and matched 
normal genomes using SAMtools (Li et al. 2009a). Because our previous work on 
human tandem repeats (Bilgin et al. 2014) suggests that the 5,000 base pairs [bps] 
upstream from the transcription start site contain most regulatory signals, we focused 
on this region, and refer to it as the promoter. While generating the consensus 
sequences, we noticed that some genomes contained many more unaligned sequences 
than others. We eliminated genomes, whose promoters contain unaligned nucleotides 
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that comprise more than 10 percent of the whole promoter, which reduced our data set 
to 37 genomes (see Supplementary Table 1, for a list of genomes). After removing 
genes from the data set whose promoter sequences could not be aligned, we focused 
our analysis on the remaining “global” set of 18,709 genes. Apart from analyzing this 
global set, we also performed a more detailed analysis of 375 cancer genes 
(Supplementary Table 2) that fall into five well-studied cancer associated pathways 
(Cancer and Atlas 2012; Fearon 2011; Vogelstein and Kinzler 2004). 
Tandem Repeat Identification  
We used the program Tandem Repeat Finder 4.07b (Gelfand et al. 2007) to identify 
tandem repeats in the consensus promoters. Specifically, we identified repeats with (i) 
Tandem Repeat Finder scores exceeding 80, (ii) an incidence of indels in adjacent 
repeat units below 10 percent (e.g., a repeat unit of 20 nucleotides can have up to two 
indels relative to the consensus pattern, which is the repeat unit most common in the 
whole repeat sequence (Gelfand et al. 2007)), and (iii) a sequence identity of repeat 
units above 90 percent (e.g., at least 18 nucleotides of a repeat unit of 20 nucleotides 
must match the consensus pattern). One motivation for these stringent thresholds is 
that we were most interested in how repeat variation might cause gene expression 
differences, and variation of tandem repeats increases strongly for repeats of high 
sequence similarity and Tandem Repeat Finder Scores (O’Dushlaine and Shields 
2008). We considered both micro- and minisatellites with tandem repeat units up to 
100 nucleotides in length. Longer repeats are more stable and therefore less likely to 
cause expression differences (O’Dushlaine and Shields 2008).  
 
 
167 
Repeat variation 
To compute repeat copy number variation, we first identified repeats that had the 
same repeat units and that occurred upstream of the same genes in each tumor and its 
matched normal genome. We allowed positional variation of repeats up to 50 
nucleotides within a promoter, because indels can cause substantial shifting even 
within a species (Durbin et al. 2010). We then computed the difference in repeat copy 
number between a tumor genome and its matched normal genome for each of these 
repeats. To this end, we computed for each gene its repeat variation between each 
genome pair, to generate an array of size 37. A 0 in those arrays indicates either there 
is no repeat in both gene pairs or the repeat has the same copy number in both genes. 
A value greater than 0 indicates repeat copy number variation between the gene pairs. 
For example, a gene that contains a sequence that is repeated three times in one 
genome and five times in another genome would have repeat variation of 2. Because 
none of the genes we analyzed had more than one repeat that varied in copy number, 
we were able to uniquely assign repeat variation values to genes.  
Gene expression analysis 
The gene expression data we used is based on RNA sequencing of 350-450 base pair-
long Illumina Cluster Station and Genome Analyzer reads by The Cancer Genome 
Atlas (TCGA) Consortium (Cancer and Atlas 2012). The data comprises expression 
levels in reads per kilobase of transcript per million reads mapped (rpkm) for 18,709 
genes in the 37 tumor genomes, whose genomes we analyzed.  
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5.4. Results  
De novo repeat gain and loss are more frequent in tumor/normal genome 
pairs. 
We identified genes with tandem repeats in the 5000 bp upstream from the 
transcription start site of n = 18,709 genes in 37 colorectal tumors and their matched 
normal genomes. We found that a tumor genome has on average 4192 promoters with 
tandem repeats, a number that is very similar to the 4165 promoters with tandem 
repeats in matched normal genomes.  
A mean number of 1043 (±337 s.dev.) of genes in a tumor genome show repeats that 
do not occur in the same gene’s promoter in the matched normal genome, compared 
to a mean number of 1016 (±334 s.dev.) promoter repeats that are specific to normal 
genomes and do not occur in tumor genomes. In total, there are 2059 (±373 s.dev.)  
genes which either lost a repeat or gained a de novo repeat in a tumor compared to 
their matched genes in normal genome. This number is significantly higher than the 
number of such genes with repeat losses or gains within normal genome pairs (1274 
±481 s.dev., Wilcoxon Rank Sum (WRS) test (Mann and Whitney 1947), P < 10
-16
), 
when the 37 normal genomes are paired in all possible (666) combinations (see Figure 
1).  
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Figure 1. Repeat gain and losses are significantly more frequent between tumor and normal genomes. 
Histograms of the number of genes within a normal-normal pair (green bars, left axis, n = 666) and within a tumor-
matched normal pair (orange bars, right axis, n = 37) with repeat gains and losses. A WRS test shows that the two 
distributions are significantly different (P < 10-16). 
Tumors are enriched for repeat copy number variation. 
For those genes where both the tumor and matched normal genomes contain a repeat, 
we next asked how many repeats vary in the copy number of their repeat unit. 
Averaged over all 37 tumor/normal genome pairs, the number of genes with repeat 
variation is 157.6 (±23.7 s.dev.), or approximately 5 percent of all 2916 (±752 s.dev.) 
gene pairs where both members carry a repeat. This number is significantly higher 
than the number of genes with repeat variation between all possible pair combinations 
of normal genomes, which is 80.5 (±18.5 s.dev.) out of 2996.5 (±790 s.dev.) gene 
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pairs, that is ~ 2.7 percent (WRS test, P < 10
-24
, see Figure 2). Overall, we conclude 
that tumor genomes harbor more repeat copy number variation than normal genomes.  
 
Figure 2. Repeat variation is significantly more frequent in tumor genomes. Histograms of proportion of 
genes within a normal-normal genome pair (green bars, left axis, n = 666) and within a tumor-matched normal pair 
(orange bars, right axis, n = 37) with repeat copy number variation. A WRS test shows that tumor genomes contain 
significantly more repeat variation (P < 10-24). 
Genes with repeat instability are significantly overexpressed. 
Gene expression data sometimes provide tumor signatures, i.e. most tumors show 
expression patterns that are unique to their cancer type (Chung et al. 2002). Several 
studies reported gene expression changes due to tandem repeat mutations in gene 
promoters in healthy tissues of various organisms (Fondon et al. 2008; Gemayel et al. 
2010; Vinces et al. 2009). We wondered, whether repeat instability in tumors has an 
effect on gene expression and in what direction they change gene expression. To this 
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end, we identified genes whose promoters contain any of several possible instability 
(de novo repeat gain, repeat loss or copy number variation) in at least one 
tumor/normal genome pair. We found 7258 such genes. Next, we retrieved RNA-seq 
based gene expression data from the Cancer Genome Atlas Data Portal (TCGA) 
(Cancer and Atlas 2012) for these genes in the 37 tumors. We computed for each gene, 
the binary logarithm of the mean expression level for those genes expressed in 
genomes, where the gene has a repeat instability and for the remaining, where the 
gene doesn’t show any such instability. We then compared those mean gene 
expression levels with a Wilcoxon signed rank (WSR) test (Woolson 2008) and found 
that they differ significantly (P < 10
-104
). Moreover, the genes with repeat instability 
were significantly overexpressed (see Figure 3).  
Figure 3. Genes with repeat instability are overexpressed. 
Box plot of binary logarithm of mean expression levels of those 
genes expressed in genomes, where the gene has a repeat 
instability (right box) and for the remaining, where the gene 
doesn’t show any such instability (left box) in at least one of the 
37 tumor/normal genome pairs. Horizontal lines in the middle 
of each box mark the median, edges of boxes correspond to the 
25th and 75th percentiles, and whiskers cover 99.3 percent of 
the data’s range. *** indicates a highly significant difference (P 
< 10-104, n = 7258) between the two data categories based on a 
WSR test. 
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Wnt signaling and p53 pathways show significantly higher repeat 
variation.  
Many unique mutations in a cancer associated signaling pathway have the same 
functional effect on the pathway (Kan et al. 2010; Vogelstein and Kinzler 2004), 
which makes the analysis of entire pathways important to understand tumorigenesis 
(Cancer and Atlas 2012; Dhillon et al. 2007; Fearon 2011; Fresno Vara et al. 2004; 
Logan and Nusse 2004; Vogelstein and Kinzler 2004). We therefore next focused on 
five well-studied signaling pathways that are known to play a central role in 
carcinogenesis: Wnt, TGF beta, MAPK, mTOR, and p53 pathways, (Supplementary 
Table S2; (Cancer and Atlas 2012; Fearon 2011)). We identified 375 genes in these 
five pathways, which we will refer to as cancer genes. We found that, out of these 
375 cancer genes, 126 show repeat instability (de novo repeat gain, repeat loss or 
copy number variation) between at least one tumor and one matched normal genome.  
To find out whether particular cancer pathways are enriched for repeat variation, we 
calculated repeat variation between tumor/normal genome pairs, which is an array of 
size 37 for each cancer gene (see Methods). We then computed the mean of each 
array to arrive at a mean repeat variation value for each cancer gene. Similarly, we 
calculated the mean repeat variation of each cancer gene for 666 normal genome 
pairs. A comparison of these mean repeat variations of genes found in each pathway 
revealed that Wnt signaling and p53 pathways were significantly enriched for variable 
repeats (WSR test, P = 0.007 and 0.04 respectively, after Bonferroni correction, see 
Figure 4). TGF beta, on the other hand, showed no repeat variation either in 
tumor/normal pairs or in normal genome pairs. For MAPK and mTOR pathways, 
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mean repeat variation between tumor and matched normal genomes were both greater 
than mean repeat variation in normal genomes, but not significantly. These findings 
indicate an overall enrichment for variable repeats in most cancer-associated signaling 
pathways. 
 
Figure 4. WNT and p53 pathways are significantly enriched for variable repeats. Bar plot of repeat variation 
for all 375 cancer genes in five cancer pathways averaged over all 37 tumor/normal genome pairs (orange bars) 
and 666 normal genome pairs (green bars). Red star indicates a significant difference based on a WSR test (after 
Bonferroni correction).  
Four out of five cancer pathways are enriched for repeat gain and loss.  
To find out whether particular cancer pathways are enriched for de novo repeat gain 
and repeat loss, we calculated first, for each cancer gene, in how many tumor/normal 
genome pairs it has a gain or loss. We then calculated in how many normal genome 
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pairs genes have a gain or loss. When we compared the proportion of genes with 
repeat gain or loss in each pathway, we found that four out of five pathways in 
tumor/normal genome pairs were enriched for repeat gain or loss compared to normal 
genome pairs. These are the Wnt pathway (WSR test, P = 0.015, after Bonferroni 
correction, see Figure 5), the MAPK pathway (P = 0.01), the mTOR pathway (P < 10
-
7
) and the p53 pathway (P < 10
-7
). Only the TGF beta pathway did not show any 
significant difference.  
 
Figure 5. Most cancer pathways are significantly enriched for repeat repeat gain and loss. Bar plot of 
proportion of genes with repeat gain or loss for all 375 cancer genes in 37 tumor/normal genome pairs (orange 
bars) and in 666 normal genome pairs (green bars). * indicates a significant difference between two data categories 
based on a WSR test (P < 0.05), whereas *** indicates a highly significant difference (P < 10-7 after Bonferroni 
correction). 
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Genes with repeat instability are significantly overexpressed in the Wnt, 
mTOR and p53 pathways.  
In one of the above analyses, we showed that genes with repeat instability have 
significantly increased expression levels. We wondered whether this also holds for 
each individual cancer pathway. We therefore repeated our expression analysis for 
each pathway and for cancer genes with repeat instability. We found that in the Wnt 
(WSR test, P = 0.03, after Bonferroni correction), mTOR (P < 10
-5
), and p53 (P < 10
-
4
) signaling pathways, genes with such instability were significantly overexpressed 
compared to the genes with no such instability, whereas the TGF beta (P = 0.56) and 
the MAPK (P = 0.77) pathways did not show a significant difference (see Figure 6). 
 
Figure 6. Genes with repeat gain, loss or variation are overexpressed in the Wnt, mTOR and p53 pathways. 
Box plot of binary logarithm of mean expression levels of cancer genes expressed in genomes, where the gene has 
a repeat instability (left box in each panel) and for the remaining, where the gene doesn’t show any such instability 
(right box in each panel) in at least one of the 37 tumor/normal genome pairs for the Wnt (n=32, for both boxes), 
TGF beta (n=6), MAPK (n=19), mTOR (n=38) and p53 (n=31) signaling pathways. Horizontal lines in the middle 
of each box mark the median, edges of boxes correspond to the 25th and 75th percentiles, and whiskers cover 99.3 
percent of the data’s range. * indicates a significant difference between two data categories based on a WSR test (P 
< 0.01), whereas *** indicates a highly significant difference (P < 10-4) after Bonferroni correction. 
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5.5. Discussion 
We identified tandem repeat variation between colorectal tumor and healthy tissues in 
promoter regions of 18,709 human genes and their upstream regions, and in a smaller 
set of 375 genes and five signaling pathways associated with cancer. We found 
evidence that tumors are associated with greatly enhanced de novo evolution or loss 
of promoter repeats, as such events were significantly more abundant between tumor 
and matched normal genomes than between normal genome pairs. There were on 
average 2059 repeat gain or loss between tumor/normal genome pairs, whereas 
between normal genomes we found only 1274 gain or loss. We also observed a 
significant enrichment in repeat copy number variation in tumor/normal genome pairs. 
5 percent of the repeats we identified vary in copy number between tumor and their 
matched normal genome, whereas only 2.7 percent of the repeats identified in normal 
genomes showed such copy number variation. Furthermore, genes are significantly 
overexpressed in tumor genomes where they show repeat instability compared to 
tumor genomes where they don’t show any such instability. 
Identification of mutated cancer genes provides insights into the biological processes 
underlying tumorigenesis (Futreal et al. 2004). However, the catalogue of mutated 
genes can be quite diverse and heterogenous even within same type of tumor (Jass 
2007; Kan et al. 2010; Vogelstein and Kinzler 2004), whereas certain pathway 
dysregulations are shared among multiple cancer types (Kan et al. 2010; Van 
Limbergen et al. 2002; Segditsas and Tomlinson 2006; Vogelstein and Kinzler 2004). 
We therefore analyzed five cancer-associated pathways for repeat instability in the 
promoters of pathway-associated genes. One of them is the Wnt signaling pathway, 
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which is commonly implicated in carcinogenesis due to its regulatory role in cell 
proliferation, gene transcription and cell migration (Cancer and Atlas 2012; Logan 
and Nusse 2004). Colorectal cancers of all subtypes almost invariably start with an 
activating mutation in this pathway (Fearon 2011; Sadanandam et al. 2013), causing 
dysregulation of the pathway (Logan and Nusse 2004). Remarkably, we found that 
genes in the Wnt pathway are significantly enriched for repeat instability and genes in 
this pathway with repeat instability are significantly overexpressed. The MAPK (Kan 
et al. 2010) and mTOR (Fresno Vara et al. 2004) pathways, which are often 
hyperactivated in cancer cells, show higher repeat instability in tumor/normal genome 
pairs than in normal genome pairs. Genes with repeat instability are significantly 
overexpressed in the mTOR pathway. Conversely, none of the genes in the TGF beta 
pathway show increased repeat instability or expression alterations that associate with 
repeat instability. This observation is in line with a previous finding (Cancer and Atlas 
2012), which suggests that this pathway is the least divergent pathway between 
colorectal tumors and their matched normal genomes in terms of copy number 
variation and gene expression. The final pathway we analyzed, (p53) plays a crucial 
role in the cell cycle and can initiate cell death (Harris and Levine 2005; Vazquez et al. 
2008). Inactivation of p53 pathway through multiple mutations is an almost universal 
feature of human cancer cells (Grochola et al. 2010; Whibley et al. 2009). In 
agreement with this, we found that genes in the p53 pathway are significantly 
enriched for unstable repeats in tumor/normal pairs compared to normal genome pairs 
and genes with such repeats are significantly overexpressed. 
Overexpression through molecular alterations is a common phenomenon in 
carcinogenesis. For example, in the breast cancer Rac1 gene, a molecular switch to 
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control cell growth is activated through an insertion of 19 codons to its open reading 
frame, which is implicated in disease aggression (Schnelzer et al. 2000). Another 
example comes from lung cancer, where small deletions or substitutions clustered 
around ATP-binding pocket of EGFR, a receptor tyrosine kinase gene, activates the 
tyrosine kinase activity, leading to increased growth factor signaling (Lynch et al. 
2004). Likewise, in basal cell carcinoma, activating mutations in the Smoothened gene 
cause overexpression, which then functions as an oncogene (Xie et al. 1998). 
Among the limitations of our study is that we cannot distinguish between somatic and 
germline mutations. This is relevant, because some mismatch repair genes can 
experience germline mutations that cause colorectal cancer (Vilar and Gruber 2010). 
These germline mutations also play a role in forming different subtypes of colorectal 
cancer, as they trigger accumulation of different sets of somatic mutations throughout 
carcinogenesis (Fearon 2011). However, because 90 percent of cancer mutations are 
somatic (Futreal et al. 2004), this should not be a serious limitation. Second, our 
cancer gene set is unlikely to encompass all genes that may play a role in cancer, 
because we focused on particular, well studied cancer associated pathways. Another 
obstacle of our study is the limited number of genomes we could analyze, and the lack 
of gene expression information in matched normal genomes. Finally, limitations in 
genome alignment quality may cause false detection of repeat copy numbers and this 
may increase apparent repeat variation. Information coming from more and higher 
quality genomes will enable more precise identification of repeat instability and allow 
researchers to associate them better with expression variation in a causative manner. 
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As genetic instability is not only central to pathogenesis but also may underlie the 
development of resistance to chemotherapeutic agents, identification of mutational 
mechanisms responsible for it is an important area of study. We believe that our 
findings will increase the understanding of the molecular basis of genetic instability in 
carcinogenesis, and thereby facilitate the development of more precise and effective 
molecular diagnostic and therapeutic approaches.  
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Genome cancer type 
 
Genome cancer type 
A6_2676 colon 
 
AF_2691 rectum  
A6_2678 colon  
 
AF_2692 rectum 
A6_3807 colon 
 
AG_3574 rectum 
AA_3514 colon  
 
AG_3728 rectum 
AA_3516 colon  
 
AG_3878 rectum 
AA_3529 colon 
 
AG_3887 rectum 
AA_3548 colon 
 
AG_3892 rectum 
AA_3549 colon 
 
AG_3894 rectum 
AA_3555 colon 
 
AG_3909 rectum 
AA_3664 colon 
 
AG_4001 rectum 
AA_3666 colon 
 
AG_4005 rectum 
AA_3861 colon 
 
AG_4007 rectum 
AA_3947 colon 
 
AG_4008 rectum 
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AA_3956 colon 
 
AG_4015 rectum 
AA_3968 colon 
 
AG_A002 rectum 
AA_A00U colon 
 
AG_A00Y rectum 
AA_A00Z colon 
 
AG_A011 rectum 
AA_A01K colon 
 
AG_A032 rectum 
AA_A02R colon 
   
Supplementary Table S1. List of genomes considered in the study. The left column indicates TCGA sequence 
IDs, the right column cancer type (colon or rectal). 
pathway gene pathway gene pathway gene 
Wnt APC2 TGF beta TGFA MAPK JUN 
Wnt APCDD1L TGF beta TGFB1I1 MAPK PDCD4 
Wnt APCDD1 TGF beta TGFB1 MAPK MAPK10 
Wnt APCS TGF beta TGFB2 MAPK MAPK11 
Wnt APC TGF beta TGFB3 MAPK MAPK12 
Wnt WNT10A TGF beta TGFBI MAPK MAPK13 
Wnt WNT10B TGF beta TGFBR1 MAPK MAPK14 
Wnt WNT11 TGF beta TGFBR2 MAPK MAPK15 
Wnt WNT16 TGF beta TGFBR3 MAPK MAPK1 
Wnt WNT1 TGF beta TGFBRAP1 MAPK MAPK3 
Wnt WNT2B TGF beta SMAD1 MAPK MAPK4 
Wnt WNT2 TGF beta SMAD2 MAPK MAPK6 
Wnt WNT3A TGF beta SMAD3 MAPK MAPK7 
Wnt WNT3 TGF beta SMAD4 MAPK MAPK8 
Wnt WNT4 TGF beta SMAD5 MAPK MAPK9 
Wnt WNT5A TGF beta SMAD6 MAPK MAPKAP1 
Wnt WNT5B TGF beta SMAD7 MAPK MAPKBP1 
Wnt WNT6 TGF beta SMAD9 MAPK MAP2K1 
Wnt WNT7A TGF beta TNFRSF1A MAPK MAP2K2 
Wnt WNT7B TGF beta TNFRSF1B MAPK MAP2K3 
Wnt WNT8A TGF beta TNF MAPK MAP2K4 
Wnt WNT8B TGF beta ACVR1B MAPK MAP2K5 
Wnt WNT9A TGF beta ACVR1C MAPK MAP2K6 
Wnt WNT9B TGF beta ACVR1 MAPK MAP2K7 
Wnt CTNNB1 TGF beta ACVR2A MAPK MAP3K10 
Wnt CTNNBL1 TGF beta ACVR2B MAPK MAP3K11 
Wnt AXIN1 TGF beta ACVRL1 MAPK MAP3K12 
Wnt AXIN2 TGF beta BMPR1A MAPK MAP3K13 
Wnt GSK3A TGF beta BMPR1B MAPK MAP3K14 
Wnt GSK3B TGF beta HRAS MAPK MAP3K15 
Wnt BTRC p53 TP53AIP1 MAPK MAP3K1 
Wnt CSNK1A1L p53 TP53BP1 MAPK MAP3K2 
Wnt CSNK1A1 p53 TP53BP2 MAPK MAP3K3 
Wnt CSNK1D p53 TP53I11 MAPK MAP3K4 
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Wnt CSNK1E p53 TP53I13 MAPK MAP3K5 
Wnt CSNK1G1 p53 TP53I3 MAPK MAP3K6 
Wnt CSNK1G2 p53 TP53INP1 MAPK MAP3K7 
Wnt CSNK1G3 p53 TP53INP2 MAPK MAP3K8 
Wnt DVL1 p53 TP53RK MAPK MAP3K9 
Wnt DVL2 p53 TP53TG1 MAPK MAP4K1 
Wnt DVL3 p53 TP53TG3B MAPK MAP4K2 
Wnt TCF12 p53 TP53TG5 MAPK MAP4K3 
Wnt TCF15 p53 TP53 MAPK MAP4K4 
Wnt TCF19 p53 MDM2 MAPK MAP4K5 
Wnt TCF20 p53 ATMIN MAPK MAP4 
Wnt TCF21 p53 ATM MAPK MAP6D1 
Wnt TCF23 p53 CASP10 MAPK MAP6 
Wnt TCF25 p53 CASP12 MAPK MAP7D1 
Wnt TCF3 p53 CASP14 MAPK MAP7D2 
Wnt TCF4 p53 CASP1 MAPK MAP7D3 
Wnt TCF7L1 p53 CASP2 MAPK MAP7 
Wnt TCF7L2 p53 CASP3 MAPK MAP9 
Wnt TCF7 p53 CASP4 MAPK KRAS 
Wnt TCFL5 p53 CASP5 MAPK BRAF 
Wnt TLE1 p53 CASP6 MAPK NRAS 
Wnt TLE2 p53 CASP7 MAPK EGFR 
Wnt TLE3 p53 CASP8 MAPK ERBB2 
Wnt TLE4 p53 CASP9 MAPK ERBB3 
Wnt TLE6 p53 FASLG MAPK ERBB4 
Wnt CREBBP p53 FASN MAPK FGF10 
Wnt EP300 p53 FASTKD1 MAPK FGF11 
Wnt LRP10 p53 FASTKD2 MAPK FGF12 
Wnt LRP11 p53 FASTKD3 MAPK FGF13 
Wnt LRP12 p53 FASTKD5 MAPK FGF14 
Wnt LRP1B p53 FASTK MAPK FGF16 
Wnt LRP1 p53 FAS MAPK FGF17 
Wnt LRP4 p53 CDC20B MAPK FGF18 
Wnt LRP5L p53 CDC20 MAPK FGF19 
Wnt LRP5 p53 CDC23 MAPK FGF1 
Wnt LRP6 p53 CDC25A MAPK FGF20 
Wnt LEF1 p53 CDC25B MAPK FGF21 
Wnt MT1B p53 CDC25C MAPK FGF22 
Wnt NKD1 p53 CDC26 MAPK FGF23 
Wnt NKD2 p53 CDC27 MAPK FGF2 
Wnt DKK1 p53 BAX MAPK FGF3 
Wnt DKK2 p53 NOXA1 MAPK FGF4 
Wnt DKK3 p53 BBC3 MAPK FGF5 
Wnt DKK4 p53 CHEK1 MAPK FGF6 
Wnt CTBP1 p53 CHEK2 MAPK FGF7 
Wnt CTBP2 p53 SIRT1 MAPK FGF8 
 
 
185 
Wnt SFRP1 p53 CDK10 MAPK FGF9 
Wnt SFRP2 p53 CDK11A MAPK FGFR1 
Wnt SFRP4 p53 CDK11B MAPK FGFR2 
Wnt SFRP5 p53 CDK12 MAPK FGFR3 
Wnt RHOA p53 CDK13 MAPK FGFRL1 
Wnt RTKN2 p53 CDK14 MAPK MYC 
Wnt RTKN p53 CDK15 MAPK RAF1 
Wnt CDX2 p53 CDK16 MAPK RASA1 
Wnt FBXW2 p53 CDK17 MAPK RASA2 
mTOR PIP4K2A p53 CDK18 MAPK RASA3 
mTOR PIP4K2B p53 CDK19 MAPK RASA4 
mTOR PIP4K2C p53 CDK1 MAPK RASD1 
mTOR PIP5K1A p53 CDK20 MAPK RASD2 
mTOR PIP5K1B p53 CDK2 MAPK RASEF 
mTOR PIP5K1C p53 CDK3 MAPK RASGEF1A 
mTOR PIP5K1P1 p53 CDK4 MAPK RASGEF1B 
mTOR PIP5KL1 p53 CDK5 MAPK RASGEF1C 
mTOR PIPOX p53 CDK6 MAPK RASGRF1 
mTOR PIPSL p53 CDK7 MAPK RASGRF2 
mTOR PIP p53 CDK8 MAPK RASGRP1 
mTOR PTENP1 p53 CDK9 MAPK RASGRP2 
mTOR PTEN p53 CDKL1 MAPK RASGRP3 
mTOR MTOR p53 CDKL2 MAPK RASGRP4 
mTOR IGF1R p53 CDKL3 MAPK PRKAA1 
mTOR IGF1 p53 CDKL4 MAPK PRKAA2 
mTOR IGF2R p53 CDKL5 MAPK PRKAB1 
mTOR IGF2 p53 CDKN1A MAPK PRKAB2 
mTOR IRS1 p53 CDKN1B MAPK PRKACA 
mTOR IRS2 p53 CDKN1C MAPK PRKACB 
mTOR IRS4 p53 CDKN2A MAPK PRKACG 
mTOR PIK3AP1 p53 CDKN2B MAPK PRKAG1 
mTOR PIK3C2A p53 CDKN2C MAPK PRKAG2 
mTOR PIK3C2B p53 CDKN2D MAPK PRKAG3 
mTOR PIK3C2G p53 CDKN3 
  mTOR PIK3C3 p53 BCL2A1 
  mTOR PIK3CA p53 BCL2L10 
  mTOR PIK3CB p53 BCL2L11 
  mTOR PIK3CD p53 BCL2L12 
  mTOR PIK3CG p53 BCL2L13 
  mTOR PIK3R1 p53 BCL2L14 
  mTOR PIK3R2 p53 BCL2L15 
  mTOR PIK3R3 p53 BCL2L1 
  mTOR PIK3R4 p53 BCL2L2 
  mTOR PIK3R5 p53 BCL2 
  mTOR PIK3R6 p53 CCNE1 
  mTOR PDK1 p53 CCNE2 
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mTOR PDK2 p53 CCND1 
  mTOR PDK3 p53 CCND2 
  mTOR PDK4 p53 CCND3 
  mTOR AKT1 
    mTOR AKT2 
    mTOR AKT3 
    mTOR STK11 
    
Supplementary Table S2. List of genes involved in cancer pathways, indicated with their HUGO (Eyre et al. 
2006) gene IDs and the pathways they are associated with. 
 
